{"AllianceGenome": "3527", "HGNC": "3527", "MIM": "601573", "_id": "2146", "_version": 3, "accession": {"genomic": ["A58329.1", "AACC02000041.1", "AC006323.3", "AC073140.5", "CH471146.2", "CP068271.2", "HF548015.1", "JF939048.1", "NC_000007.14", "NC_060931.1", "NG_032043.1", "U52965.1"], "protein": ["AAC50591.1", "AAC51520.1", "AAH10858.1", "AAS02035.1", "AAS02036.1", "AAS07448.1", "AAS09975.1", "AEA07595.1", "AEN79481.1", "BAD92132.1", "BAG36948.1", "BAG52592.1", "BAH11472.1", "BAH13652.1", "BAH13991.1", "BAH14002.1", "CAA03482.1", "CAA64955.1", "CCO13726.1", "EAL24423.1", "EAL24424.1", "EAW80067.1", "EAW80068.1", "EAW80069.1", "EAW80070.1", "NP_001190176.1", "NP_001190177.1", "NP_001190178.1", "NP_004447.2", "NP_694543.1", "Q15910.2", "WHP70863.1", "WHP70864.1", "WHP70865.1", "WHP70866.1", "WHP70867.1", "WHP70868.1", "WHP70869.1", "WHP70870.1", "WHP70871.1", "WHP70872.1", "WHP70873.1", "WHP70874.1", "XP_005250019.1", "XP_005250020.1", "XP_005250021.1", "XP_011514185.1", "XP_011514187.1", "XP_011514189.1", "XP_011514191.1", "XP_011514192.1", "XP_011514194.1", "XP_011514195.1", "XP_011514196.1", "XP_011514197.1", "XP_011514198.1", "XP_011514201.1", "XP_011514203.1", "XP_016867306.1", "XP_016867308.1", "XP_016867309.1", "XP_047275945.1", "XP_047275946.1", "XP_047275947.1", "XP_047275948.1", "XP_047275949.1", "XP_047275950.1", "XP_047275951.1", "XP_047275952.1", "XP_047275953.1", "XP_047275954.1", "XP_047275955.1", "XP_047275956.1", "XP_047275957.1", "XP_047275958.1", "XP_047275960.1", "XP_047275961.1", "XP_047275962.1", "XP_047275963.1", "XP_047275964.1", "XP_047275965.1", "XP_054213455.1", "XP_054213456.1", "XP_054213457.1", "XP_054213458.1", "XP_054213459.1", "XP_054213460.1", "XP_054213461.1", "XP_054213462.1", "XP_054213463.1", "XP_054213464.1", "XP_054213465.1", "XP_054213466.1", "XP_054213467.1", "XP_054213468.1", "XP_054213469.1", "XP_054213470.1", "XP_054213471.1", "XP_054213472.1", "XP_054213473.1", "XP_054213474.1", "XP_054213475.1", "XP_054213476.1", "XP_054213477.1", "XP_054213478.1", "XP_054213479.1", "XP_054213480.1", "XP_054213481.1", "XP_054213482.1", "XP_054213483.1", "XP_054213484.1", "XP_054213485.1", "XP_054213486.1", "XP_054213487.1", "XP_054213488.1", "XP_054213489.1", "XP_054213490.1", "XP_054213491.1"], "rna": ["AB208895.1", "AK092676.1", "AK293239.1", "AK302216.1", "AK303585.1", "AK303637.1", "AK314291.1", "AY519465.1", "BC010858.2", "BG829016.1", "BM974565.1", "BU953788.1", "CN283479.1", "JF327843.1", "NM_001203247.2", "NM_001203248.2", "NM_001203249.2", "NM_004456.5", "NM_152998.3", "OR019837.1", "OR019838.1", "OR019839.1", "OR019840.1", "OR019841.1", "OR019842.1", "OR019843.1", "OR019844.1", "OR019845.1", "OR019846.1", "OR019847.1", "OR019848.1", "OR020024.1", "OR020025.1", "OR020026.1", "OR020027.1", "OR020029.1", "OR020030.1", "OR020031.1", "OR020032.1", "OR020033.1", "OR020034.1", "OR020035.1", "OR020036.1", "OR020037.1", "OR020038.1", "OR020039.1", "U61145.1", "X95653.1", "XM_005249962.5", "XM_005249963.5", "XM_005249964.5", "XM_011515883.3", "XM_011515885.3", "XM_011515887.4", "XM_011515889.3", "XM_011515890.3", "XM_011515892.3", "XM_011515893.3", "XM_011515894.3", "XM_011515895.3", "XM_011515896.3", "XM_011515899.4", "XM_011515901.4", "XM_017011817.3", "XM_017011819.2", "XM_017011820.3", "XM_047419989.1", "XM_047419990.1", "XM_047419991.1", "XM_047419992.1", "XM_047419993.1", "XM_047419994.1", "XM_047419995.1", "XM_047419996.1", "XM_047419997.1", "XM_047419998.1", "XM_047419999.1", "XM_047420000.1", "XM_047420001.1", "XM_047420002.1", "XM_047420004.1", "XM_047420005.1", "XM_047420006.1", "XM_047420007.1", "XM_047420008.1", "XM_047420009.1", "XM_054357480.1", "XM_054357481.1", "XM_054357482.1", "XM_054357483.1", "XM_054357484.1", "XM_054357485.1", "XM_054357486.1", "XM_054357487.1", "XM_054357488.1", "XM_054357489.1", "XM_054357490.1", "XM_054357491.1", "XM_054357492.1", "XM_054357493.1", "XM_054357494.1", "XM_054357495.1", "XM_054357496.1", "XM_054357497.1", "XM_054357498.1", "XM_054357499.1", "XM_054357500.1", "XM_054357501.1", "XM_054357502.1", "XM_054357503.1", "XM_054357504.1", "XM_054357505.1", "XM_054357506.1", "XM_054357507.1", "XM_054357508.1", "XM_054357509.1", "XM_054357510.1", "XM_054357511.1", "XM_054357512.1", "XM_054357513.1", "XM_054357514.1", "XM_054357515.1", "XM_054357516.1"], "translation": [{"protein": "XP_047275954.1", "rna": "XM_047419998.1"}, {"protein": "XP_016867306.1", "rna": "XM_017011817.3"}, {"protein": "XP_054213462.1", "rna": "XM_054357487.1"}, {"protein": "BAD92132.1", "rna": "AB208895.1"}, {"protein": "XP_054213478.1", "rna": "XM_054357503.1"}, {"protein": "XP_047275950.1", "rna": "XM_047419994.1"}, {"protein": "XP_011514203.1", "rna": "XM_011515901.4"}, {"protein": "XP_011514198.1", "rna": "XM_011515896.3"}, {"protein": "XP_047275948.1", "rna": "XM_047419992.1"}, {"protein": "WHP70873.1", "rna": "OR019847.1"}, {"protein": "XP_047275956.1", "rna": "XM_047420000.1"}, {"protein": "XP_011514191.1", "rna": "XM_011515889.3"}, {"protein": "XP_054213465.1", "rna": "XM_054357490.1"}, {"protein": "XP_054213466.1", "rna": "XM_054357491.1"}, {"protein": "XP_054213456.1", "rna": "XM_054357481.1"}, {"protein": "XP_016867309.1", "rna": "XM_017011820.3"}, {"protein": "XP_054213476.1", "rna": "XM_054357501.1"}, {"protein": "XP_054213482.1", "rna": "XM_054357507.1"}, {"protein": "NP_694543.1", "rna": "NM_152998.3"}, {"protein": "XP_047275953.1", "rna": "XM_047419997.1"}, {"protein": "XP_047275962.1", "rna": "XM_047420006.1"}, {"protein": "XP_054213468.1", "rna": "XM_054357493.1"}, {"protein": "XP_047275946.1", "rna": "XM_047419990.1"}, {"protein": "XP_011514197.1", "rna": "XM_011515895.3"}, {"protein": "XP_054213457.1", "rna": "XM_054357482.1"}, {"protein": "XP_011514185.1", "rna": "XM_011515883.3"}, {"protein": "XP_047275945.1", "rna": "XM_047419989.1"}, {"protein": "XP_054213473.1", "rna": "XM_054357498.1"}, {"protein": "XP_054213491.1", "rna": "XM_054357516.1"}, {"protein": "XP_047275957.1", "rna": "XM_047420001.1"}, {"protein": "XP_054213485.1", "rna": "XM_054357510.1"}, {"protein": "XP_047275960.1", "rna": "XM_047420004.1"}, {"protein": "XP_011514192.1", "rna": "XM_011515890.3"}, {"protein": "XP_011514194.1", "rna": "XM_011515892.3"}, {"protein": "BAG36948.1", "rna": "AK314291.1"}, {"protein": "XP_054213490.1", "rna": "XM_054357515.1"}, {"protein": "XP_011514201.1", "rna": "XM_011515899.4"}, {"protein": "XP_047275958.1", "rna": "XM_047420002.1"}, {"protein": "XP_047275961.1", "rna": "XM_047420005.1"}, {"protein": "WHP70871.1", "rna": "OR019845.1"}, {"protein": "XP_054213475.1", "rna": "XM_054357500.1"}, {"protein": "XP_047275949.1", "rna": "XM_047419993.1"}, {"protein": "XP_054213460.1", "rna": "XM_054357485.1"}, {"protein": "XP_054213484.1", "rna": "XM_054357509.1"}, {"protein": "BAH13991.1", "rna": "AK303585.1"}, {"protein": "XP_005250021.1", "rna": "XM_005249964.5"}, {"protein": "XP_011514189.1", "rna": "XM_011515887.4"}, {"protein": "AEA07595.1", "rna": "JF327843.1"}, {"protein": "WHP70868.1", "rna": "OR019842.1"}, {"protein": "XP_054213487.1", "rna": "XM_054357512.1"}, {"protein": "XP_054213483.1", "rna": "XM_054357508.1"}, {"protein": "XP_054213469.1", "rna": "XM_054357494.1"}, {"protein": "WHP70865.1", "rna": "OR019839.1"}, {"protein": "AAS09975.1", "rna": "AY519465.1"}, {"protein": "BAH11472.1", "rna": "AK293239.1"}, {"protein": "XP_011514195.1", "rna": "XM_011515893.3"}, {"protein": "WHP70872.1", "rna": "OR019846.1"}, {"protein": "XP_054213472.1", "rna": "XM_054357497.1"}, {"protein": "AAC51520.1", "rna": "U61145.1"}, {"protein": "XP_054213480.1", "rna": "XM_054357505.1"}, {"protein": "XP_054213479.1", "rna": "XM_054357504.1"}, {"protein": "WHP70869.1", "rna": "OR019843.1"}, {"protein": "NP_001190177.1", "rna": "NM_001203248.2"}, {"protein": "XP_047275965.1", "rna": "XM_047420009.1"}, {"protein": "WHP70866.1", "rna": "OR019840.1"}, {"protein": "XP_011514187.1", "rna": "XM_011515885.3"}, {"protein": "XP_047275955.1", "rna": "XM_047419999.1"}, {"protein": "WHP70874.1", "rna": "OR019848.1"}, {"protein": "XP_005250020.1", "rna": "XM_005249963.5"}, {"protein": "WHP70867.1", "rna": "OR019841.1"}, {"protein": "XP_054213461.1", "rna": "XM_054357486.1"}, {"protein": "XP_054213464.1", "rna": "XM_054357489.1"}, {"protein": "NP_001190176.1", "rna": "NM_001203247.2"}, {"protein": "NP_001190178.1", "rna": "NM_001203249.2"}, {"protein": "XP_054213455.1", "rna": "XM_054357480.1"}, {"protein": "XP_054213458.1", "rna": "XM_054357483.1"}, {"protein": "XP_047275963.1", "rna": "XM_047420007.1"}, {"protein": "BAH13652.1", "rna": "AK302216.1"}, {"protein": "XP_054213471.1", "rna": "XM_054357496.1"}, {"protein": "XP_005250019.1", "rna": "XM_005249962.5"}, {"protein": "XP_054213489.1", "rna": "XM_054357514.1"}, {"protein": "XP_054213486.1", "rna": "XM_054357511.1"}, {"protein": "WHP70870.1", "rna": "OR019844.1"}, {"protein": "XP_047275952.1", "rna": "XM_047419996.1"}, {"protein": "NP_004447.2", "rna": "NM_004456.5"}, {"protein": "XP_011514196.1", "rna": "XM_011515894.3"}, {"protein": "XP_054213474.1", "rna": "XM_054357499.1"}, {"protein": "CAA64955.1", "rna": "X95653.1"}, {"protein": "XP_054213477.1", "rna": "XM_054357502.1"}, {"protein": "WHP70863.1", "rna": "OR019837.1"}, {"protein": "XP_054213488.1", "rna": "XM_054357513.1"}, {"protein": "BAG52592.1", "rna": "AK092676.1"}, {"protein": "XP_047275947.1", "rna": "XM_047419991.1"}, {"protein": "XP_054213467.1", "rna": "XM_054357492.1"}, {"protein": "XP_054213459.1", "rna": "XM_054357484.1"}, {"protein": "BAH14002.1", "rna": "AK303637.1"}, {"protein": "XP_054213463.1", "rna": "XM_054357488.1"}, {"protein": "XP_054213470.1", "rna": "XM_054357495.1"}, {"protein": "WHP70864.1", "rna": "OR019838.1"}, {"protein": "XP_016867308.1", "rna": "XM_017011819.2"}, {"protein": "XP_047275951.1", "rna": "XM_047419995.1"}, {"protein": "XP_047275964.1", "rna": "XM_047420008.1"}, {"protein": "XP_054213481.1", "rna": "XM_054357506.1"}, {"protein": "AAH10858.1", "rna": "BC010858.2"}]}, "alias": ["ENX-1", "ENX1", "EZH2b", "KMT6", "KMT6A", "WVS", "WVS2"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2022-08-03T16:00:00.000Z", "disease_label": "Weaver syndrome", "gcep": "Intellectual Disability and Autism Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0010193", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5dcf5941-6076-4486-94be-7ba3944abaee-2022-08-03T160000.000Z", "sop": "SOP9"}}, "ec": "2.1.1.356", "ensembl": {"gene": "ENSG00000106462", "protein": ["ENSP00000223193", "ENSP00000320147", "ENSP00000417062", "ENSP00000417377", "ENSP00000417704", "ENSP00000419050", "ENSP00000419711", "ENSP00000419856", "ENSP00000506949", "ENSP00000507503", "ENSP00000508286", "ENSP00000508407"], "transcript": ["ENST00000320356", "ENST00000350995", "ENST00000460911", "ENST00000469631", "ENST00000476773", "ENST00000478654", "ENST00000483012", "ENST00000483967", "ENST00000492143", "ENST00000498186", "ENST00000682263", "ENST00000682317", "ENST00000682401", "ENST00000683292", "ENST00000683293", "ENST00000683744", "ENST00000684300", "ENST00000684400", "ENST00000684436", "ENST00000684510"], "translation": [{"protein": "ENSP00000507503", "rna": "ENST00000683292"}, {"protein": "ENSP00000417377", "rna": "ENST00000492143"}, {"protein": "ENSP00000320147", "rna": "ENST00000320356"}, {"protein": "ENSP00000417062", "rna": "ENST00000478654"}, {"protein": "ENSP00000419711", "rna": "ENST00000460911"}, {"protein": "ENSP00000223193", "rna": "ENST00000350995"}, {"protein": "ENSP00000506949", "rna": "ENST00000683744"}, {"protein": "ENSP00000508286", "rna": "ENST00000682317"}, {"protein": "ENSP00000508407", "rna": "ENST00000684300"}, {"protein": "ENSP00000419050", "rna": "ENST00000476773"}, {"protein": "ENSP00000419856", "rna": "ENST00000483967"}, {"protein": "ENSP00000417704", "rna": "ENST00000483012"}], "type_of_gene": "protein_coding"}, "entrezgene": "2146", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 32.0766503496, "exp_mis": 254.874084967, "exp_syn": 100.411946122, "lof_z": 5.61027559306258, "mis_z": 5.44962202671529, "mu_lof": 2.19570198399e-06, "mu_mis": 2.2361010347e-05, "mu_syn": 8.42616719489e-06, "n_lof": 0.0, "n_mis": 77.0, "n_syn": 101.0, "p_li": 0.999990079045986, "p_null": 1.39275423749753e-13, "p_rec": 9.92095387428438e-06, "syn_z": -0.0363837967451428}, "bp": 2256, "cds_end": 148544390, "cds_start": 148504737, "n_exons": 19, "nonpsych": {"exp_lof": 28.6534698272, "exp_mis": 230.306654049, "exp_syn": 90.5035086584, "lof_z": 5.25703154897934, "mis_z": 5.52736532756564, "mu_lof": 2.19570198399e-06, "mu_mis": 2.2361010347e-05, "mu_syn": 8.42616719489e-06, "n_lof": 0.0, "n_mis": 64.0, "n_syn": 92.0, "p_li": 0.999968837756664, "p_null": 2.759642038078e-12, "p_rec": 3.11622405764732e-05, "syn_z": -0.0990386230001556}, "nontcga": {"exp_lof": 29.4735773147, "exp_mis": 234.447232597, "exp_syn": 92.3420542332, "lof_z": 5.35547128016798, "mis_z": 5.31820270811805, "mu_lof": 2.19570198399e-06, "mu_mis": 2.2361010347e-05, "mu_syn": 8.42616719489e-06, "n_lof": 0.0, "n_mis": 71.0, "n_syn": 95.0, "p_li": 0.999974785320975, "p_null": 1.34823742933108e-12, "p_rec": 2.5214677676396e-05, "syn_z": -0.175133544346149}, "transcript": "ENST00000320356.2"}, "exons": [{"cdsend": 148847298, "cdsstart": 148807645, "chr": "7", "position": [[148807382, 148807706], [148809070, 148809155], [148809309, 148809390], [148810332, 148810414], [148811624, 148811720], [148813958, 148814137], [148814913, 148815039], [148815505, 148815546], [148816683, 148816778], [148817221, 148817391], [148817876, 148818117], [148819595, 148819687], [148826468, 148826632], [148827163, 148827266], [148828739, 148828880], [148829727, 148829848], [148832633, 148832750], [148846469, 148846598], [148847181, 148847305], [148884163, 148884291]], "strand": -1, "transcript": "NM_001203247", "txend": 148884291, "txstart": 148807382}, {"cdsend": 148847298, "cdsstart": 148807645, "chr": "7", "position": [[148807382, 148807706], [148809070, 148809155], [148809309, 148809390], [148810332, 148810414], [148811624, 148811720], [148813958, 148814137], [148814913, 148815039], [148815505, 148815546], [148816683, 148816778], [148817221, 148817391], [148817876, 148818117], [148819595, 148819687], [148826468, 148826632], [148827163, 148827266], [148828739, 148828880], [148829727, 148829848], [148832633, 148832750], [148846496, 148846598], [148847181, 148847305], [148884163, 148884291]], "strand": -1, "transcript": "NM_001203248", "txend": 148884291, "txstart": 148807382}, {"cdsend": 148847298, "cdsstart": 148807645, "chr": "7", "position": [[148807382, 148807706], [148809070, 148809155], [148809309, 148809390], [148810332, 148810414], [148811624, 148811720], [148813958, 148814137], [148815505, 148815546], [148816683, 148816778], [148817221, 148817391], [148817876, 148818117], [148819595, 148819687], [148826468, 148826632], [148827163, 148827266], [148828739, 148828880], [148829727, 148829848], [148832633, 148832750], [148846496, 148846598], [148847181, 148847305], [148883196, 148883485]], "strand": -1, "transcript": "NM_001203249", "txend": 148883485, "txstart": 148807382}, {"cdsend": 148847298, "cdsstart": 148807645, "chr": "7", "position": [[148807382, 148807706], [148809070, 148809155], [148809309, 148809390], [148810332, 148810414], [148811624, 148811720], [148813958, 148814137], [148814913, 148815039], [148815505, 148815546], [148816683, 148816778], [148817221, 148817391], [148817876, 148818117], [148819595, 148819687], [148826453, 148826632], [148827163, 148827266], [148828739, 148828880], [148829727, 148829848], [148832633, 148832750], [148846469, 148846598], [148847181, 148847305], [148884163, 148884291]], "strand": -1, "transcript": "NM_004456", "txend": 148884291, "txstart": 148807382}, {"cdsend": 148847298, "cdsstart": 148807645, "chr": "7", "position": [[148807382, 148807706], [148809070, 148809155], [148809309, 148809390], [148810332, 148810414], [148811624, 148811720], [148813958, 148814137], [148814913, 148815039], [148815505, 148815546], [148816683, 148816778], [148817221, 148817391], [148817876, 148818117], [148819595, 148819687], [148826468, 148826632], [148827163, 148827266], [148828739, 148828880], [148829727, 148829848], [148846469, 148846598], [148847181, 148847305], [148884163, 148884291]], "strand": -1, "transcript": "NM_152998", "txend": 148884291, "txstart": 148807382}], "exons_hg19": [{"cdsend": 148544390, "cdsstart": 148504737, "chr": "7", "position": [[148504474, 148504798], [148506162, 148506247], [148506401, 148506482], [148507424, 148507506], [148508716, 148508812], [148511050, 148511229], [148512005, 148512131], [148512597, 148512638], [148513775, 148513870], [148514313, 148514483], [148514968, 148515209], [148516687, 148516779], [148523560, 148523724], [148524255, 148524358], [148525831, 148525972], [148526819, 148526940], [148529725, 148529842], [148543561, 148543690], [148544273, 148544397], [148581255, 148581383]], "strand": -1, "transcript": "NM_001203247", "txend": 148581383, "txstart": 148504474}, {"cdsend": 148544390, "cdsstart": 148504737, "chr": "7", "position": [[148504474, 148504798], [148506162, 148506247], [148506401, 148506482], [148507424, 148507506], [148508716, 148508812], [148511050, 148511229], [148512005, 148512131], [148512597, 148512638], [148513775, 148513870], [148514313, 148514483], [148514968, 148515209], [148516687, 148516779], [148523560, 148523724], [148524255, 148524358], [148525831, 148525972], [148526819, 148526940], [148529725, 148529842], [148543588, 148543690], [148544273, 148544397], [148581255, 148581383]], "strand": -1, "transcript": "NM_001203248", "txend": 148581383, "txstart": 148504474}, {"cdsend": 148544390, "cdsstart": 148504737, "chr": "7", "position": [[148504474, 148504798], [148506162, 148506247], [148506401, 148506482], [148507424, 148507506], [148508716, 148508812], [148511050, 148511229], [148512597, 148512638], [148513775, 148513870], [148514313, 148514483], [148514968, 148515209], [148516687, 148516779], [148523560, 148523724], [148524255, 148524358], [148525831, 148525972], [148526819, 148526940], [148529725, 148529842], [148543588, 148543690], [148544273, 148544397], [148580288, 148580577]], "strand": -1, "transcript": "NM_001203249", "txend": 148580577, "txstart": 148504474}, {"cdsend": 148544390, "cdsstart": 148504737, "chr": "7", "position": [[148504474, 148504798], [148506162, 148506247], [148506401, 148506482], [148507424, 148507506], [148508716, 148508812], [148511050, 148511229], [148512005, 148512131], [148512597, 148512638], [148513775, 148513870], [148514313, 148514483], [148514968, 148515209], [148516687, 148516779], [148523545, 148523724], [148524255, 148524358], [148525831, 148525972], [148526819, 148526940], [148529725, 148529842], [148543561, 148543690], [148544273, 148544397], [148581255, 148581383]], "strand": -1, "transcript": "NM_004456", "txend": 148581383, "txstart": 148504474}, {"cdsend": 148544390, "cdsstart": 148504737, "chr": "7", "position": [[148504474, 148504798], [148506162, 148506247], [148506401, 148506482], [148507424, 148507506], [148508716, 148508812], [148511050, 148511229], [148512005, 148512131], [148512597, 148512638], [148513775, 148513870], [148514313, 148514483], [148514968, 148515209], [148516687, 148516779], [148523560, 148523724], [148524255, 148524358], [148525831, 148525972], [148526819, 148526940], [148543561, 148543690], [148544273, 148544397], [148581255, 148581383]], "strand": -1, "transcript": "NM_152998", "txend": 148581383, "txstart": 148504474}], "generif": [{"pubmed": 12374981, "text": "is overexpressed in hormone-refractory, metastatic prostate cancer; may be involved in the progression of prostate cancer, as well as being a marker that distinguishes indolent prostate cancer from those at risk of lethal progression"}, {"pubmed": 14500907, "text": "functional role of EZH2 in cancer cell invasion and breast cancer progression"}, {"pubmed": 14532106, "text": "essential for the proliferation of both transformed and non-transformed human cells"}, {"pubmed": 14965441, "text": "deregulated expression of EZH2 is associated with loss of differentiation and development of poorly differentiated breast cancer in humans"}, {"pubmed": 15077161, "text": "Ezh2 competes with HDAC1 in binding to pRb2/p130, disrupting their occupancy on the cyclin A promoter."}, {"pubmed": 15099518, "text": "Different EZH2-containing complexes target methylation of histones or nucleosomal histones"}, {"pubmed": 15208672, "text": "Activated p53 suppresses EZH2 expression, suggesting a further role for p53 in epigenetic regulation and in the maintenance of genetic stability."}, {"pubmed": 15817459, "text": "hDAB2IP gene is a target gene of Ezh2 in prostatic epithelium, which provides an underlying mechanism of the down-regulation of hDAB2IP gene in prostate cancer"}, {"pubmed": 15856046, "text": "The findings of this study indicate that EZH2 mRNA expression was upregulated in human HCC and may play an important role in tumour progression, especially by facilitating portal vein invasion."}, {"pubmed": 15882624, "text": "Results show the existence of the cytosolic Ezh2-containing methyltransferase complex and tie the function of this complex to regulation of actin polymerization in various cell types."}, {"pubmed": 16015586, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16215315, "text": "Deregulated expression of EZH2 is associated with bladder carcinoma."}, {"pubmed": 16224021, "text": "results imply that Akt regulates the methylation activity, through phosphorylation of EZH2, which may contribute to oncogenesis"}, {"pubmed": 16314526, "text": "EZH2 is essential for BMI1 recruitment to the polycomb bodies."}, {"pubmed": 16331887, "text": "A link between EZH2, a regulator of homeotic gene expression, and recombination DNA repair."}, {"pubmed": 16357870, "text": "EZH2 is required for DNA methylation of EZH2-target promoters; results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases"}, {"pubmed": 16361539, "text": "Increased EZH2 expression correlates with oncogenesis of the bladder."}, {"pubmed": 16489070, "text": "Findings indicate an important relationship not only between EZH2 and markers of tumor cell proliferation but also with aggressive disease."}, {"pubmed": 16575874, "text": "A fraction of late-stage tumors contains the gene amplification leading to the overexpression of the EZH2 gene, thus indicating the importance of EZH2 in the progression of prostate cancer"}, {"pubmed": 16717091, "text": "EZH2 is important for the maintenance of circadian rhythms and has a role in the core clockwork mechanism of mammals"}, {"pubmed": 16855786, "text": "We summarize the current knowledge on the function of EZH2 in cancer, with special focus on breast cancer, and propose a link between EZH2, the homologous recombination pathway of DNA repair, and breast tumorigenesis."}, {"pubmed": 16963837, "text": "Advanced cell- & animal imaging, expression profiling, stable siRNA-gene targeting, and TMAs of experimental and clinical samples indicate that activation of the Ezh2 oncogene-associated PcG pathway plays an essential role in metastatic prostate cancer."}, {"pubmed": 17018586, "text": "Review. EZH2 is up-regulated in ductal carcinoma in situ, atypical ductal hyperplasia, and even morphologically normal breast epithelial cells from women who have an increased risk of breast cancer. EZH2 may promote neoplastic conversion."}, {"pubmed": 17134822, "text": "PcG protein EZH2 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer."}, {"pubmed": 17237810, "text": "Our data disclose a hitherto unexplored link between the putative oncogene EZH2 and the tumor suppressor PSP94, and show that MSMB is silenced by EZH2 in advanced prostate cancer cells."}, {"pubmed": 17332078, "text": "Ezh2 has a role in aging of the hematopoietic stem cell system [review]"}, {"pubmed": 17344414, "text": "Study shows that the ability of the oncogene BMI1 to repress the INK4A-ARF locus requires its direct association and is dependent on the continued presence of the EZH2-containing Polycomb-Repressive Complex 2 complex."}, {"pubmed": 17453341, "text": "EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor"}, {"pubmed": 17502350, "text": "These experiments indicated that EZH2 is a dual function transcription regulator with a dynamic activity, and we provide a mechanism for EZH2 in tumorigenesis."}, {"pubmed": 17541304, "text": "APAF-1 methylation is related to transcriptional activity of EZH2 expression in early-stage tumor disease of the bladder."}, {"pubmed": 17545586, "text": "Expressed target cancer genes with minimal DNA methylation have increased transcription during EZH2 knockdown, densely DNA hypermethylated and silenced genes retain their methylation and remain transcriptionally silent."}, {"pubmed": 17596871, "text": "EZH2 plays a key role in hepatocellular carcinoma tumorigenesis, and is a novel therapeutic target."}, {"pubmed": 17640228, "text": "EZH2 protein levels increase incrementally from benign nevi to melanoma, which suggests that EZH2 may play a role in the pathogenesis and progression of melanoma"}, {"pubmed": 17676662, "text": "The comprehensive downstream pathways of EZH2 were determined by proteomic profiling."}, {"pubmed": 17694325, "text": "EZH2 expression levels were correlated to pathological tumor features and outcome in patients with urothelial carcinoma of the bladder."}, {"pubmed": 17804093, "text": "NIPP1 is present in a complex with EED and EZH2 in vivo and has distinct binding sites for these proteins."}, {"pubmed": 17911618, "text": "EZH2 is involved in transcriptional down-regulation of interferon gamma-induced MHC class II transactivator (CIITA) expression in uveal melanoma."}, {"pubmed": 17996646, "text": "ADRB2 inhibition confers cell invasion and transforms benign prostate epithelial cells, whereas ADRB2 overexpression counteracts EZH2-mediated oncogenesis"}, {"pubmed": 18095286, "text": "EZH2 may regulate actin polymerization dynamics and thereby promote prostate cancer cell motility and invasiveness."}, {"pubmed": 18159594, "text": "Data show that EZH2 mRNA expression in circulating epithelial cells represents a promising marker for detecting early metastasis in prostate cancer."}, {"pubmed": 18269588, "text": "EZH2 expression was associated with decreased survival of patients with basal-like phenotype of breast cancer."}, {"pubmed": 18285464, "text": "PHF1 modulates the activity of Ezh2 in favor of the repressive H3K27me3 mark"}, {"pubmed": 18377425, "text": "This study provides into the mechanisms underlying the functional role of EZH2 overexpression in gastric cancer cells and a new modality of regulation of E-cadherin expression in silencing mechanisms of tumor suppressor genes."}, {"pubmed": 18406871, "text": "Overexpression of EZH2 is associated with primary prostate carcinoma"}, {"pubmed": 18430739, "text": "RUNX3 is a target for repression by EZH2 in gastric cancer cells"}, {"pubmed": 18488029, "text": "EZH2 mediates histone H3 lysine 27 trimethylation as a mechanism of tumor-suppressor gene silencing in cancer that is potentially independent of promoter DNA methylation"}, {"pubmed": 18502945, "text": "A direct mediator of long-range intra- and interchromosomal interactions that can regulate transcriptional down-regulation of multiple genes by facilitating physical proximities between distant chromatin regions"}, {"pubmed": 18591938, "text": "overexpression associated with the malignant progression of hepatocellular carcinoma"}, {"pubmed": 18623083, "text": "EZH2 gene plays a role for both the proliferation and the apoptosis resistance of renal cell carcinoma cells"}, {"pubmed": 18628979, "text": "the two PRC2 components SUZ12 and EZH2 are sumoylated in vitro and in vivo"}, {"pubmed": 18637271, "text": "Expression changes in EZH2 are associated with DNA methylation in prostate cancer."}, {"pubmed": 18713946, "text": "MYC stimulates EZH2 expression by repression of its negative regulator miR-26a"}, {"pubmed": 18806826, "text": "Repression of E-cadherin by the polycomb group protein EZH2 in cancer is reported."}, {"pubmed": 18980972, "text": "EZH2 nuclear overexpression contributes to pancreatic cancer cell proliferation."}, {"pubmed": 19008416, "text": "study proposes that the genomic loss of miR-101 in cancer leads to overexpression of EZH2 and concomitant dysregulation of epigenetic pathways, resulting in cancer progression"}, {"pubmed": 19026781, "text": "EZH2 maintains repressive chromatin through different mechanisms."}, {"pubmed": 19047178, "text": "E7 target gene EZH2 is a major determinant for the proliferation of HPV-positive cancer cells and contributes to their apoptotic resistance."}, {"pubmed": 19074885, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19079346, "text": "EZH2 is important in ER-negative breast cancer growth in vivo and in vitro, and BRCA1 is required for the proliferative effects of EZH2"}, {"pubmed": 19099573, "text": "EZH2 overexpression is associated with TP53 mutation in breast cancer."}, {"pubmed": 19258506, "text": "Results confirm that miR-101 directly represses EZH2 and stable EZH2 knockdowns in TCC cell lines create a similar growth suppressive phenotype."}, {"pubmed": 19279403, "text": "Panobinostat treatment depletes EZH2 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells."}, {"pubmed": 19289832, "text": "EZH2 regulated stemness genes such as nerve growth factor receptor (NGFR), as well as genes involved in neuroectodermal and endothelial differentiation (EMP1, EPHB2, GFAP, and GAP43).EZH2 might have a central role in Ewing tumors pathology"}, {"pubmed": 19340297, "text": "study reveals a novel epigenetic mechanism governing CDKN1C repression in breast cancer. As a newly identified EZH2 target with prognostic value, it has implications in patient stratification for cancer therapeutic targeting EZH2-mediated gene repression"}, {"pubmed": 19386347, "text": "Distinct expression of EZH2 in hepatocellular carcinoma is reported."}, {"pubmed": 19564843, "text": "EZH2 may be responsible for the escape from cellular senescence followed by malignant transformation in the gallbladder of pancreaticobiliary maljunction."}, {"pubmed": 19578722, "text": "histone modification including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4 may involve in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation[polycomb repressive complex 2 ]"}, {"pubmed": 19709408, "text": "An increase in EZH2 protein levels is evident in tumors from BRCA1-mutation carriers.  BRCA1-deficient cells are dependent on EZH2, whereas BRCA1-proficient cells are not."}, {"pubmed": 19723877, "text": "EZH2-mediated neoplastic transformation of the normal prostate epithelial cell line benign prostate hyperplasia 1 (BPH1) was confirmed by in vivo tumor growth and in vitro colony formation."}, {"pubmed": 19773751, "text": "increased EZH2 protein expression and Ki-67 expression in >40% of the tumour cells are both associated with an improved relapse-free survival in colon cancer stages II and III, but not so in rectal cancer."}, {"pubmed": 19893569, "text": "Data show that E2F1 induces EZH2 expression, which in turn antagonizes the induction of E2F1 pro-apoptotic target Bim expression."}, {"pubmed": 19901851, "text": "Genetic polymorphisms in the EZH2 gene is associated with lung cancer."}, {"pubmed": 19901851, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19904743, "text": "findings suggest that high expression of EZH2 correlates with tumor aggressiveness and adverse patient outcome in ESCC treated with definitive chemoradiotherapy"}, {"pubmed": 19934278, "text": "Data show that EZH2 is a crucial regulator of GAGE2 expression."}, {"pubmed": 19934320, "text": "Direct transcriptional regulation of c-myc by EZH2 may constitute a novel mechanism underlying GBM CSC maintenance."}, {"pubmed": 19969553, "text": "Omega-3 PUFAs degrade EZH2 via posttranslational mechanisms. EZH2 downregulation by omega-3 PUFAs decreases histone 3 lysine 27 trimethylation activity of EZH2 & upregulation of E-cadherin & IGFBP3, which are known targets of EZH2."}, {"pubmed": 20015867, "text": "Although EZH2 does not influence the basal level of apoptotic activity, its overexpression protects the tumor cells against the proapoptotic action of (-)-epigallocatechin-3-gallate."}, {"pubmed": 20081860, "text": "EZH2 proteins with mutant Tyr641 have reduced enzymatic activity in vitro."}, {"pubmed": 20087897, "text": "There is a strong correlation between EZH2 overexpression and advanced stage, aggressive prostate cancers."}, {"pubmed": 20127006, "text": "EZH2 and BMI-1 are upregulated in osteosarcoma. EZH2 and BMI-1 may be useful targets for cancer immunotherapy of osteosarcoma, although knock-down of EZH2 and BMI-1 could not prevent osteosarcoma growth."}, {"pubmed": 20132185, "text": "high EZH2 expression is associated with tumor cell proliferation and metastasis in gastric cancer."}, {"pubmed": 20306127, "text": "study concludes EZH2 has no prognostic value in breast cancer; high levels of EZH2 are associated with poor outcome to tamoxifen therapy in advanced breast cancer; downregulated EZH2 leads to upregulation of the ER and better response to anti-estrogens"}, {"pubmed": 20369694, "text": "The over-expressions of the EZH2 protein and EZH2 mRNA may play an important role in the pathogenesis and progression of prostate cancer."}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20402834, "text": "PcG protein EZH2 plays an important role in the multi-step process of intestinal-type gastric carcinogenesis."}, {"pubmed": 20478051, "text": "miR-101 targets Ezh2 and decreases the invasiveness of prostate cancer cells"}, {"pubmed": 20478527, "text": "found that ERG disrupts androgen receptor (AR) signaling by inhibiting AR expression, binding to and inhibiting AR activity at gene-specific loci, and inducing repressive epigenetic programs via direct activation of the H3K27 methyltransferase EZH2"}, {"pubmed": 20479932, "text": "The prostate-specific tumor suppressor gene Nkx3.1 was controlled by ERG and ESE3 both directly and through induction of EZH2."}, {"pubmed": 20480530, "text": "EZH2 and STAT6 expressions have significant values in distinguishing clinical stages of colorectal cancer and predicting the prognosis of the patients."}, {"pubmed": 20564407, "text": "High EZH2 expression was correlated with tumor aggressiveness"}, {"pubmed": 20569692, "text": "required for the direct conversion of differentiated cells toward pluripotency"}, {"pubmed": 20573371, "text": "Our study suggests that E-cadherin down-regulation may lead to enhancer of zeste homologue 2-mediated invasion and metastasis."}, {"pubmed": 20601953, "text": "homozygous EZH2 mutations found in individuals with 7q acquired uniparental disomy; monoallelic or biallelic mutations found in myeloid disorders; mutations resulted in premature chain termination or abrogation of histone methyltransferase activity"}, {"pubmed": 20601954, "text": "study reports that EZH2, located at 7q36.1, is frequently targeted in myelodysplastic syndromes (MDS); as EZH2 functions as a histone methyltransferase, abnormal histone modification may contribute to epigenetic deregulation in MDS"}, {"pubmed": 20616235, "text": "findings show that the lincRNA HOTAIR serves as a scaffold for at least two distinct histone modification complexes; A 5' domain of HOTAIR binds polycomb repressive complex 2 (PRC2), whereas a 3' domain of HOTAIR binds the LSD1/CoREST/REST complex"}, {"pubmed": 20684863, "text": "Knock-down of EZH2 inhibited liver metastasis of pancreatic cancer in vivo. EZH2 has a crucial role in tumor growth and liver metastasis of pancreatic cancer."}, {"pubmed": 20686362, "text": "Data suggest that EZH2 could be a potential novel epigenetic target to overcome drug resistance."}, {"pubmed": 20724984, "text": "Mutations in EZH2 is associated with myeloid malignancies."}, {"pubmed": 20736451, "text": "EZH2 is involved in regulating a specific epigenetic program in normal germinal centers, including silencing of antiproliferative genes, which may contribute to the malignant transformation of GC B cells into DLBCLs"}, {"pubmed": 20858097, "text": "Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma."}, {"pubmed": 20863566, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20864510, "text": "Data show that that ANCCA is crucial for proliferation and survival of triple-negative/basal-like cancer cells and that it controls the expression of B-Myb and histone methyltransferase EZH2."}, {"pubmed": 20920340, "text": "Enhancer of zeste homolog 2 (EZH2) has a role in progression of renal cell carcinoma"}, {"pubmed": 20935635, "text": "Blockage of Thr 350 phosphorylation not only diminishes the global effect of EZH2 on gene silencing, it also mitigates EZH2-mediated cell proliferation and migration."}, {"pubmed": 20946108, "text": "The data suggest that EZH2 plays a role in glioma progression"}, {"pubmed": 20952513, "text": "miR-26a functionally antagonizes human breast carcinogenesis by targeting MTDH and EZH2."}, {"pubmed": 21078963, "text": "the malignant phenotype of disease requires the combined activities of a H3K27 monomethylating enzyme (PRC2 containing WT EZH2 or EZH1) together with the mutant PRC2s for augmented conversion of H3K27 to the trimethylated form"}, {"pubmed": 21087793, "text": "EZH2 mutations are not associated with splenic b-cell marginal zone lymphoma."}, {"pubmed": 21115743, "text": "EZH2 is frequently overexpressed in human EOC cells and its overexpression promotes the proliferation and invasion of human EOC cells"}, {"pubmed": 21116854, "text": "These results suggest loss of FOXO1 expression and elevated AURKA/B and EZH2 expression in lesional psoriatic tissues have potential contribution to the development of psoriasis."}, {"pubmed": 21125401, "text": "Overexpression of the EZH2, RING1, and BMI1 genes is common in MDS and indicate poor prognosis. The products of these genes might participate in epigenetic regulation of Myelodysplastic syndromes."}, {"pubmed": 21131960, "text": "Findings define a signalling link between CDK1 and EZH2 that may have an important role in diverse biological processes, including cancer-cell invasion and osteogenic differentiation of mesenchymal stem cells."}, {"pubmed": 21165554, "text": "High expression of EZH2 is associated with P53 alteration and results in squamous cell carcinoma of the esophagus."}, {"pubmed": 21190999, "text": "a disease-associated gain-of-function mutation in a histone methyltransferase, whereby somatic EZH2 Y641 mutations in lymphoma act dominantly to increase, rather than decrease, histone methylation"}, {"pubmed": 21199804, "text": "RalA interaction with the Exo84 but not Sec5 exocyst component was necessary for supporting anchorage-independent growth, whereas RalB interaction with Sec5 but not Exo84 was necessary for inhibition of anchorage-independent growth"}, {"pubmed": 21205084, "text": "EZH2 gene acts as an oncogene in tumorigenesis of ovarian cancer with the possible mechanism to suppress the anti-oncogene p57."}, {"pubmed": 21215703, "text": "EZH2 expression-mediated downregulation of DNA damage repair leads to accumulation of recurrent RAF1 gene amplification in breast tumor initiating cells (BTICs), which activates p-ERK-beta-catenin signaling to promote BTIC expansion."}, {"pubmed": 21216957, "text": "EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling."}, {"pubmed": 21228036, "text": "Data show there was an inverse correlation between the expression level of EZH2 and that of miR-101 or miR-128a, suggesting that the altered expression of the latter miRNAs accounts for the overexpression of the former."}, {"pubmed": 21232178, "text": "SATB1 is a bona fide EZH2 target gene in HeLa cells and the repression of SATB1 by EZH2 may be mediated by trimethylation modification on H3K"}, {"pubmed": 21233829, "text": "EZH2 Y641 mutations are not associated with follicular lymphoma"}, {"pubmed": 21289264, "text": "EZH2 is specifically overexpressed in ATC, and it directly contributes to transcriptional silencing of PAX8 gene and anaplastic thyroid carcinoma differentiation."}, {"pubmed": 21292308, "text": "Enhancer of zeste homolog 2 may play an important role in the regulation of biologic behavior of high-grade neuroendocrine carcinomas."}, {"pubmed": 21297974, "text": "by identifying a pro-angiogenic VEGF/miR-101/EZH2 axis in endothelial cells we provide evidence for a functional link between growth factor-mediated signaling, post-transcriptional silencing, and histone-methylation in the angiogenesis process"}, {"pubmed": 21307773, "text": "Studies indicate that additional mutations in genes which appear to affect the epigenome of MPN patients have been discovered including mutations in TET2, IDH1/ 2, EZH2, and ASXL1."}, {"pubmed": 21321380, "text": "EZH2 has a versatile function in glioblastoma progression and that its overexpression is at least partly due to decreased miR-101 expression."}, {"pubmed": 21325804, "text": "The aim of this study was to investigate the correlation between the expression of EZH 2 with p53 and Ki-67 expression and other clinicopathological parameters in primary breast carcinomas"}, {"pubmed": 21339190, "text": "Elevated EZH2 expression is associated with glioma."}, {"pubmed": 21339759, "text": "Mutations in the EZH2 gene is associated with chronic myelomonocytic leukemia."}, {"pubmed": 21367748, "text": "Aberrations of EZH2 in cancer."}, {"pubmed": 21368858, "text": "The enhancer of zeste homolog 2 protein is associated with a higher risk of relapse in nasopharyngeal carcinoma patients."}, {"pubmed": 21383005, "text": "these findings describe a novel mechanism whereby EZH2 activation during tumor progression represses p21, leading to suppression of cellular senescence and enhanced tumorigenicity."}, {"pubmed": 21396836, "text": "Data indicate that elevated polycomb group protein enhancer of zest homolog 2 (EZH2) protein levels are associated with more aggressive urothelial carcinoma (UC), and may therefore serve as a useful biomarker for UC."}, {"pubmed": 21399615, "text": "EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development."}, {"pubmed": 21399658, "text": "Data show that, in response to IFNalpha, STAT2 is recruited onto the endogenous P2p73 promoter together with the polycomb group protein Ezh2."}, {"pubmed": 21406404, "text": "Results show the mechanism by which EZH2 regulates BRCA1 expression and genomic stability mediated by the PI3K/Akt-1 pathway."}, {"pubmed": 21455215, "text": "6 novel mutations in EZH2 in the primary myelofibrosis & CMML samples in this cohort. All of these mutations were heterozygous mutations, which resulted in a premature stop codon & were distributed along multiple exons."}, {"pubmed": 21499305, "text": "findings demonstrated that MEK-ERK1/2-Elk-1 pathway leads to EZH2 overexpression in breast cancer"}, {"pubmed": 21512140, "text": "Data indicate that EZH2-mediated epigenetic silencing contributes to constitutive activation of Wnt/beta-catenin signaling and consequential proliferation of HCC cells."}, {"pubmed": 21515604, "text": "These data strongly suggest that the chronic inflammatory environment of the RA joint induces EZH2 and thus might cause changes in the epigenetic programmes of SF."}, {"pubmed": 21532618, "text": "A polycomb-mediated repression of rap1GAP was demonstrated that involves EZH2, a histone methyltransferase in head and neck cancers. It was also shown that the loss of miR-101 expression correlates with EZH2 upregulation and rap1GAP downregulation."}, {"pubmed": 21539681, "text": "study finds EZH2 to be highly overexpressed in lung and other cancers, and show that EZH2 is integral to proliferation in cancer cells"}, {"pubmed": 21546904, "text": "EZH2 regulates DNA damage response in p53 wild-type cells mainly through transcriptional repression of FBXO32, which binds to and directs p21 for proteasome-mediated degradation."}, {"pubmed": 21572997, "text": "DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs.("}, {"pubmed": 21609503, "text": "In this review, an overview of the recently reported functions of EZH2 in soft tissue sarcomas is given and the hypothesis that its expression might be involved in soft tissue sarcomagenesis is discussed."}, {"pubmed": 21614565, "text": "EZH2 may be a useful biomarker of long-term metastatic risk in women with familial early-stage breast cancer."}, {"pubmed": 21614903, "text": "High intensity staining for EZH2 expression was associated with higher histologic grade, negative estrogen and progestin receptor expression and positive Ki-67 expression in breast carcinomas."}, {"pubmed": 21629038, "text": "associated with tumor cell proliferation and invasion in cervical cancer"}, {"pubmed": 21659531, "text": "a novel function for CDK1-mediated Ezh2 phosphorylation and provide a mechanism by which Ezh2 protein levels can be regulated in cells."}, {"pubmed": 21685935, "text": "Data suggest a critical role of EZH2 in the control of cell invasionand/or metastasis by forming a co-repressor complex with HDAC1/HDAC2/Snail to repress E-cadherin."}, {"pubmed": 21690062, "text": "The overexpression of EZH2 is correlated to nasopharyngeal carcinoma progression and poor prognosis."}, {"pubmed": 21697275, "text": "High EZH2 is associated with oral cancer development in patients with oral leukoplakia."}, {"pubmed": 21703114, "text": "Depletion of SIRT1 increases the protein stability of EZH2. The regulation of EZH2 protein level by SIRT1 affects the repressive effects of EZH2 on the target gene expression."}, {"pubmed": 21713757, "text": "Results indicate that EZH2 expression status may be used to identify a subset of patients with inflammatory breast cancer who have a relatively worse prognosis."}, {"pubmed": 21715480, "text": "Knockdown of EZH2, the enzyme which is required for trimethyl histone lysine 27 (H3K27me3) synthesis induced up to 40% of the latent HIV proviruses."}, {"pubmed": 21719208, "text": "overexpression of EZH2 and loss of PTEN expression might be closely related to the carcinogenesis, progression, clinical biological behavior, and prognosis of gallbladder adenocarcinoma."}, {"pubmed": 21761357, "text": "Developmental programming of EZH2 is a novel mechanism by which in utero exposure to endocrine disruptors leads to epigenetic regulation of the mammary gland."}, {"pubmed": 21765901, "text": "A possible role of EZH2 for the growth control of colon cancer cells, was investigated."}, {"pubmed": 21769904, "text": "Long noncoding RNA-HEIH was associated with enhancer of zeste homolog 2 (EZH2) and that was required for the repression of EZH2 target genes in hepatocellular carcinoma."}, {"pubmed": 21828135, "text": "Novel UTX, DNMT3A, and EZH2 mutations were found in 8%, 10%, and 5.5% of patients with chronic myelomonocytic leukemia."}, {"pubmed": 21837672, "text": "EZH2 promotes progression and invasion of nonsmall cell lung cancer (NSCLC), and its expression is a novel prognostic biomarker in NSCLC."}, {"pubmed": 21856302, "text": "Data demonstrate that while the Y641C mutation of EZH2 ablates enzymatic activity against unmethylated and monomethylated H3K27, it is superior to wild-type in catalyzing the formation of trimethylated H3K27 from the dimethylated precursor."}, {"pubmed": 21865393, "text": "Correlating with the loss of H3K27me3, human papillomavirus 16 E6/E7-expressing cells exhibited derepression of specific EZH2-, KMD6A-, and BMI1-targeted HOX genes."}, {"pubmed": 21884980, "text": "EZH2 functions as a double-facet molecule in breast cancers, either as a transcriptional activator or repressor of NF-kappaB targets, depending on the cellular context"}, {"pubmed": 21892211, "text": "KLF2 repression has an important role in EZH2 oncogenesis"}, {"pubmed": 21903722, "text": "loss of EZH2-dependent methyltransferase activity in the endometrium is integral to the process of chromatin remodeling that enables the transition from a proliferative to a decidual phenotype in response to differentiation cues."}, {"pubmed": 21914347, "text": "Abnormal expression of Ezh2, Runx3 and caspase-3 is associated with the development and progression of endometrioid adenocarcinoma."}, {"pubmed": 21921040, "text": "study concludes that EZH2 mutations are independently associated with shorter survival in patients with primary myelofibrosis"}, {"pubmed": 21921784, "text": "Malignant rhabdoid tumors express many stem cell-associated transcription factors, which may be regulated by the expression of EZH2 and the Id family of proteins."}, {"pubmed": 21926398, "text": "An EZH2 SNP may be useful to predict clinical outcome in metastatic colorectal cancer patients."}, {"pubmed": 21932133, "text": "EZH2 expression was significantly higher in malignant than benign intraductal papillary mucinous neoplasms of the pancreas (IPMN), indicating that overexpression of EZH2 could promote malignant transformation of IPMN."}, {"pubmed": 21941025, "text": "The results implicate EZH2-driven mechanisms by which Myc may stimulate prostate tumor initiation and disease progression."}, {"pubmed": 21989926, "text": "The current results indicated that EZH2 is an independent prognostic indicator for patients with HNSCC."}, {"pubmed": 22068036, "text": "determined that the tumor suppressors CLU, NGFR, and RUNX3 were also directly repressed by EZH2 like CASZ1 in NB cells"}, {"pubmed": 22161744, "text": "EZH2 plays major roles in the progression of oral tongue squamous cell carcinoma."}, {"pubmed": 22177091, "text": "These data showed that mutations in EZH2 cause Weaver syndrome."}, {"pubmed": 22187039, "text": "address the current understanding of the mechanisms underlying EZH2 regulation alongside the function of EZH2 gene targets that are involved in cancer progression"}, {"pubmed": 22190405, "text": "Our data establish EZH2 mutations as the cause of Weaver syndrome and provide further links between histone modifications and regulation of human growth."}, {"pubmed": 22194861, "text": "EZH2 mutations constitute an additional genetic \"hit\" in many BCL2-rearranged germinal center B cell lymphomas."}, {"pubmed": 22211105, "text": "The contribution of EZH2 and the PRC2 complex in controlling the H3K27 methylation status and subsequent consequences on genomic instability and the cell cycle in breast cancer cells is discussed. [review]"}, {"pubmed": 22222375, "text": "These results strongly suggested that the oncogenic RAS upregulates EZH2 through MEK-ERK signaling, resulted in downregulation of tumor suppressors including RUNX3 in pancreatic carcinogenesis."}, {"pubmed": 22228224, "text": "EZH2 variants were significantly associated with gastric cancer risk."}, {"pubmed": 22235851, "text": "EZH2 mutations seem to be associated with PICALM-MLLT10 positive acute leukaemia."}, {"pubmed": 22237151, "text": "study reports presence of loss-of-function mutations and deletions of the EZH2 and SUZ12 genes, which encode components of the Polycomb repressive complex 2 (PRC2), in 25% of T cell acute lymphoblastic leukemias; study suggesst tumor suppressor role for PRC2 in leukemia and suggest a gnized dynamic interplay between oncogenic NOTCH1 and PRC2"}, {"pubmed": 22266912, "text": "EZH2 mutation is associated with childhood acute myeloid leukemia."}, {"pubmed": 22272343, "text": "Results suggest that EZH2-mediated transcriptional repression of TIMP3 directly leads to activation of MMP-9."}, {"pubmed": 22287205, "text": "High EZH2 expression is associated with medulloblastoma."}, {"pubmed": 22308284, "text": "Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies."}, {"pubmed": 22323599, "text": "Structural modeling of wild type and mutant EZH2 suggested that the A677G mutation acquires the ability to methylate H3K27me2."}, {"pubmed": 22349693, "text": "The emerging picture presents PRC2 as a cooperative multipart machine, intricately outfitted to sense and respond to the local chromatin environment and other cues[review]"}, {"pubmed": 22370893, "text": "Our study demonstrated that EZH2 epigenetically silenced multiple miRNAs that negatively regulate hepatocellular carcinoma metastasis."}, {"pubmed": 22383679, "text": "EZH2 polymorphism and benefit from bevacizumab in colorectal cancer."}, {"pubmed": 22431509, "text": "studies document that deregulation of EZH2 and associated genes leads to the development of mouse, and likely human adult T-cell acute leukemia"}, {"pubmed": 22436627, "text": "Our results show that high enhancer of zeste homolog 2 expression is significantly associated with triple-negative breast cancer and decreased survival"}, {"pubmed": 22442719, "text": "the loss of let-7 mediated increased expression of EZH2 contributes to PCa aggressiveness, which could be attenuated by BR-DIM treatment, and thus BR-DIM is likely to have clinical impact."}, {"pubmed": 22450781, "text": "Deletions and/or microdeletions at both miR-101 genomic loci cause mature miR-101 down-regulation, subsequent EZH2 over-expression and E-cadherin dysfunction, specifically in intestinal-type gastric carcinoma."}, {"pubmed": 22465358, "text": "Data show that pEZH2 was found concentrated in the liver Mallory-Denk bodies (MDB) of alcoholic hepatitis or hepatocellular carcinoma."}, {"pubmed": 22469510, "text": "miR-26a expression inhibited the expression of enhancer of zeste homolog 2 and transactivated downstream target genes, which suggests that EZH2 is a potential target of miR-26a; miR-26a plays an important role as an anti-oncogene in the molecular mechanism of lung cancer"}, {"pubmed": 22505648, "text": "data implicate EZH2 in the regulation of RKIP transcription, suggesting a potential mechanism by which EZH2 promotes tumor progression and metastasis"}, {"pubmed": 22527102, "text": "detailed histological characterization of a large cohort of invasive breast carcinomas from Ghana; a high frequency of basal-like, high grade tumors with squamous differentiation was found; EZH2 overexpression occurs in 42 % of the invasive carcinomas and is associated with basal-like features"}, {"pubmed": 22544210, "text": "High EZH2 expression was noted in 120 of 140 triple negative breast cancers and was not associated with other variables."}, {"pubmed": 22552406, "text": "EZH2 contributes to the progression of lung adenocarcinoma"}, {"pubmed": 22563434, "text": "EZH2 knockdown decreases CIITApIV histone H3K27 trimethylation."}, {"pubmed": 22588437, "text": "results support the possible involvement of EZH2 mRNA overexpression in the development of prostate inflammation, and its new regulatory role in suppressing the expression of some inflammatory network genes"}, {"pubmed": 22593192, "text": "Taken together, our findings indicate that KSHV regulates the host epigenetic modifier EZH2 to promote angiogenesis."}, {"pubmed": 22609199, "text": "these results show nuclear EZH2 as a prognostic marker of worse survival in human RCC, and identify miR-101 as a negative regulator of EZH2 expression and renal cancer cell proliferation."}, {"pubmed": 22659877, "text": "Overexpression of EZH2-bound intronic RNA for the H3K4 methyltransferase gene SMYD3 is concomitant with an increase in EZH2 occupancy throughout the corresponding genomic fragment and is sufficient to reduce levels of the endogenous transcript and protein"}, {"pubmed": 22675170, "text": "Data indicate in primary gastric cancers, EZH2 expression was negatively correlated with p53 pathway activation, suggesting that higher levels of EZH2 may repress p53 activity."}, {"pubmed": 22677129, "text": "Ezh2 inhibits differentiation programs in leukemic stem cells, thereby augmenting their leukemogenic activity."}, {"pubmed": 22696229, "text": "Studies indicate that DAB2IP and EZH2 are inversely expressed in medulloblastoma."}, {"pubmed": 22705924, "text": "Increased EZH2 expression associates with a more undifferentiated and aggressive state in urothelial carcinoma."}, {"pubmed": 22766277, "text": "High expression of EZH2 was associated with poor distant disease-free survival whereas high expression of H3K27me3 was associated with better survival in patients with in breast tumor."}, {"pubmed": 22766604, "text": "Both Bmi1 and EZH2, not each alone, could be potent candidates of new target therapy in esophageal squamous cell carcinoma."}, {"pubmed": 22800347, "text": "EZH2 significantly enhanced the proliferation and invasion of nasopharyngeal carcinoma cells in vitro."}, {"pubmed": 22809481, "text": "EZH2 is a sensitive marker of hepatocellular carcinoma, but its specificity is very low"}, {"pubmed": 22850114, "text": "EZH2 SET domain point mutation A687V, occurring in 1-2% of lymphoma patients, is a gain-of-function mutation that greatly enhances its ability to perform dimethylation relative to wild-type EZH2 and is equally proficient at catalyzing trimethylation."}, {"pubmed": 22855181, "text": "EZH2 may play an important role in the progression and metastasis of lung cancer"}, {"pubmed": 22867052, "text": "MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma."}, {"pubmed": 22869879, "text": "In patients with myelodysplatic syndrome, EZH2 mutation status combinined with the Lower-Risk Prognostic Scoring System identifies 29% of patients with a worse-than-expected prognosis."}, {"pubmed": 22871469, "text": "Overexpression of EZH2, FAK and pFAK correlates with well established pathologic risk factors and may predict a more aggressive biologic behavior in endometrial carcinoma."}, {"pubmed": 22914328, "text": "Interaction of EZH2 with LIMK1 changed the activity of cofilin (a downstream target of LIMK1) towards actin filaments, thereby leading to lower filamentous actin content within these cells."}, {"pubmed": 22930729, "text": "Authors propose the hypermethylation of miR-26a as an alternative pathway of ERG rearrangement-independent EZH2 activation."}, {"pubmed": 22948084, "text": "miR-31 overexpression resulted in down-regulation of EZH2 and a de-repression of its target gene rap1GAP; increased expression of EZH2 was associated with melanoma progression and overall patient survival."}, {"pubmed": 22956625, "text": "data suggest that EZH2 is overexpressed in B-ALL and promotes the progression of B-ALL by directly mediating the inactivation of tumor suppressor genes p21 and PTEN"}, {"pubmed": 22972404, "text": "results demonstrate EZH2 expression in nasopharyngeal carcinoma is directly and negatively regulated by let-7a; let-7a is downregulated in nasopharyngeal carcinoma cells resulting in increased EZH2 expression leading to enhanced proliferation and inhibition of apoptosis"}, {"pubmed": 22986524, "text": "Our findings reveal a novel role for EZH2 in controlling basal-like breast cancer differentiation state and intra-tumoral cell composition."}, {"pubmed": 22992977, "text": "study demonstrated that the Ezh2 gene is highly expressed in glioma cells and the downregulation of Ezh2 expression induces apoptosis through the mitochondrial pathway by regulating the Bcl-2/Bax family in glioma cells"}, {"pubmed": 22994729, "text": "The average overall survival and disease-free survival of patients with both EZH2 and H3K27me3 expression was 18.8 and 12.9 months, respectively."}, {"pubmed": 23001607, "text": "EZH2 has roles in cancer through its interactions with non-coding RNA [review]"}, {"pubmed": 23063525, "text": "The enhancer of zeste homolog 2 (EZH2) methyltransferase has distinct substrate specificities for histone H3K27 and nonhistones exemplified by an orphan nuclear receptor, RORalpha."}, {"pubmed": 23077658, "text": "Collectively these data suggest that EZH2 drives glioma invasiveness via transcriptional control of AXL independent of histone or DNA methylation."}, {"pubmed": 23095338, "text": "Report association of EZH2 staining with actinic keratosis and squamous cell carcinoma of the skin."}, {"pubmed": 23099237, "text": "EZH2 mutations might predict an increased risk of transformation to acute myeloid leukemia."}, {"pubmed": 23116973, "text": "Integrin alpha2 is identified to be a novel EZH2 target by chromatin immunoprecipitation and short hairpin RNA analysis."}, {"pubmed": 23121604, "text": "EZH2 is a useful prognostic marker for aggressive behavior of clearb cell renal carcinoma and may be applicable as a therapeutic target molecule."}, {"pubmed": 23135913, "text": "MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase."}, {"pubmed": 23159737, "text": "The EZH2-MMSET-histone methylase axis coordinately functions as a master regulator of transcriptional repression, activation, and oncogenesis."}, {"pubmed": 23163606, "text": "Overexpression of EZH2 may be associated with malignant behaviour in intraductal papillary neoplasm of the bile duct in parallel with up-regulated MUC1 expression and down-regulated MUC6 expression."}, {"pubmed": 23190500, "text": "Overexpression of EZH2 is associated with atypical rhabdoid teratoid tumor."}, {"pubmed": 23228130, "text": "The complex PRAME/EZH2 is able to repress TRAIL expression, in a cancer-specific manner; inhibition of PRAME/EZH2 releases apoptosis-mediating TRAIL. (Review)"}, {"pubmed": 23239736, "text": "the oncogenic function of EZH2 in cells of castration-resistant prostate cancer is independent of its role as a transcriptional repressor. Instead, it involves the ability of EZH2 to act as a coactivator for critical transcription factors including the androgen receptor."}, {"pubmed": 23283488, "text": "EZH2 as a critical mediator of cancer stem cell maintenance in breast and pancreatic tumor cell lines."}, {"pubmed": 23289480, "text": "EZH2 is overexpressed in nasopharyngeal cancer and reduces expression of p16(INK4a) by influencing DNA methylation."}, {"pubmed": 23291714, "text": "EZH2 plays a role in the development of multidrug resistance in hepatocellular carcinoma cells."}, {"pubmed": 23294722, "text": "Both EZH2 and RUNX3 may play important roles in the development and progression of RCC, and the detection on EZH2 and RUNX3 expressions will be helpful for early diagnosis and prognosis prediction of RCC."}, {"pubmed": 23300840, "text": "EZH2 mRNA levels may serve as a prognostic predictor for patients with non-small cell lung cancer."}, {"pubmed": 23343715, "text": "The knockdown of EZH2 phenocopied the tumor suppressive effects of miR-138 in cell models, whereas ectopic expression of EZH2 rescued the suppressive effects of miR-138."}, {"pubmed": 23354591, "text": "Long non-coding RNA H19 is associated with enhancer of zeste homolog 2 (EZH2)"}, {"pubmed": 23361872, "text": "EZH2 point mutation is associated with B-cell non-Hodgkin lymphomas."}, {"pubmed": 23395645, "text": "EZH2 is up-regulated in PDAC samples from patients and silences miR-218. MicroRNA-218 prevents proliferation of PDAC cells in culture, and tumor growth and metastasis in nude mice."}, {"pubmed": 23421437, "text": "These results revealed a novel therapeutic mechanism underlying sorafenib treatment in suppressing hepatoma growth and survival by accelerating EZH2 degradation."}, {"pubmed": 23438432, "text": "this study demonstrated that ANCR is associated with enhancer of zeste homolog 2 (EZH2) and that this association results in the inhibition of both Runx2 expression and subsequent osteoblast differentiation."}, {"pubmed": 23486531, "text": "EZH2 mutations were characterized by decreased H3K27 trimethylation and increased chromatin relaxation at specific gene loci accompanied by higher transcriptional activity"}, {"pubmed": 23523787, "text": "EZH2 can modulate the transcription of basally expressed hMLH1 (human mutL homolog 1 gene) via a non-DNA-methylation-dependent pathway, but it has no effect on hMLH1 silencing that is mediated by DNA hypermethylation."}, {"pubmed": 23526793, "text": "Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke"}, {"pubmed": 23529930, "text": "Our study uncovers an oncogenic role of EZH2 independent of its methyltransferase activity in natural killer T-cell lymphoma."}, {"pubmed": 23538750, "text": "findings represent a novel promising approach for silencing MYC-miRNA-EZH2 amplification loop for combinatorial therapy of aggressive B-cell lymphomas"}, {"pubmed": 23539298, "text": "EZH2 role in breast cancer metastasis"}, {"pubmed": 23557329, "text": "miR-101 and Ezh2 are key players in UVB-induced senescence of human diploid fibroblasts."}, {"pubmed": 23562851, "text": "EZH2 is highly expressed in the human hepatic multidrug-resistant cancer cell line Bel/Fu"}, {"pubmed": 23592277, "text": "NSD1 mutations that cause Sotos syndrome are loss-of-function, primarily truncating mutations or missense mutations at key residues in functional domains. EZH2 mutations that cause Weaver syndrome are primarily missense variants"}, {"pubmed": 23603558, "text": "EZH2 has a role in regulation of p21 and mutant p53 involved in growth of ovarian cancer"}, {"pubmed": 23613835, "text": "these results showed EZH2 mutation in de novo acute myeloid leukemia as a recurrent genetic abnormality to be associated with lower blast percentage in bone marrow and -7/del(7q)."}, {"pubmed": 23624935, "text": "BRCA1 deficiency blocks embryonic stem (ES) cell differentiation and enhances breast cancer migration and invasion in an EZH2-dependent manner."}, {"pubmed": 23636686, "text": "This review therefore provides a comprehensive overview of EZH2 in the context of prostate cancer."}, {"pubmed": 23636867, "text": "As a solitary marker, EZH2 exhibited a sensitivity of 90% and a specificity of 100% (P < 0.0001). EZH2 functioned as a unique and accurate marker of malignancy in this series of effusions."}, {"pubmed": 23677067, "text": "FEZF2 acted as a histone deacetylase-associated repressor downregulating multiple oncogenes including EZH2 and MDM2, through direct binding to their promoters."}, {"pubmed": 23684459, "text": "EZH2 binds to and methylates STAT3, leading to enhanced STAT3 activity by increased tyrosine phosphorylation of STAT3."}, {"pubmed": 23707559, "text": "EZH2-mediated signal loop, EZH2-CDK4/6-pRb-E2F1, is probably involved in GBM tumorigenicity, and this loop can be blocked by miRNA-138"}, {"pubmed": 23739676, "text": "EZH2 is essential for prostate cancer stem cell growth."}, {"pubmed": 23759589, "text": "In EZH2 wild-type solid tumors, the ECM tumor microenvironment plays an important role in determining sensitivity to EZH2 inhibition."}, {"pubmed": 23759596, "text": "ALDH1 within the DCIS lesion can add to the prognostic significance of EZH2, particularly in the context of risk of development of invasive disease."}, {"pubmed": 23792601, "text": "EZH2 Overexpression is associated with endometrial Cancer."}, {"pubmed": 23803132, "text": "there was no evidence of EZH2 mutations in the 55 cases of chronic myeloid leukemia Blast Crisis analyzed.  the EZH2 mutations might not involved in the leukemogenesis of CML and the progression from CMLCP to CML-BC."}, {"pubmed": 23815091, "text": "MiR-144 downregulation relieves miR-144-mediated repression of EZH2, which results in activation of Wnt/b-catenin signaling and subsequent cell proliferation."}, {"pubmed": 23826380, "text": "Study suggests a mechanism for EZH2-H3K27me3 epigenetic repression of DLC1 and multilayered regulation of DLC1/Rho/ROCK signaling by EZH2, and advocated the significant pro-metastatic role of EZH2 via repressing tumor and metastasis suppressors."}, {"pubmed": 23857401, "text": "findings present evidence for the role of EZH2 in the regulation of cell cycle and apoptosis, providing a biological mechanism to explain the tumorigenicity of EZH2 in small-cell lung cancers"}, {"pubmed": 23874688, "text": "GSK3beta inactivation may account for EZH2 overexpression and subsequent tumour progression, and this mechanism might be a potential target for nasopharyngeal carcinoma therapy."}, {"pubmed": 23887863, "text": "EZH2 upregulation correlated with lymph node metastasis in cholangiocarcinoma."}, {"pubmed": 23893242, "text": "SAFB1 formed a complex with the histone methyltransferase EZH2."}, {"pubmed": 23907130, "text": "Therapeutic targeting of EZH2 activity might serve as a strategy for improving conventional chemotherapy in a given malignancy."}, {"pubmed": 23918806, "text": "Data indicate a critical role played by EZH2 in determining the cancer phenotype."}, {"pubmed": 23948956, "text": "in aggressive lymphoma variants, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2."}, {"pubmed": 23949225, "text": "CXXC4 is a novel potential tumor suppressor directly regulated by EZH2, and its expression is a significant prognosis factor for patients with early stages of gastric cancer."}, {"pubmed": 23962556, "text": "Data indicate that miR-101 overexpression downregulates microphthalmia-associated transcription factor (MITF) and enhancer of zeste homolog 2 (EZH2) protein in melanoma cells."}, {"pubmed": 23967231, "text": "Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer."}, {"pubmed": 24018208, "text": "these data imply that Sp1 and EZH2 may activate LMX1A expression upon oncogenic stress during cervical cancer development."}, {"pubmed": 24032713, "text": "In prostate epithelial cells, overexpression of DeltaS2 PRLR increased the levels of EZH2 methyltransferase mRNA and protein, induced EZH2 methyltransferase recruitment to chromatin, leading to decreased expression of the p53 gene."}, {"pubmed": 24040354, "text": "rs6950683 and rs3757441 polymorphic genotypes of EZH2 might contribute to the prediction of susceptibility to and pathological development of hepatocellular carcinoma"}, {"pubmed": 24052547, "text": "Data suggest that the high incidence of EZH2 mutations in follicular lymphoma (FL) and their stability during disease progression makes FL an appropriate disease to evaluate EZH2 targeted therapy."}, {"pubmed": 24055345, "text": "Data indicate that PAF-EZH2-beta-catenin complex hyperactivates Wnt signaling."}, {"pubmed": 24074410, "text": "Downregulation of mutant p53 with concomitant enhanced expression of p21(waf1/cip1) and its transcriptional trans-activators may contribute toward EZH2-mediated suppression of pancreatic ductal adenocarcinoma."}, {"pubmed": 24077223, "text": "These findings support a model in which PRC2's promiscuous binding to RNA transcripts allows it to scan for target genes that have escaped repression, thus leading to maintenance of the repressed state."}, {"pubmed": 24079712, "text": "EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers"}, {"pubmed": 24079759, "text": "EZH2 expression is associated with increased metastatic potential and a worse clinical outcome."}, {"pubmed": 24097338, "text": "review examines the role of EZH2 in normal and malignant hematopoiesis and recent developments in harnessing the therapeutic potential of EZH2 inhibition"}, {"pubmed": 24097870, "text": "In lung, EZH2 expression is involved in early pathogenesis of squamous cell carcinomas."}, {"pubmed": 24107828, "text": "EZH2 is involved in the long-term silencing of HOX genes in MCL, and allude to its potential as a therapeutic target with clinical impact."}, {"pubmed": 24122997, "text": "P53 alteration may be involved in dysregulated EZH2 expression, and aberrant expression of EZH2 may play a role in carcinogenesis of oral squamous cell carcinoma."}, {"pubmed": 24123378, "text": "Both Ezh2 and Kdm6a were shown to affect expression of master regulatory genes involved in adipogenesis and osteogenesis."}, {"pubmed": 24132606, "text": "EZH2 accelerates cancer cell migration, in part, via the repression of TIMP-3 expression."}, {"pubmed": 24132643, "text": "we report that the EZH2-miR-30d-KPNB1 signalling pathway is critical for malignant peripheral nerve sheath tumour cell survival in vitro and tumourigenicity in vivo"}, {"pubmed": 24139839, "text": "time that the combination of Bmi1 and EZH2 overexpression may be a highly sensitive marker for the prognosis in glioma patients."}, {"pubmed": 24211739, "text": "There was a negative correlation between expression levels of miR-101 and EZH2"}, {"pubmed": 24212330, "text": "Cancer-associated fibroblasts enhance the migration ability of ovarian cancer cells partly by increasing EZH2 expression."}, {"pubmed": 24213577, "text": "EZH2 is a key factor in the proliferation and survival of PAX3-FOXO1 alveolar RMS cells working, at least in part, by repressing FBXO32"}, {"pubmed": 24214728, "text": "As mutation testing becomes increasingly accessible and larger numbers of EZH2 mutation-positive individuals are identified, knowledge of the clinical spectrum and prognostic implications of EZH2 mutations should improve."}, {"pubmed": 24218139, "text": "In a patient cohort of myelodysplastic disorders, EZH2 mutations were found and often coincided with tet methylcytosine dioxygenase 2 (TET2) mutations."}, {"pubmed": 24266940, "text": "High EZH2 expression was associated with a high nuclear grade in invasive lobular carcinoma of the breast."}, {"pubmed": 24289559, "text": "Overexpression of EZH2 attenuated the Triptolide induced cell growth inhibition."}, {"pubmed": 24292603, "text": "To our knowledge EZH2 gene amplification presents the first genetic aberration common to parathyroid adenomas, secondary hyperplastic parathyroid glands, and parathyroid carcinomas."}, {"pubmed": 24312307, "text": "prognostic value of EZH2 expression and activity in renal cell carcinoma"}, {"pubmed": 24320048, "text": "EZH2-EED is necessary and sufficient for binding to the lncRNA HOTAIR."}, {"pubmed": 24335192, "text": "The expression of BRCA1 is modulated by EZH2 in epithelial ovarian cancer and BRCA1 is required for the effects of EZH2 downregulation on biological behaviors of tumor cells."}, {"pubmed": 24339737, "text": "Knockdown of EZH2 increased the ubiquitination level of H2BK120."}, {"pubmed": 24344012, "text": "In aneuploid tumors, EZH2 expression and paxillin expression correlate with more aggressive phenotype of breast cancer."}, {"pubmed": 24346863, "text": "High EZH2 expression is associated with colorectal cancer."}, {"pubmed": 24349473, "text": "By integrating our WES and CN data we identified three mutated putative candidate genes targeted by 7q deletions (CUL1, EZH2 and FLNC), with FLNC positioned within the well-characterized 7q minimally deleted region."}, {"pubmed": 24351808, "text": "The drop in EZH2 is inversely correlated with: (i) lipid accumulation; (ii) the expression of pro-inflammatory markers including TNF-alpha and TGF-beta; and (iii) the expression of miR-200b and miR-155."}, {"pubmed": 24367611, "text": "protein interactions within the PRC2 complex modulate the trajectory of the post-SET and I-SET domains of EZH2 in favor of a catalytically competent conformation"}, {"pubmed": 24367637, "text": "disease-associated mutations and putative mechanism of autoinhibition revealed by X-ray crystallographic analysis of the EZH2-SET domain"}, {"pubmed": 24389103, "text": "Ezh2 and G9a/GLP share an important number of common genomic targets, encoding developmental and neuronal regulators."}, {"pubmed": 24403021, "text": "the interaction of lncRNAs with signaling pathways in gliomas is discussed systematically, with particular emphasis on the interaction of lncRNAs with EZH2"}, {"pubmed": 24406044, "text": "MiR-138 is a tumor-suppressor miRNA in ccRCC that induces SN-12 cell senescence by downregulating EZH2 expression and upregulating P16 expression."}, {"pubmed": 24413452, "text": "EZH2 expression increases incrementally from normal skin to actinic keratosis and further to squamous cell carcinoma, suggesting a role for EZH2 in the progression and differentiation of SCC."}, {"pubmed": 24424512, "text": "EZH2 acts as an oncogene and plays an important role in oral squamous cell carcinoma metastasis and inhibition of apoptosis."}, {"pubmed": 24429498, "text": "Loss of EZH2 is associated with myeloid neoplasms."}, {"pubmed": 24446035, "text": "high EZH2 expression is significantly associated with adverse prognostic factors and shorter metastasis-free and cancer-specific survival in patients with upper urinary tract carcinoma."}, {"pubmed": 24469040, "text": "beta-TrCP has an important role in controlling H3K27 trimethylation activity and lymphoma pathogenesis by targeting EZH2 for degradation."}, {"pubmed": 24469045, "text": "By challenging the role of EZH2 in aberrant gene silencing in cancer, these findings have therapeutical implications, notably for the choice of epigenetic drugs for tumors with multiple regional epigenetic alterations."}, {"pubmed": 24474760, "text": "study not only uncovers a functional posttranslational modification of EZH2 but also reveals a unique epigenetic role of OGT in regulating histone methylation"}, {"pubmed": 24487593, "text": "Immunostaining for EZH2 and p16(INK4a) may be useful for differential diagnosis among cholangiolocellular carcinomas, bile duct adenomas, and ductular reactions."}, {"pubmed": 24488618, "text": "EZH2 polymorphisms are associated with colorectal cancer."}, {"pubmed": 24499724, "text": "MYC, in concert with EZH2, epigenetically attenuates MST1 expression and suggest that the loss of MST1/Hippo functions is critical for the MYC or EZH2 mediation of cancer cell survival."}, {"pubmed": 24501407, "text": "Short-chain fatty acids from periodontal pathogens suppress EZH2, and SUV39H1 to promote Kaposi's sarcoma-associated herpesvirus replication."}, {"pubmed": 24516139, "text": "EZH2 acts as an activator of the NOTCH1 promoter and signaling to expand the stem cell pool, leading to accelerated breast cancer initiation and growth."}, {"pubmed": 24588771, "text": "Data suggest that EZH2 depletion promotes the progression of senescence by mediating the activation of tumor suppressor genes p21 and p16."}, {"pubmed": 24608043, "text": "Role of C9orf140 in the promotion of colorectal cancer progression and mechanisms of its upregulation via activation of STAT5, beta-catenin and EZH2."}, {"pubmed": 24612037, "text": "EZH2 plays a crucial role to maintain mixed lineage leukemia fusion leukemia through inhibition of p16."}, {"pubmed": 24612432, "text": "EZH2 may contribute to RCC progression and is a potential therapeutic target for advanced Renal Cell Carcinoma (RCC)."}, {"pubmed": 24634383, "text": "EZH2 mutation is associated with follicular lymphomas."}, {"pubmed": 24652950, "text": "G9a- and EZH2-mediated histone hypermethylation."}, {"pubmed": 24658854, "text": "study indicate that miR-124 can suppress gastric cancer cell growth by directly targeting the EZH2 gene and sensitize the treatment effect of 5-FU."}, {"pubmed": 24671995, "text": "The epigenetic regulators CDYL and EZH2 to dendrite morphogenesis and might shed new light on our understanding of the regulation of the neurodevelopment."}, {"pubmed": 24691023, "text": "The rs6950683 SNPs of EZH2 might contribute to the prediction of UCC susceptibility. This is the first study to provide insight into risk factors associated with EZH2 variants in carcinogenesis of UCC in Taiwan."}, {"pubmed": 24705718, "text": "Our meta-analysis confirmed the view that EZH2 expression might participate in the development of gastric carcinogenesis"}, {"pubmed": 24738879, "text": "EZH2 depletion promoted DOX-induced cell senescence and apoptosis in gastric cancer cells with mutant p53, but had almost no cooperative effect in cells with wild-type p53."}, {"pubmed": 24739462, "text": "study shows IKKalpha restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiation"}, {"pubmed": 24745014, "text": "This study clearly demonstrates that modulation of EZH2 expression with siRNA affects the cell cycle and the expression levels of p53 and p21, thereby changing cyclin B1 and Cdc2 expression and inducing G2/M arrest."}, {"pubmed": 24771265, "text": "Our findings suggest that EZH2-specific microRNA-98 can effectively inhibit cell proliferation in vitro and regulate the pRb-E2F pathway in human ovarian cancer"}, {"pubmed": 24798718, "text": "EZH2 is a prognostic factor for locally advanced/metastatic pancreatic ductal adenocarcinoma, while candidate polymorphisms cannot predict clinical outcome"}, {"pubmed": 24804542, "text": "TET1 suppresses cancer formation by coupling DNA demethylation with DNA-PK activation of p53 and suppression of oncogenic protein EZH2."}, {"pubmed": 24807198, "text": "Data showed that miR-101 was downregulated and its target EZH2 was upregulated in retinoblastoma tissues and ther expression is significantly associated with adverse clinicopathological and histopathological features."}, {"pubmed": 24813658, "text": "The expression profiling revealed in the more aggressive diseases (i.e. occurrence of metastases; persistent disease; disease-related death) a significant increase of EZH2 and SMYD3 gene expression."}, {"pubmed": 24845612, "text": "hyper-expression of the EZH2 correlates closely with the poor prognosis of hepatocellular carcinoma patients"}, {"pubmed": 24850841, "text": "EZH2 depletion decreases the malignant potential of lung adenocarcinoma and sensitivity of the cells to both platinum-based and VEGFR-2-targeted therapy."}, {"pubmed": 24857928, "text": "EZH2 mutation is associated with germinal center lymphomas."}, {"pubmed": 24878960, "text": "overexpression of Ezh2 mRNA with a 3'-untranslated region (3'-UTR) lacking a functional miR-124 binding site, but not with the wild-type Ezh2 3'-UTR, hampered neuronal and promoted astrocyte-specific differentiation"}, {"pubmed": 24916103, "text": "EZH2 occupancy coincides with trimethylation of histone H3 lysine 27 at E2F1 and NOTCH2 promoters."}, {"pubmed": 24928441, "text": "EZH2 binds to the promoter of Nrf2, where it increases H3K27me3 and represses Nrf2 expression"}, {"pubmed": 24953053, "text": "Ezh2 loss significantly promotes RUNX1S291fs-induced myelodysplastic syndrome but prevents the transformation of acute myeloid leukaemia."}, {"pubmed": 24967960, "text": "SPRY4-IT1 repression has an important role in EZH2 oncogenesis."}, {"pubmed": 24986100, "text": "EZH2 correlates positively with VEGF and associates with adverse clinicopathologic characteristics and shorter survival time in clear cell renal cell carcinoma patients"}, {"pubmed": 25005166, "text": "Upregulated EZH2 expression may contribute to the progression of patients with colorectal cancer through cell proliferation and migration."}, {"pubmed": 25007342, "text": "lncRNA-EBIC is an oncogenic lncRNA, which can promote tumor cell invasion in cervical cancer by binding to EZH2 and inhibiting E-cadherin expression."}, {"pubmed": 25017254, "text": "Study demonstrated that high levels of EZH2 expression predicted poor prognosis in luminal-subtype breast cancer patients. Importantly, EZH2 and HIF-1alpha co-overexpression predicted poorer overall survival."}, {"pubmed": 25017995, "text": "autoregulatory feedback loop of EZH2/miR-200c/E2F3 served an important function in prostate cancer development"}, {"pubmed": 25025074, "text": "Both tumor cells and cancer-associated fibroblasts express EZH2 which then contributes to the malignant grade of serous ovarian tumor"}, {"pubmed": 25032847, "text": "Hypermethylated HAND1 has a minimum enrichment of EZH2-H3K27me3 in cancer cells."}, {"pubmed": 25036033, "text": "EZH2 SNP 626 - 394T > C was observed to be associated with susceptibility of esophageal squamous cell carcinoma."}, {"pubmed": 25043748, "text": "EZH2 is not a mandatory H3K27 methyltransferase."}, {"pubmed": 25046371, "text": "EZH2 regulates the biology of gliomas by controlling of different pathways; Knockdown of EZH2 alters expression of apoptosis associated-genes and reduces transcription of AXL receptor kinase in gliomas"}, {"pubmed": 25047840, "text": "Results show that EZH2 is required for increased binding of HP1alpha to H3 tails."}, {"pubmed": 25051981, "text": "EZH2 correlates with locoregional recurrence in inflammatory breast cancer patients who received radiation treatment."}, {"pubmed": 25055869, "text": "EZH2 is recruited to reactivated FMR1 alleles in Fragile X syndrome in response to FMR1 transcription."}, {"pubmed": 25064842, "text": "EZH2 can activate MAPK signaling by inhibiting CXXC4 expression."}, {"pubmed": 25077680, "text": "EZH2-''induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in epithelial ovarian cancer"}, {"pubmed": 25084021, "text": "EZH2-mediated p27Kip1 downregulation is associated with the accelerated cell proliferation and malignant step in pancreatic IPMN."}, {"pubmed": 25085702, "text": "These results suggest that miR-214 may induce pathologic cardiac hypertrophy in part by reducing EZH2 messenger RNA levels."}, {"pubmed": 25088689, "text": "Data indicate that histone methyltransferase EZH2 is transcriptionally regulated by estradiol in vitro and in vivo."}, {"pubmed": 25115397, "text": "Data indicate a PRC2 dependent mechanism in ID4 promoter silencing in prostate cancer through recruitment of EZH2 and a corresponding increase in H3K27Me3."}, {"pubmed": 25131810, "text": "EZH2 overexpression is related to a poor prognosis of CLL and could be a useful tool to assess its aggressiveness."}, {"pubmed": 25154026, "text": "show that coupling of EZH@ with the wild-type enzyme is needed to achieve H3K27me3 for several mutants, but that others are capable of achieving H3K27me3 on their own"}, {"pubmed": 25159232, "text": "low EZH2 expression might be a useful predictive factor of good tumor response to Neoadjuvant chemoradiotherapy in locally advanced rectal cancer"}, {"pubmed": 25189741, "text": "EZH2 modulates angiogenesis in vitro and in a mouse model of limb ischemia."}, {"pubmed": 25190211, "text": "Results indicate that miR-101 may act as a tumor suppressor in osteosarcoma, as it has a suppressive role in cell migration and invasion by targeting EZH2."}, {"pubmed": 25193989, "text": "In addition to EZH2 mRNA levels, these results suggest that protein expression of EZH2 can be used as a marker to predict outcome to tamoxifen therapy."}, {"pubmed": 25225797, "text": "the KDM2B/let-7b/EZH2 axis is involved in epigenetic regulation in MDS, with direct effects on di- and tri-methylation of H3K27."}, {"pubmed": 25226601, "text": "Aberrant upregulation of 14-3-3sigma and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma."}, {"pubmed": 25237831, "text": "EZH2 inhibited miR-1 transcription via promoter binding activity, leading to enhanced expression of ET-1 which is suppressed by miR-1 targeting of ET-1 3'UTR. Knockdown of EZH2 or overexpression of miR-1 exerted anti-angiogenic effect on NPC cells."}, {"pubmed": 25243792, "text": "found that expression of PcG proteins and H3K27me3 showed prognostic value in our study cohort"}, {"pubmed": 25252918, "text": "the existence of an Rb-E2F-Ezh2 axis in bladder whose disruption can promote tumor development."}, {"pubmed": 25253781, "text": "A687V EZH2 likely increases global H3K27me3 indirectly through increased catalytic activity with H3K27me1 and cells harboring this mutation are highly dependent on EZH2 activity for their survival."}, {"pubmed": 25260883, "text": "miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer"}, {"pubmed": 25262426, "text": "advanced NSCLC patients with positive expression of EZH2 exhibited resistance to cisplatin-based chemotherapy. EZH2 may be a predictive and prognostic factor for cisplatin-based therapy response and disease survival in advanced NSCLC."}, {"pubmed": 25263318, "text": "High level of EZH2 expression is associated with T cell lymphomas."}, {"pubmed": 25266721, "text": "c-Rel regulates Ezh2 expression in lymphocytes and malignant lymphoid cells in a novel transcriptional network"}, {"pubmed": 25275047, "text": "Activating mutations affecting the NF-kappa B pathway and EZH2-mediated epigenetic regulation are rare events in primary mediastinal large B-cell lymphoma."}, {"pubmed": 25275664, "text": "Increase of EZH2 and P53 expression is associated with lymph node metastasis in cervical squamous cell carcinoma."}, {"pubmed": 25280519, "text": "Overexpression of EZH2 can promote the proliferation of cholangiocarcinoma cells and inhibit their apoptosis."}, {"pubmed": 25289642, "text": "immunostaining for EZH2 and p16INK4a may be useful for differential diagnosis for bile ductular tumors/lesions--{review}"}, {"pubmed": 25294424, "text": "EZH2 expression can be considered a risk factor in glioblastoma multiforme."}, {"pubmed": 25326896, "text": "Data show that overall enhancer of zeste 2 (EZH2), embryonic ectoderm development (EED) and suppressor of zeste 12 homolog (SUZ12) expression in the colorectal cancer (CRC) tissues was significantly increased than in the non-cancerous tissue."}, {"pubmed": 25341040, "text": "EZH2 integrates the epigenetic silencing of miR-205 and miR-31 to confer resistance to chemotherapy-induced apoptosis."}, {"pubmed": 25350786, "text": "IL-6 gene expression was correlated strongly with DNMT1/3A/3B and EZH2 expression, highlighting a potential relationship between IL-6 and important epigenetic regulatory enzymes."}, {"pubmed": 25355039, "text": "Study showed that the expression of COX-2, EZH-2, and p53 may be a predictor for distinguishing cytologically atypical hyperplastic from malignant breast lesions and may be regarded as potential prognostic factor in breast cancer patients."}, {"pubmed": 25400732, "text": "Suggest that decreased expression of miR-101 might promote metastasis of human esophageal squamous cell carcinoma by inducing accumulation of EZH2 protein."}, {"pubmed": 25400745, "text": "Suggest that EZH2 plays an important part in the development of multidrug resistance and may represent a novel therapeutic target for multidrug-resistant glioblastoma."}, {"pubmed": 25428391, "text": "We for the first time proposed the role interleukin-1beta-mir-101-EZH2 axes in the particle-induced lung cancer"}, {"pubmed": 25428914, "text": "HOTAIR promotes cell cycle progression in glioma as a result of the binding of its 5' domain to EZH2"}, {"pubmed": 25431950, "text": "Pharmacologic downregulation suppresses bladder cancer"}, {"pubmed": 25431952, "text": "combinatorial silencing along with Ring1b depleted epigenetically modified H2- and H3-histones and inhibited pancreatic cancer cell growth in vitro and in vivo (xenograft model)"}, {"pubmed": 25444902, "text": "overexpression of EZH2 is associated with glioblastoma."}, {"pubmed": 25472588, "text": "EZH2 was identified as the functional downstream target of miR-32."}, {"pubmed": 25486432, "text": "EZH2-induced downregulation of WIF1 expression may partially regulate Wnt/beta-catenin-dependent crypt hyperplasia in response to citrobacter rodentium infection."}, {"pubmed": 25494962, "text": "results indicate that miR-26a exerts growth inhibition in HCC and that its inhibitory effect is mediated briefly by blocking EZH2 expression."}, {"pubmed": 25499219, "text": "Thus, EZH2 is reciprocally regulated by a novel signaling network consisting of Sp proteins, oncogenic miRs and ZBTB4, and modulation of this gene network is a novel therapeutic approach for treatment of breast cancer and possibly other cancers."}, {"pubmed": 25500144, "text": "CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patient."}, {"pubmed": 25501205, "text": "EZH2 gene silencing effectively suppressed the proliferation, invasion, and migration abilities of human bladder cancer cells, promoting apoptosis."}, {"pubmed": 25537508, "text": "Data show that sepression of runt-related transcription factor (RUNX1) is important for the growth promotion ability of enhancer of zeste homolog 2 (EZH2) in androgen receptor (AR)-independent cells."}, {"pubmed": 25549357, "text": "EZH2-silenced cells the signaling activity of the de-repressed ITGalpha2 is able to increase cofilin phosphorylation, which in turn reduces cell migration."}, {"pubmed": 25550361, "text": "Mutation in EZH2 gene is associated with secondary acute myeloid leukemia."}, {"pubmed": 25571919, "text": "Upregulation of EZH2, MMP2 and TIMP2 expression was correlated with metastasis of RCC to bone tissues ex vivo and in vitro."}, {"pubmed": 25578878, "text": "The related enzymatic subunits EZH1 and EZH2 undergo an expression switch during blood cell development."}, {"pubmed": 25586788, "text": "EZH2 is a novel, independent marker of a poor prognosis in patients with ependymoma."}, {"pubmed": 25595591, "text": "EZH2 and DNMT1-mediated epigenetic silencing contributed to the progression of gastric cancer and glioblastoma."}, {"pubmed": 25600645, "text": "MALAT1 is transcriptionally activated by c-Fos and interacts with Ezh2."}, {"pubmed": 25601206, "text": "EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner"}, {"pubmed": 25609585, "text": "EZH2-mediated epigenetic repression is highly relevant especially during advanced melanoma progression"}, {"pubmed": 25614281, "text": "EZH2 is both a transcriptional inhibitor and a target gene of miR-101 in HUVECs, and it contributes to some of the miR-101-induced defects of gestational diabetis-HUVECs."}, {"pubmed": 25614949, "text": "Combined immunohistochemical expression of EZH2, H3K4me2, and H3K27me3 might identify cancer cells with potential stem cell properties, particularly at the invasive front, in malignant melanoma."}, {"pubmed": 25633838, "text": "EZH2 promotes lung cancer progression via the VEGF-A/AKT signaling pathway."}, {"pubmed": 25644061, "text": "SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells."}, {"pubmed": 25648270, "text": "Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming"}, {"pubmed": 25651430, "text": "High-level EZH2 and H3K27me3 were common in DLBCL independent of cell-of-origin and EZH2 mutation."}, {"pubmed": 25657202, "text": "In ACC, the results also showed strong correlation between the transcriptional repressor EZH2 and TOP2A expression, suggesting a novel role for EZH2 as an additional marker of prognosis."}, {"pubmed": 25671303, "text": "Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth."}, {"pubmed": 25695204, "text": "The present study demonstrated an epigenetic link between the activity of the EZH2 methyltransferase at the CLDN23 locus and the expression of CLDN23 in CRC tissue."}, {"pubmed": 25739318, "text": "EZH2 as a novel therapeutic target for cervical cancer"}, {"pubmed": 25746006, "text": "High DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2."}, {"pubmed": 25762643, "text": "Define Snail and Slug/miR-101/EZH2 pathway as a novel regulatory axis of epithelial-mesenchymal transformation in tongue squamous cell carcinoma."}, {"pubmed": 25767098, "text": "STAT3-driven transcription is dependent on dimethylation of K49 by EZH2"}, {"pubmed": 25800736, "text": "identified that PCAF interacts with and acetylates EZH2 mainly at lysine 348"}, {"pubmed": 25824776, "text": "High EZH2 expression is associated with cisplatin-resistance of non-small cell lung and gastric cancer."}, {"pubmed": 25833838, "text": "Results suggest that the testicular nuclear receptor 4 (TR4) and oncogene EZH2 signaling may play a critical role in the prostate cancer stem/progenitor cell invasion."}, {"pubmed": 25869101, "text": "microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer."}, {"pubmed": 25877750, "text": "In conclusion, YB1 and EZH2 expression was correlated and associated with RCC incidence, tumor stage, grade, metastasis, and survival."}, {"pubmed": 25890085, "text": "DZNep suppressed EZH2/miR-30a,d/KPNB1 signaling."}, {"pubmed": 25907866, "text": "miR-144 may function as a tumor suppressor by regulating EZH2 expression, and miR-144/EZH2 expression may be a highly sensitive marker for the prognosis in astrocytoma patients."}, {"pubmed": 25917318, "text": "EZH2 regulates the chromatin structure at the TAGLN promoter through tri-methylation of H3K27, acting as an epigenetic integrator of IL-1beta and TGFbeta2 signaling."}, {"pubmed": 25938557, "text": "EZH2 gene expression in squamous cell differentiation may occur independently on cell proliferation and cell differentiation."}, {"pubmed": 25947258, "text": "ANXA6 is a EZH2 target gene involving gastric cellular proliferation."}, {"pubmed": 25955299, "text": "blockade of CD82 in leukemia cells lowered EZH2 expression via activation of p38 MAPK signaling."}, {"pubmed": 25955318, "text": "EZH2 is involved in cisplatin resistance in ovarian cancer cells by interacting with several genes."}, {"pubmed": 25969142, "text": "Ezh2 is required for optimal epidermal cancer stem cells survival and tumor formation."}, {"pubmed": 25979827, "text": "EZH2 and Lat1 expression are co-regulated in models of cancer cell differentiation and co-expression is observed at the invasive front of human lung tumors."}, {"pubmed": 26002960, "text": "Data suggest that, during neurogenesis, Mediator complex cyclin-dependent kinases (CDK8, CDK19) interact directly with PRC2 (polycomb repressive complex 2) subunit EZH2 (enhancer of zeste homolog 2), as well as SUZ12 (suppressor of zeste 12 homolog)."}, {"pubmed": 26004298, "text": "Data show a role of EZH2 in the regulation of INK4/ARF expression and senescence procedure in gastric cancer cells, and show that the cellular senescence could just depend on the activation of p15(INK4b)/Rb pathway."}, {"pubmed": 26032517, "text": "EZH2 (enhancer of zeste homolog 2) was up-regulated in human oral tongue squamous cell carcinoma tissues and its level positively correlated with level of hMOF."}, {"pubmed": 26096306, "text": "our study suggests a possible epigenetic mechanism of p16 loss in CDKN2A non-deleted high grade gliomas mediated by strong EZH2 expression"}, {"pubmed": 26104761, "text": "EZH2, a component of PRC2 that can affect DNA methylation through association with DNA methyltransferases (DNMTs), did not co-immunoprecipitate with SIRT1, and SIRT1 knockdown did not affect the expression of EZH2 protein"}, {"pubmed": 26111449, "text": "CENP-W is a novel kinetochore component that may be involved in the EZH2-mediated silencing machinery."}, {"pubmed": 26162541, "text": "This is the first study to demonstrate a significant association between TNBC risk and the polymorphisms of EZH2 and DNMT1, and our researches indicate that the SNPs of EZH2 and DNMT1 are risk predictors for TNBC."}, {"pubmed": 26191190, "text": "miR-1297 plays a key role in inhibition of the hepatocellular carcinoma cells proliferation, and enhancing cell apoptosis through targeting EZH2."}, {"pubmed": 26265454, "text": "demonstrated that EZH2 plays a crucial role in tumor growth and distant metastasis in osteosarcoma; its oncogenic role is related to its regulation of the expression of TSSC3"}, {"pubmed": 26268246, "text": "Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer"}, {"pubmed": 26271144, "text": "Review/meta-analysis: over-expression of EZH2 was correlated with a poor breast cancer patient survival."}, {"pubmed": 26280220, "text": "specificity of EZH2i toward human RB cells, but not RPE, warrants further in vivo testing in animal models of RB, especially those EZH2i currently in clinical trials for solid tumors and lymphoma"}, {"pubmed": 26304929, "text": "EZH2 has a critical role in the proliferation and viability of melanoma"}, {"pubmed": 26305882, "text": "EZH2 protein expression was associated with a tumor suppressor gene methylator phenotype. DNMT1, DNMT3B, and EZH2 were expressed at significantly higher levels in tumor vs. normal tissues."}, {"pubmed": 26317265, "text": "Studies indicate that polycomb repressive complex 2 (EZH2) is overexpressed in multiple tumor types and is often an independent prognostic indicator."}, {"pubmed": 26360609, "text": "Suggest that acquired-resistance to EZH2i may arise in WT and mutant EZH2 patients through a single mutation that remains targetable by second generation EZH2 inhibitors."}, {"pubmed": 26362062, "text": "Overexpression of DNMT1 diminishes ursolic acid-reduced EZH2 protein expression."}, {"pubmed": 26364600, "text": "Authors demonstrate that inhibition of the non-canonical NF-kB pathway by targeting NF-kB2/p52 or the upstream kinase NIK restores the senescence program in melanoma cells through the decrease of EZH2."}, {"pubmed": 26370511, "text": "Chromatin immunoprecipitation confirmed that PARP1 inhibition led to H3K27me3 deposition at EZH2 target genes, which resulted in gene silencing."}, {"pubmed": 26377323, "text": "EZH2 expression in salivary gland tumors, similarly to the tumors of other organs is not characteristic for any tumor type, but is a solid marker of the malignant nature of the tumors."}, {"pubmed": 26378043, "text": "A xenograft tumor model was used to confirm that EZH2 depletion inhibited HNSCC cell growth and induced tumor cell apoptosis."}, {"pubmed": 26378045, "text": "DKK1 is found to be regulated by NBAT1 in a PRC2 dependent manner, and is responsible for NBAT1's effects in inhibiting migration and invasion of breast cancer cells."}, {"pubmed": 26392259, "text": "EZH2 has strong prognostic impact in prostate cancer and might contribute to the development of a fraction of genetically instable and particularly aggressive prostate cancers."}, {"pubmed": 26404566, "text": "EZH2/miR-622 promotes hepatoma tumorigenesis through CXCR4 activation."}, {"pubmed": 26415832, "text": "Posttranscriptional silencing of MALAT1 by miR-217 provides a link, through EZH2, between ncRNAs and the EMT and establishes a mechanism for cigarette smoke extract-induced lung carcinogenesis."}, {"pubmed": 26416763, "text": "Fluid shear stress decreases the expression of the Polycomb methyltransferase EZH2."}, {"pubmed": 26424790, "text": "this study concludes that the epigenetic activity of EZH2 is required for skeletal patterning and development, but EZH2 expression declines during terminal osteoblast differentiation and matrix production."}, {"pubmed": 26427660, "text": "lncRNA PVT1 may contribute to tumorigenesis of thyroid cancer through recruiting EZH2 and regulating TSHR expression."}, {"pubmed": 26431491, "text": "Data show that basal-like subgroup was enriched for aggressive tumors and somatic mutations in trithorax-group genes and it overexpressed polycomb genes EZH2 and CBX2."}, {"pubmed": 26435191, "text": "EZH2 serves as an oncogene and is involved in multiple glioma cell processes, including cell cycle, invasion, glioma stem cell maintenance, drug and radiotherapy resistance."}, {"pubmed": 26452129, "text": "miR-506-EZH2 axis inhibits colon tumor cell proliferation and metastasis by activating/suppressing specific downstream tumor-associated genes and the Wnt/beta-catenin signaling pathway."}, {"pubmed": 26457648, "text": "Data show that RAS protein activation was the initiating oncogenic event, with polycomb repressive complex 2 (PRC2) subunits impairment being a secondary event."}, {"pubmed": 26469332, "text": "Varying degrees of immunoreactivity to Cyclin D1, VEGF, and EZH2 were noted in the majority of the AT/RTs, and detection of these markers may be of value in the development of novel therapeutic agents and in determining which patients can benefit from them"}, {"pubmed": 26484567, "text": "Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis."}, {"pubmed": 26497210, "text": "EZH2 regulates normal hematopoietic stem cell self-renewal and differentiation. EZH2 also controls normal B cell differentiation."}, {"pubmed": 26499080, "text": "study provides evidence that epigenetic regulation of Reelin by Ezh2 maintains appropriate Reelin expression pattern to fulfill proper orientation of migrating neurons"}, {"pubmed": 26506125, "text": "EZH2 activity and expression are impaired by excess S-adenosylhomocysteine in endothelial cells. EZH2 suppression may mediate S-adenosylhomocysteine - induced NFkappaB activation and inflammatory responses."}, {"pubmed": 26516927, "text": "Data show that long non-coding RNA MALAT1 may be a crucial RNA cofactor of Polycomb protein enhancer of zeste homolog 2 (EZH2) and that may provide a new avenue for development new strategies for treatment of castration-resistant prostate cancer (CRPC)."}, {"pubmed": 26517514, "text": "Data show a mutual suppression regulation between chromodomain helicase DNA binding protein 5 (CHD5) and enhancer of zeste homolog 2 (EZH2, which may provide new insights into their potential therapeutic significance for hepatocellular carcinoma (HCC)."}, {"pubmed": 26517640, "text": "Cancer stem cell markers are variably expressed in prostate adenocarcinoma and immunohistochemical staining for ALDH1 and EZH2 may have a role in predicting tumour aggressiveness before treatment of prostate cancer"}, {"pubmed": 26517683, "text": "Data show that increased polycomb repressive complex 2 EZH2 and/or polycomb repressive complex 1 BMI1 expression repress the expression of microRNA miR-200 family members."}, {"pubmed": 26517694, "text": "Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma."}, {"pubmed": 26552009, "text": "SWI/SNF-mutant cancer cells are primarily dependent on a non-catalytic role of EZH2 in the stabilization of the PRC2 complex."}, {"pubmed": 26552012, "text": "EZH2 might contribute to the genetic etiology of autism in Chinese Han population"}, {"pubmed": 26553291, "text": "EZH2 rs3757441 C/C genotype is associated with stronger EZH2 and H3K27me3 immunoreactivity in primary colorectal cancer : this SNP may serve as a promising biomarker for EZH2-targeting agents"}, {"pubmed": 26573802, "text": "Mechanistic investigations revealed that miR-124 directly downregulated AR splice variants AR-V4 and V7 along with EZH2 and Src"}, {"pubmed": 26587974, "text": "p53 gain-of-function mutations accelerate endometrial carcinoma progression and metastasis by interfering with Drosha and p68 binding and pri-miR-26a-1 processing, resulting in reduced miR-26a expression and EZH2 overexpression."}, {"pubmed": 26590165, "text": "Study shows that EZH2 is overexpressed in multiple myeloma and proposes that it plays an important role in multiple myeloma development and progression."}, {"pubmed": 26592252, "text": "Our results suggested that EZH2 in leukemic cell lines might inhibit ATO-induced apoptosis and that EZH2 may be a potential therapeutic target in AML patients undergoing ATO treatment."}, {"pubmed": 26593398, "text": "EZH2 is highly expressed in pituitary adenomas, positively associated with Ki-67 expression, and associated with proliferation."}, {"pubmed": 26631032, "text": "western blotting results revealed that higher expression of EZH2 was related with lower level of Dicer in HeLa/DDP cells. Finally, in vivo tumorigenicity experiments results demonstrated that interference with endogenous EZH2 by shRNA specific to EZH2 or inhibition EZH2 by DZNep could significantly increase antitumor effects in nude mice."}, {"pubmed": 26631178, "text": "expression of EZH2 and H3K27me3 could serve as biomarkers in the prediction of esophageal squamous cell carcinoma (ESCC) patients' survival and ESCC metastasis."}, {"pubmed": 26632198, "text": "Data suggest that depletion of [human] EZH2 (enhancer of zeste homolog 2 protein) leads to up-regulation of [HIV-1] Tat-mediated HIV-1 transactivation; Tat up-regulates phosphorylation and cytoplasmic translocation of EZH2."}, {"pubmed": 26648239, "text": "The miR-335 expression was inversely correlated with Sox4 expression in the identical clinical specimens, but it was not related to the prognosis. Sox4/Ezh2 axis was closely associated with the prognosis in pancreatic cancer patients"}, {"pubmed": 26655220, "text": "WT1 isoforms induce an array of miRNAs, which target the 3' UTR of EZH2 and other Polycomb-associated transcripts."}, {"pubmed": 26659825, "text": "Results uncovered the collaboration between EZH2 and E2F1 in controlling downstream genes that are highly expressed in aggressive tumors."}, {"pubmed": 26683709, "text": "High EZH2 expression was significantly associated with different types of breast cancer."}, {"pubmed": 26715809, "text": "MiR-203 may contribute to the metastasis and enhance apoptosis of hepatocellular carcinoma cells by regulating EZH2 and Bmi-1 expression."}, {"pubmed": 26718325, "text": "Ectopic expression of EZH2 inhibited the transcriptional activities of miR-101-1 promoter. Subsequent analyses revealed that miR-101-1 directly represses the expression of EZH2, and miR-101-1 and EZH2 form a reciprocal negative feedback loop."}, {"pubmed": 26733151, "text": "Data indicate that microRNA miR-26a regulated epithelial-mesenchymal transition (EMT) by targeting enhancer of zeste homolog 2 (EZH2)."}, {"pubmed": 26735435, "text": "the expression of metastasis associated 1 family, member 2 and enhancer of zeste 2 polycomb repressive complex 2 subunit correlated negatively with expression of tuberous sclerosis 2"}, {"pubmed": 26746204, "text": "Enhancer of Zeste homologue2 (EZH2) is an epigenetic regulator that functions as oncogene in astrocytic tumors."}, {"pubmed": 26754405, "text": "EZH2 overexpression was associated with poor overall survival in lung cancer, this effect appears also significant when the analysis is restricted in Asian population, lung AC and stage I patients, but not among Caucasians."}, {"pubmed": 26762561, "text": "We found a novel heterozygous EZH2 mutation within exon 5 that caused an amino acid change from proline to leucine at position 132 (p.Pro132Leu) within the catalytic D1 domain. Analysis of a remission sample also showed this mutation, indicating a germline mutation."}, {"pubmed": 26766588, "text": "Modulation of Polycomb repressive complexes by either Ezh2 overexpression or Eed deletion enhances KRAS-driven adenomagenesis and inflammation"}, {"pubmed": 26781064, "text": "an imbalanced double-negative feedback loop between EZH2 and miR-26a exists in HCC cells, which contributes to miR-26a deregulation and regulates tumor cells proliferation"}, {"pubmed": 26791102, "text": "miR-214 was able to prevent cell death by targeting EZH2, the catalytic core component of PRC2 complex that is responsible for tri-methylation reaction at lysine 27 (K27) of histone 3 (H3) (H3K27me3), by which As-induced miR-214 reduction"}, {"pubmed": 26812882, "text": "Loss of EZH2 expression is associated with increased transformation of myelodysplastic syndrome into acute myeloid leukemia."}, {"pubmed": 26840083, "text": "Mechanistic investigations showed that LINC01133 could interact with EZH2, LSD1 and recruit them to KLF2, P21 or E-cadherin promoter regions to repress their transcription."}, {"pubmed": 26848027, "text": "Suppression of EHZ2 using lentiviral small hairpin RNA inhibited hepatoblastoma cell proliferation, induced cell cycle arrest in G1 phase and enhanced the expression of G1/Sphase checkpoint protein p27."}, {"pubmed": 26848979, "text": "EZH2 could be explored further as a diagnostic marker and a potential drug target for clear cell sarcoma of the kidney"}, {"pubmed": 26848980, "text": "EZH2 is recruited to the E-cadherin promoter by the long non-coding RNA, MALAT-1 (metastasis associated in lung adenocarcinoma transcript 1), where it represses E-cadherin expression"}, {"pubmed": 26853880, "text": "NOS2 is associated with Ezh2-mediated histone H3 lysine 27 methylation in HUVECs"}, {"pubmed": 26871294, "text": "an inverse association was identified between EZH2 and miR-31 in colorectal cancers"}, {"pubmed": 26871474, "text": "we found that long noncoding RNA (lncRNA) MALAT1 binds EZH2, suppresses the tumor suppressor PCDH10, and promotes gastric cellular migration and invasion"}, {"pubmed": 26871869, "text": "JMJD3 and EZH2 in prostate biopsies also demonstrated an increase of JMJD3 and EZH2 in adenocarcinoma with Gleason score 7 and 8 by comparison with a normal biopsy."}, {"pubmed": 26876532, "text": "EZH2 and ZFX genes do not seem to have an impact on the onset of most parathyroid tumours, both benign and malignant, though further studies on larger cohorts of different ethnicity are needed."}, {"pubmed": 26888970, "text": "This study reveals the important role of EZH2-regulated DNA damage-repair genes via histone methylation in fibroid biology, and may provide novel therapeutic targets for the medical treatment of women with symptomatic uterine fibroids."}, {"pubmed": 26890396, "text": "We found that the AR promoter was enriched in silencing histone modifications (H3K27me3 and H3K9me2) and that EZH2 inhibition with 3-deazaneplanocin A (DZNep) resulted in AR expression and growth inhibition in AR(-)SCPC cell lines. We conclude that the epigenome of AR(-) is distinct from that of AR(+) castration-resistant prostate carcinomas, and that the AR(-) phenotype can be reversed with epigenetic drugs."}, {"pubmed": 26892683, "text": "Data indicate an epigenetic prognostic signature in glioblastomas based on expression of polycomb repressive complex 2 (EZH2), DNA-methyltransferases DNMT1 and 3B which can be used easily in routine neuropathology practice."}, {"pubmed": 26897964, "text": "EZH2 mediates the regulation of E-cadherin expression by S100A4 and controls the proliferation and migration of gastric cancer cells."}, {"pubmed": 26936398, "text": "H3K27 trimethylation by hyperactive EZH2 correlates with DNA hypermethylation of target genes."}, {"pubmed": 26936398, "text": "Hyperactivation of EZH2 by mutations or amplification drives epigenetic silencing of genes involved in tumor suppression and immune responses in cancer"}, {"pubmed": 26936398, "text": "Study identifies transcript NM_001203247 as canonical isoform of EZH2 (lacking extension of exon 8) and activating somatic cancer mutation Y641H/N/S/C/F masking phosphorylation site of SET domain."}, {"pubmed": 26936398, "text": "Taken together, EZH2 and its associated chromatin remodeling machinery represent a promising opportunity for therapeutic intervention in melanoma."}, {"pubmed": 26939702, "text": "BRD4 positively regulates EZH2 transcription through upregulation of C-MYC, and is a novel promising target for pharmacologic treatment in transcriptional program intervention against this intractable disease."}, {"pubmed": 26964089, "text": "Uropathogen-induced paracrine factors act epigenetically by altering expression of EZH2, which plays a key role in early host cell proliferative responses to infection."}, {"pubmed": 26970171, "text": "Down-regulation of EZH2 expression is associated with myelodysplastic syndromes."}, {"pubmed": 27000413, "text": "Mutating or deleting EZH2 can have both oncogenic and tumor suppressive functions by increasing or decreasing H3K27me3. (Review)"}, {"pubmed": 27000755, "text": "These data suggest that higher expression of EZH2 may be associated with extramedullary infiltration in acute myeloid leukemia"}, {"pubmed": 27010137, "text": "In patients with B-cell non-hodgkin's lymphoma, none of them had well-known hot spot mutations in EZH2 and CD79B."}, {"pubmed": 27036951, "text": "The data suggest that EZH2-H3K27me3 regulatory mechanism dynamically changes the expression levels of DNA mismatch repair gene MutS homolog 2, through epigenetic mark H3K27me3."}, {"pubmed": 27040767, "text": "H19 inhibited E-cadherin expression and promoted cell invasion of NPC cells via the miR-630/EZH2 pathway"}, {"pubmed": 27045473, "text": "ASC-J9((R)) could suppress prostate carcinoma stem cell invasion via altering the EZH2/STAT3 and/or AKT/EZH2/STAT3 signals."}, {"pubmed": 27050973, "text": "Notch1 and EZH2 coexpression contributes to the progression and prognosis of breast invasive ductal carcinoma."}, {"pubmed": 27052808, "text": "we propose that epigenetic silencing of miR26A1 is required for the maintenance of increased levels of EZH2, which in turn translate into a worse outcome, as shown in CLL, highlighting miR26A1 as a tumor suppressor miRNA."}, {"pubmed": 27054919, "text": "Our data reveal that EZH2 expression correlates with the proliferation marker Ki67 and with aggressive Basal Cell Carcinoma subtypes"}, {"pubmed": 27070757, "text": "In chronic myeloid leukemia cells, EZH2 modulates epigenetic changes at DNA methylated regions encoding miR-219 and downregulates the level of miR-219. Downregulation of miR-219 results in upregulation of XIAP and supports the survival of leukemia cells."}, {"pubmed": 27090213, "text": "exon-skipping event in Enhancer of Zeste Homologue 2 (EZH2) along with expression changes showed significant down regulation on Day 5 and Day 9 but returned to normal level on Day 13 and Day 17."}, {"pubmed": 27092879, "text": "Enhancer of zeste homolog 2 (EZH2) expression is positively correlated with the expression of Wnt/beta-catenin signaling and negatively correlated with the expression of GSK-3beta and TP53 in cervical cancer tissues."}, {"pubmed": 27113214, "text": "EZH2 overexpression is associated aggressive pathologic features including high nuclear grade, high proliferative index, and positivity of HER2 of breast carcinoma."}, {"pubmed": 27121240, "text": "Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis."}, {"pubmed": 27129219, "text": "Data show that HMG-box transcription factor 1 protein HBP1-mediated elevation of CDK inhibitor p21 through the Mdm2/p53 and TCF4/EZH2 pathways contributes to both cellular senescence and tumor inhibition."}, {"pubmed": 27135738, "text": "Ezh2(Y641F) induces lymphoma and melanoma through a vast reorganization of chromatin structure"}, {"pubmed": 27151441, "text": "S6K1 phosphorylation of H2B mediates EZH2 trimethylation of H3 early in adipogenesis, contributing to the promotion of obesity."}, {"pubmed": 27168161, "text": "EZH2 not only acts through the direct regulation of signaling modules and lineage-specific transcription factors but also targets many novel genes important for mediating mesenchymal stem cell osteogenic differentiation."}, {"pubmed": 27169594, "text": "findings indicate that EZH2 aberrations might contribute to the disease in specific cases. Hereby, EZH2 promoter hypermethylation might have functionally similar consequences as loss-of-function mutations"}, {"pubmed": 27172794, "text": "EZH2 was more highly expressed in the colorectal cancer stem (CCS)-like cell subpopulation than in the non-CCS-like cell subpopulation. EZH2 knockdown significantly reduced the CD133+/CD44+ subpopulation, suppressed mammosphere formation, and decreased the expression of self-renewal-related genes and strongly impaired tumor-initiating capacity in a re-implantation mouse model."}, {"pubmed": 27183582, "text": "The EZH2 was recruited to the IRF8 promoter after RANKL stimulation to deposit the negative histone mark H3K27me3 and downregulate IRF8 expression."}, {"pubmed": 27191993, "text": "The histone methyltransferase EZH2 is overexpressed in adverse-prognosis CLL and associated with increased cell survival and proliferation."}, {"pubmed": 27195672, "text": "Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells."}, {"pubmed": 27207647, "text": "EZH2 mediated hepatocellular carcinoma aggressiveness and epigenetically silenced CLDN14."}, {"pubmed": 27223261, "text": "Results suggest that EZH2 is critical for the growth and metastasis of osteosarcoma."}, {"pubmed": 27239242, "text": "Data present convincing mechanistic results confirming the oncogenic function of EZH2 related to PRC2 functioning (repression of tumor suppressor genes through H3K27me3) in several biological models."}, {"pubmed": 27239797, "text": "A long noncoding RNA, lnc-beta-Catm, elicits EZH2-dependent beta-catenin stabilization and sustains liver cancer stem cells self-renewal."}, {"pubmed": 27250566, "text": "decline in HDAC9c expression over time was accompanied by increased EZH2 expression."}, {"pubmed": 27253463, "text": "These results illustrate that EZH2 may promote carcinogenesis and cancer development of nasopharyngeal carcinoma by transcriptional repression of XPA gene and inactivation of nucleotide excision repair pathway."}, {"pubmed": 27259264, "text": "EZH2 promotes tumorigenesis and malignant progression in part by activating glycolysis through an EAF2-HIF1alpha signaling axis."}, {"pubmed": 27266699, "text": "The function of hsa-miR-138-5p and its target EZH2 was involved in hippocampus in Down syndrome patients"}, {"pubmed": 27272214, "text": "PVT1 binds to EZH2, recruits EZH2 to the miR-200b promoter, increases histone H3K27 trimethylation level on the miR-200b promoter, and inhibits miR-200b expression."}, {"pubmed": 27282353, "text": "Report differential expression of EZH2 protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas."}, {"pubmed": 27290698, "text": "Results demonstrate that EZH2 and ALDH1 proteins are expressed in the stromal component of phyllodes tumors (PTs), and that EZH2 is associated with a diagnosis of malignant PT with progression to sarcoma."}, {"pubmed": 27297789, "text": "In natural killer/T-cell lymphoma (NKTL) as a disease model, phosphorylation of EZH2 by JAK3 promotes the dissociation of the PRC2 complex leading to decreased global histone H3 lysine 27 methylation levels."}, {"pubmed": 27303043, "text": "Loss of PRC2-mediated gene expression is accompanied by up-regulation of EZH2 and HIF1A in breast cancer."}, {"pubmed": 27311868, "text": "These evidences suggest that EZH2 and EZH1 are important in the counter-balancing mechanisms controlling proliferation/resting of lymphoid cells. The disruption of the balanced EZH2/EZH1 ratio may play important roles in the pathogenesis of lymphomas"}, {"pubmed": 27323178, "text": "Authors investigated the expression and clinical implications of enhancer of Zeste homolog 2 (EZH2) in cervical squamous cell carcinoma (SCC) and precancerous lesions. The positive expression rate of EZH2 in SCC patients with and without lymph node metastasis was 82.9 and 70.4%."}, {"pubmed": 27345740, "text": "LncRNA MINCR might stimulate the expression of EZH2 in gallbladder cancer cells, promoting tumor proliferation, invasion, and metastasis."}, {"pubmed": 27378697, "text": "Data show that EZH2 plays a critical role in the FMR1 gene silencing process and that its inhibition can prolong expression of the FMR1 gene even in the presence of its transcript."}, {"pubmed": 27385092, "text": "EZH2, miRNA and beta-catenin signaling have roles in aerobic glycolysis in glioma"}, {"pubmed": 27391784, "text": "These data demonstrate a dependency of SS18-SSX-positive, SMARCB1-deficient synovial sarcomas on EZH2 enzymatic activity and suggests the potential utility of EZH2-targeted drugs in these genetically defined cancers."}, {"pubmed": 27399922, "text": "EZH2 expression was significantly associated with markers of poor prognosis such as estrogen receptor negativity, progesterone receptor negativity and high Ki-67 proliferation index. High EZH2 expression was not correlated with the response to neoadjuvant chemotherapy. Conclusions Our data suggested that EZH2 protein expression may not correlate with the clinical response to neoadjuvant chemotherapy."}, {"pubmed": 27419533, "text": "the functional association between EZH2 expression and silencing of key tumor suppressor loci , was investigated."}, {"pubmed": 27436059, "text": "EZH2 inhibits the expression of tumor suppressor gene RASSF2A via promoter hypermethylation. Thus, it plays an important role in tumorigenesis."}, {"pubmed": 27452518, "text": "High EZH2 expression is associated with liver neoplasms."}, {"pubmed": 27466490, "text": "The aurora kinase A inhibited by MLN 8054 are both implicated in cell cycle progression and, thus, in cellular proliferation.Epigenetic regulators were targeted by SAHA inhibiting HDACs and by DZNep inhibiting the histone methyltransferase EZH2, which silences genes by trimethylating histone H3K27.Combinations of small molecular inhibitors act synergistically in rhabdoid tumor"}, {"pubmed": 27468692, "text": "that EZH2 is phosphorylated by the DNA damage responsive complex DNA-PK and regulates DNA damage-mediated T-cell apoptosis."}, {"pubmed": 27472460, "text": "EZH2 directly binds to the Puma promoter thus epigenetically repressing PUMA expression in non-small cell lung cancer cells."}, {"pubmed": 27494834, "text": "GSK3beta phosphorylates EZH2 at Ser363 and Thr367, resulting in reduced H3K27 trimethylation and biological activity of EZH2 in breast cancer"}, {"pubmed": 27539752, "text": "the induction of EZH2 led to beta-catenin signaling activation by increasing H3K27me3 on the promoter of SFRP1, while the inhibition of EZH2 silenced beta-catenin signaling. Finally, intraarticular injection of EPZ005687 delayed OA development in mice. These results implicated EZH2 activity in OA development. Pharmacological inhibition of EZH2 may be an effective therapeutic approach for osteoarthritis."}, {"pubmed": 27542077, "text": "overexpression in laryngeal squamous cell carcinoma significantly related to T phase, pathological grades, and risk of lymphatic metastasis"}, {"pubmed": 27557505, "text": "EZH2 may have a role in invasive cervical carcinoma"}, {"pubmed": 27563817, "text": "Data show that the enhancer of zeste homolog 2 (EZH2) knockdown (using siRNA) or enzymatic inhibition (by GSK126) induced epithelial-to-mesenchymal transition (EMT)-like changes in ovarian cancer (OC) cells."}, {"pubmed": 27577075, "text": "Results suggest that long noncoding RNA FOXF1-AS1 might regulate epithelial-mesenchymal transition (EMT), stemness and metastasis of non-small cell lung cancer (NSCLC) cells via EZH2, indicating it as a therapeutic target for future treatment of NSCLC."}, {"pubmed": 27594424, "text": "Results identified EZH2, HOTAIR and MiR-34a as major players in pancreatic ductal adenocarcinoma (PDAC) pathogenesis. The interaction between EZH2 and HOTAIR underlay the silencing of miR-34a through induction of heterochromatin formation, promoting cell proliferation."}, {"pubmed": 27620004, "text": "Results show that EZH2 is a direct target of miR-101 and an inverse relationship was found between lncRNA XIST and miR-101 where lncRNA XIST exerted its tumor-suppressive effects at least in part through regulating miR-101 to modulate EZH2 expression."}, {"pubmed": 27622325, "text": "Data indicate that enhancer of zeste homolog 2 (Drosophila) protein (EZH2) is a direct target of microRNA miR-126 and restoration of EZH2 expression blocks the suppressive roles of miR-126."}, {"pubmed": 27630125, "text": "We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI"}, {"pubmed": 27630126, "text": "Expression of the EZH2 homolog EZH1 is reduced in EZH2-deficient CML LICs, creating a scenario resembling complete loss of PRC2. EZH2 dependence of CML LICs raises prospects for improved therapy of TKI-resistant CML and/or eradication of disease by addition of EZH2 inhibitors"}, {"pubmed": 27630289, "text": "the T allele of EZH2 rs887569 may be associated with the lower risk of bladder cancer development, especially among non-smokers"}, {"pubmed": 27638307, "text": "EZH2 promoted invasion and metastasis of laryngeal squamous cell carcinoma via epithelial-mesenchymal transition through H3K27me3"}, {"pubmed": 27644248, "text": "this work shows that NIPP1/EZH2 expression can be a reliable prognostic factor for hepatocellular carcinoma."}, {"pubmed": 27697098, "text": "Overexpression of EZH2 was found in 30 patients (76.9%) and was associated with FIGO stage, histological type, and lymph node metastasis (p < 0.05). In conclusion, our data suggest that RIPK4/EZH2 markers might be used as potential predictors of prognosis in cervical cancer."}, {"pubmed": 27713574, "text": "The mutation of Y641 and A677 present in the active region of the protein alters the interaction of the top ranked compound with the newly modeled binding groove of the SET domain, giving a GLIDE score of -12.26 kcal/mol, better than that of the wild type at -11.664 kcal/mol."}, {"pubmed": 27716745, "text": "EZH2 can directly associate with ANCR, the ANCR-EZH2 binding is probably able to facilitate CDK1 interaction with EZH2 to promote phosphorylation of EZH2 at Thr-345 and Thr-487, and potentiate EZH2 ubiquitination degradation through ubiquitin-proteasome pathway."}, {"pubmed": 27728805, "text": "N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer and redirects EZH2 activity and sensitizes cells to EZH2 inhibitors."}, {"pubmed": 27738890, "text": "No EZH2 Y646 mutations were identified among the 82 sporadic parathyroid adenomas. Furthermore, no copy number variations of EZH2 were found in any of the 61 parathyroid adenomas analyzed."}, {"pubmed": 27764181, "text": "EZH2, through a methyltransferase-independent mechanism, promotes the transcriptional activation of the non-canonical NF-kappaB subunit RelB"}, {"pubmed": 27793210, "text": "Inhibition of EZH2 has anti-tumorigenic effects on OPSCC cells in culture that is more pronounced in HPV-positive cell lines. EZH2 is a promising epigenetic target for the treatment of OPSCC."}, {"pubmed": 27815387, "text": "our findings establish CCN3 as a pivotal regulator of androgen receptor (AR) signaling and prostate cancer progression and suggest a functional intersection between EZH2 and AR signaling in castration-resistant prostate cancer"}, {"pubmed": 27830540, "text": "This perspective describes recent findings in pathogenic role of EZH2 in hematological malignancies. [review]"}, {"pubmed": 27835578, "text": "Suggest chromatin regulator EZH2 has role in regulating mRNA and lncRNA expression by acting as a transcriptional suppressor or activator in tumor cells."}, {"pubmed": 27845386, "text": "these data suggest that miR-101 is induced by osteogenic stimuli and promotes osteogenic differentiation at least partly by targeting the EZH2/Wnt/beta-Catenin signaling pathway."}, {"pubmed": 27859460, "text": "BAP1 loss and high EZH2 expression were highly specific to malignant mesothelioma in differentiating it from benign mesothelial proliferations"}, {"pubmed": 27869166, "text": "our results revealed a novel mechanism in which EZH2 stability is regulated by SKP2 through the TRAF6-mediated and K63-linked ubiquitination, which contributes to elevated levels of H3K27me3 during prostate tumorigenesis and CRPC growth."}, {"pubmed": 27879367, "text": "These results suggest SF3B3 as a key regulator of EZH2 pre-mRNA splicing and SF3B3 may represent a novel prognostic factor and potential therapeutic target in clear cell renal cell carcinoma"}, {"pubmed": 27880940, "text": "the present study showed that EZH2 was a potential prognostic marker for poor OS, PFS and lower KPS score in glioma patients."}, {"pubmed": 27882937, "text": "EZH2 may mediate, at least partially, the senescence-inducing effects of lidamycin by regulating p21 expression and DNA damage effect."}, {"pubmed": 27886392, "text": "study of two cases of CBSD showsthe involvement of EZH2 by the diminished presence ofits enzyme product histone H3K27me3"}, {"pubmed": 27890434, "text": "These results suggested that miR-98 functioned as a potential tumor suppressor by regulating Wnt/beta-catenin signal pathway through direct suppression of EZH2 expression and might sever as a potential therapeutic target for HCC patients."}, {"pubmed": 27899259, "text": "Long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma and epigenetically repressing E-cadherin expression."}, {"pubmed": 27909059, "text": "these results suggest that the inflammatory milieu found in Crohn's disease could lead to or result from deregulation of FOXP3/EZH2-enforced T cell gene networks contributing to the underlying intestinal inflammation."}, {"pubmed": 27926872, "text": "EZH2-deficient hESCs can initiate differentiation toward developmental lineages; however, they cannot fully differentiate into mature specialized tissues. Thus, EZH2 is required for stable ESC self-renewal, regulation of transcriptional programs, and for late-stage differentiation in this model of early human development."}, {"pubmed": 27938379, "text": "findings suggest that EZH2 possesses anti-apoptotic activity in gastric tumorigenesis following STAT3 activation"}, {"pubmed": 27941792, "text": "Loss of the histone methyltransferase EZH2 and subsequent reduction of histone H3K27 trimethylation is a novel pathway of acquired resistance to tyrosine kinase inhibitors (TKIs) and cytotoxic drugs in acute myeloid leukemia."}, {"pubmed": 27966775, "text": "Transwell invasion assay, wound healing assay and flow cytometry results showed that the inhibition of EZH2 or the up-regulation of miR-101-3p inhibited the viability, migration, invasion and cell cycle but promoted cell apoptosis of lung squamous cell carcinoma."}, {"pubmed": 27983539, "text": "The results of Trans-well and cell scratch tests showed that when ANCR expression was decreased, the invasion and migration abilities of SW620 cells significantly declined. In conclusion, these results suggest that lncRNA-ANCR could influence the invasion and migration of CRC cells by specifically binding to EZH2."}, {"pubmed": 27993893, "text": "Our results showed EZH2 to be highly overexpressed in astrocytic tumors with a significant positive correlation with grade.we identified SLC25A23 as important target of H3K27me3 modification, which was downregulated in GBM and its low expression was associated with poor prognosis in glioblastomas (GBMs)."}, {"pubmed": 27997717, "text": "EZH2 mutation is associated with polycythemia vera and essential thrombocythemia."}, {"pubmed": 27998273, "text": "The increased expression of p21 and p27 upon MALAT1 knockdown was regulated by enhancer of zeste homolog 2 (EZH2)."}, {"pubmed": 28034643, "text": "NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2"}, {"pubmed": 28044469, "text": "Overall, epigenetic modulation is a promising approach to evaluate the role of chromatin structure for the radioresponsiveness of glioma cell lines."}, {"pubmed": 28052011, "text": "Inhibition of EZH2 down-regulates myeloma associated oncogenes and up-regulates microRNAs with potential tumor suppressor functions in multiple myeloma cells."}, {"pubmed": 28060766, "text": "Report a functional interaction between EZH2- and PIK3CA-dependent signaling pathways in non-muscle invasive bladder cancer cells."}, {"pubmed": 28068325, "text": "TRIM28 depletion repressed EZH2 recruitment to chromatin and expression of this gene set, in parallel with decreased CD44(hi)/CD24(lo) mammosphere formation."}, {"pubmed": 28069000, "text": "these results suggested that TUG1 mediates cell growth and chemoresistance of SCLC by regulating LIMK2b via EZH2."}, {"pubmed": 28109288, "text": "LINC00152-mediated oncogenic effects occur in part through the epigenetic silencing of IL24 expression following binding with EZH2."}, {"pubmed": 28119061, "text": "Data indicate that NFIB protein increases EZH2 protein expression downstream of BRN2 protein, which further decreases MITF protein levels."}, {"pubmed": 28147317, "text": "EZH2 expression was associated with survival in patients with colorectal cancer who were treated with anti-EGFR therapeutics. Moreover, low EZH2 expression was independently associated with shorter progression-free survival in patients with cancer, suggesting that EZH2 expression is a useful additional prognostic biomarker for anti-EGFR therapy."}, {"pubmed": 28164661, "text": "TT genotype of EZH2 (rs2072408) was associated with lymph node metastasis and the depth of gastric wall invasion in patients with gastric cancer."}, {"pubmed": 28184915, "text": "High EZH2 expression is associated with esophageal squamous cell carcinoma."}, {"pubmed": 28184935, "text": "High EZH2 expression is associated with prostate cancer."}, {"pubmed": 28196596, "text": "In vivo silencing of SLFN11 was associated with marked deposition of H3K27me3, a histone modification placed by EZH2, within the gene body of SLFN11, inducing local chromatin condensation and gene silencing."}, {"pubmed": 28228601, "text": "inactivating mutations of KDM6A, which are common in urothelial bladder carcinoma, are potentially targetable by inhibiting EZH2."}, {"pubmed": 28229514, "text": "we analyzed eight probands with clinically suspected Weaver syndrome by whole-exome sequencing and identified three mutations: a 25.4-kb deletion partially involving EZH2 and CUL1 ,a missense mutation , and a missense mutation in SUZ12 inherited from her father .In vitro functional analyses demonstrated that the identified EED and SUZ12 missense mutations cause decreased decreased trimethylation of lysine 27 of H3"}, {"pubmed": 28241804, "text": "Results showed that EZH2 expression was significantly increased in metastatic lesions compared with primary lesions of breast cancer patients. High-level expression of EZH2 in metastatic lesions was associated with poorer overall survival outcomes after primary surgery and recurrence."}, {"pubmed": 28242758, "text": "the activated CDK5 kinase is involved in the EZH2 phosphorylation that is required for FBW7-mediated degradation."}, {"pubmed": 28246360, "text": "Inhibition of EZH2 (by GSK-343 or EPZ-6438) or inhibition of EHMT2 (by UNC-0638) in the Th17 primary cell model of HIV latency or resting memory T cells isolated from HIV-1-infected patients receiving highly active antiretroviral therapy, was sufficient to induce the reactivation of latent proviruses."}, {"pubmed": 28249716, "text": "EZH2 is part of the protein machinery that shapes the aging epigenome."}, {"pubmed": 28249909, "text": "nuclear expression in a majority of the lymphoblasts from bone marrow clot preparations of each of the study cases for both silent mating type information regulation 2 homolog 1 (SIRT1), an NAD+ histone deacetylase and enhancer of Zeste homolog 2 (EZH2), a histone methyltransferase."}, {"pubmed": 28253895, "text": "EZH2 expression in the normal breast epithelium is independently associated with breast cancer risk and might be used to assist in risk stratification for women with benign breast biopsies."}, {"pubmed": 28263309, "text": "Residual PRC2 activity, via EZH2 binding to mutant H3K27M histones, is required for the proliferation of H3K27M-expressing diffuse intrinsic pontine gliomas."}, {"pubmed": 28292935, "text": "We also demonstrate that tazemetostat, a potent and selective EZH2 inhibitor currently in phase II clinical trials, induces potent antiproliferative and antitumor effects in SCCOHT cell lines and xenografts deficient in both SMARCA2 and SMARCA4. These results exemplify an additional class of rhabdoid-like tumors that are dependent on EZH2 activity for survival."}, {"pubmed": 28302719, "text": "enhancer of zeste homolog 2 (EZH2) accounts for the silence of 11beta-HSD2 expression via trimethylation of histone H3 lysine 27 at the promoter of the 11beta-HSD2 gene."}, {"pubmed": 28314309, "text": "EZH2 expression in NSCLC and adenocarcinoma may have a role in significantly poorer survival"}, {"pubmed": 28338656, "text": "It has been demonstrated that FAK depletion reduces hepatocellular carcinoma cell growth by affecting cancer-promoting genes including the pro-oncogene EZH2."}, {"pubmed": 28359267, "text": "High EZH2 expression is associated with Merkel cell carcinoma"}, {"pubmed": 28362441, "text": "we demonstrate a reduction in myeloma cell proliferation with EZH2 inhibition, which leads to cell cycle arrest followed by apoptosis. This is mediated via upregulation of cyclin-dependent kinase inhibitors associated with removal of the inhibitory H3K27me3 mark at their gene loci."}, {"pubmed": 28416772, "text": "Results revealed that EZH2 interacted with the CpG site at the gene body of METTL7A and was responsible for MBD2 recruitment as well as RNA pol II rejection, which leads to METTL7A silencing in thyroid cancer."}, {"pubmed": 28418882, "text": "Kaplan-Meier survival analysis indicated that EZH2 overexpression is associated with endometrial cancer prognosis.  In addition, knockdown of EZH2 using specific siRNAs resulted in growth suppression and apoptosis induction of endometrial cancer cells, accompanied by attenuation of H3K27 trimethylation."}, {"pubmed": 28423732, "text": "Study shows that linc00673 could directly bind with EZH2 which represses HOXA5 expression."}, {"pubmed": 28430172, "text": "We propose that the copy-number status of EZH2 should also be considered when evaluating patient stratification and selecting patients for EZH2 inhibitor-targeted therapies."}, {"pubmed": 28438623, "text": "EZH2 overexpression is significantly associated with inferior outcome in patients with primary gastrointestinal diffuse large B-cell lymphoma."}, {"pubmed": 28439030, "text": "findings highlight an epigenetic mechanism by which EZH2 integrates the multifaceted effects of TNFalpha signaling to promote the inflammatory response and apoptosis in colitis."}, {"pubmed": 28466784, "text": "We also showed that knockdown of urothelial carcinoma-associated 1 increased the p21 protein expression through regulating enhancer of zeste homolog 2. In addition, bioinformatics analysis and dual-luciferase reporter assays confirmed that miR-495 was a target of urothelial carcinoma-associated 1 in renal cell carcinoma, and urothelial carcinoma-associated 1 promoted cell proliferation by negatively regulating miR-495"}, {"pubmed": 28536141, "text": "Study demonstrates that the interaction occurring between MELK and EZH2 promotes self-proliferation and stemness."}, {"pubmed": 28554757, "text": "Meta-analysis: EZH2 expression is significantly correlated with aggressive tumor behavior and poor prognosis in non-small cell lung cancer."}, {"pubmed": 28561778, "text": "Studies indicate that enhancer of zeste homolog 2 (EZH2) is a potential target for cancer therapy and a variety of inhibitors have been developed [review]."}, {"pubmed": 28620234, "text": "These results suggest that EZH2 inhibits TIMP2 expression via H3K27me3 and DNA methylation, which relieve the repression of MMP and facilitate ovarian cancer invasion and migration."}, {"pubmed": 28626218, "text": "EZH2 mutations were mostly early events in leukemogenesis and showed a complex mutational hierarchy"}, {"pubmed": 28642877, "text": "sodium valproate (NaVP)has a function in blocking the growth, invasion, and angiogenesis of tumor in the chorioallantoic membrane model; tumor growth interferes with EZH2 and p53 molecular pathways, supporting the NaVP potential in GBM therapy."}, {"pubmed": 28659443, "text": "The antitumor efficacy of pharmacological EZH2 inhibition depends on SESTRIN1, indicating that mTORC1 control is a critical function of EZH2 in lymphoma."}, {"pubmed": 28666925, "text": "EZH2 overexpression in human pituitary adenomas, especially invasive adenomas, and regulates tumor invasiveness, proliferation, and angiogenesis."}, {"pubmed": 28671703, "text": "EZH2 and HOTAIR promote the progression of the urinary bladder cancer."}, {"pubmed": 28679390, "text": "LncRNA-ANCR inhibited the cell proliferation, migration, and invasion of osteosarcoma cells, possibly through interacting with EZH2 and regulating the expression of p21 and p27."}, {"pubmed": 28681114, "text": "Study showed that EZH2 silencing in esophageal squamous cell carcinoma (ESCC) KYE30 cells can deregulate expression of important genes such as HIWI and HEY1. This is the first report highlighting transcriptionally the correlation between EZH2 and HIWI/HEY1 in the ESCC cell line."}, {"pubmed": 28681918, "text": "Results identified EZH2 as a direct downstream target gene of miR-137 in cervical cancer (CC). Forced overexpression of EZH2 in miR-137-upregulated CC cells reversed the tumor-suppression induced by miR-137."}, {"pubmed": 28696078, "text": "EZH2 haploinsufficiency is associated with tall stature and intellectual disability."}, {"pubmed": 28722764, "text": "Combination of TPA with GSK126, an inhibitor of the catalytic activity of EZH2, has a synergic effect on the induction of muscle differentiation in embryonal rhabdomyosarcoma cells."}, {"pubmed": 28738014, "text": "Patients with all of the following: the tumor size </=5 cm, low EZH2 expression, and without necrosis and distant metastasis had significantly longer survival time"}, {"pubmed": 28739498, "text": "EZH2 has prognostic value and may play an oncogenic role in Merkel cell carcinoma."}, {"pubmed": 28747286, "text": "EZH2 mutations coexisted with mutations of NOTCH1, IL7R, and PHF6 in the two Adult T-cell Acute Lymphoblastic Leukemia patients, and they responded poorly to chemotherapy and experienced difficult clinical histories and inferior outcomes"}, {"pubmed": 28748258, "text": "High EZH2 expression is associated with colon cancer."}, {"pubmed": 28754964, "text": "EZH2 promotes epithelial-mesenchymal transition in endometriosis."}, {"pubmed": 28759046, "text": "The EZH2-mediated change in the epigenome of oral squamous cell carcinoma cells induces upregulation of ROS1 and its target genes, conferring greater invasiveness and plasticity to cope with the tumor microenvironment."}, {"pubmed": 28775165, "text": "Low EZH2 expression is associated with Glioma."}, {"pubmed": 28785086, "text": "Results show that EZH2 transcription is directly regulated by MUC1-C in many human neoplasm in an E2F-dependent mechanism."}, {"pubmed": 28795320, "text": "results suggest that EZH2 regulates cell proliferation potentially by targeting RUNX3 through the Wnt/beta-catenin signaling pathway in laryngeal carcinoma."}, {"pubmed": 28810932, "text": "High EZH2 expression is associated with Growth and Metastasis of Cholangiocarcinoma."}, {"pubmed": 28813519, "text": "Study corroborated that EZH2 mRNA expression is increased in MPNST but failed to confirm its reported pivotal role in MPNST pathogenesis as EZH2 knockdown by siRNA did not interfere with cellular proliferation and viability."}, {"pubmed": 28813705, "text": "Knockdown of EZH2 abolished the function of TUG1 and suppressed cell proliferation while co-transfection of sh-EZH2 and TUG1 expression vector showed that TUG1 promoted cell proliferation inhibited by sh-EZH2."}, {"pubmed": 28826853, "text": "inhibiting EZH2 promotes mesodermal differentiation of human embryonic stem cells."}, {"pubmed": 28832071, "text": "High Twist-1 expression, aberrant E-cadherin and high EZH2 expression in primary prostate cancer are considered as adverse prognostic markers of an aggressive tumor with high metastatic potential."}, {"pubmed": 28835384, "text": "These findings suggest that EZH2 inhibition in both mutant and wild-type backgrounds leads to increased B-cell maturation and a greater dependence on B-cell activation signaling."}, {"pubmed": 28854977, "text": "lncRNA CASC9 functions as an oncogene by negatively regulating PDCD4 expression through recruiting EZH2 and subsequently altering H3K27me3 level. Our study implicates lncRNA CASC9 as a valuable biomarker for ESCC diagnosis and prognosis."}, {"pubmed": 28862715, "text": "EZH2 positivity was significantly correlated with WHO tumor grade and worse prognosis in gliomas."}, {"pubmed": 28899973, "text": "our data support further assessment of TOP2A and EZH2 as biomarkers for early identification of patients with increased metastatic potential that may benefit from adjuvant or neoadjuvant targeted therapy approaches"}, {"pubmed": 28902349, "text": "Study demonstrated that EZH2 was increased in osteosarcoma tissues and cell lines. Its expression was negatively regulated by miR-144-3p and positively regulated by TUG1. EZH2 over-expression partly abolished TUG1 knockdown or miR-144-3p overexpression induced inhibition of migration and EMT in osteosarcoma cells."}, {"pubmed": 28923203, "text": "miR-34a expression is silenced epigenetically by EZH2 and DNA methylation, which promotes cholangiocarcinoma cell growth through activation of the Notch pathway."}, {"pubmed": 28923852, "text": "Overexpression of the wild-type TET1/2/3 3'UTR caused a significant increase in EZH2 expression and tumor growth, whereas the mutation in miR-26-binding sites abolished this effect."}, {"pubmed": 28925391, "text": "Study shows that EZH2 contributes to PARP inhibitors sensitivity in breast cancer cells. Mechanistically, upon oxidative stress or alkylating DNA damage, PARP1 interacts with and attaches poly-ADP-ribose (PAR) chains to EZH2."}, {"pubmed": 28935763, "text": "Long noncoding RNA ILF3-AS1 promotes EZH2-mediated cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma."}, {"pubmed": 28939884, "text": "Data show that embryonic stem cells with deletion of EZH1 or EZH2 fail to differentiate into ectoderm lineages."}, {"pubmed": 28946213, "text": "HOXA11-AS acted as an oncogenic long non-coding RNA that promoted cell growth and metastasis of glioma through regulating miR-214-3p/EZH2 axis."}, {"pubmed": 28963737, "text": "Long non-coding RNA LOC554202 may play an important role in the progression of chordoma by the direct upregulation of EZH2 and indirect promotion of RNF144B via miR-31"}, {"pubmed": 28967906, "text": "Study identifies the residues on EZH2 that are critical for its interaction with VAV and demonstrate that EZH2 interactions with VAV proteins are crucial for the regulation of adhesion dynamics and cellular transformation."}, {"pubmed": 28970725, "text": "Negative correlation between HOTAIR and E-cadherin was found in gastric cancer tissues and cell lines, and HOTAIR contributed to the regulation of E-cadherin through binding to EZH2 with the E-cadherin promoter."}, {"pubmed": 28973837, "text": "EZH2 has a role in T cell adhesion mediated by epigenetic remodeling and up-regulation of JAM-A."}, {"pubmed": 29022920, "text": "TUG1 can epigenetically inhibit the level of RND3 through binding to EZH2, thus promoting pre-eclampsia development."}, {"pubmed": 29026152, "text": "Genetic and Epigenetic Profiling Reveals EZH2-mediated Down Regulation of OCT-4 Involves NR2F2 during Cardiac Differentiation of Human Embryonic Stem Cells."}, {"pubmed": 29035360, "text": "Low EZH2 or MUS81 expression levels predict chemoresistance."}, {"pubmed": 29035367, "text": "Given that glioblastomas contain both proneural and mesenchymal GSCs, combined EZH2 and BMI1 targeting proved more effective than either agent alone both in culture and in vivo, suggesting that strategies that simultaneously target multiple epigenetic regulators within glioblastomas may be effective in overcoming therapy resistance caused by intratumoral heterogeneity"}, {"pubmed": 29045832, "text": "Rebalance of Histone h3 lysine 27 methylation 3 levels at specific genes through EZH2 inhibitors may be a therapeutic strategy in multiple myeloma cases harboring UTX mutations."}, {"pubmed": 29046366, "text": "These data inferred that long non-coding RNA PVT1 could be served as an indicator of glioma prognosis, and PVT1-EZH2 regulatory pathway may be a novel therapeutic target for treating glioma."}, {"pubmed": 29048683, "text": "in vitro restoration of PAR5 expression inhibited human glioma cell proliferation, invasion and migration by binding to EZH2 and regulating oncogene expression. This finding may provide a therapeutic approach for the future treatment of glioma"}, {"pubmed": 29053336, "text": "Suggest that a novel and functionally interdependent interplay between EZH2 and G9a regulates histone methylation-mediated epigenetic repression of the antifibrotic CXCL10 gene in idiopathic pulmonary fibrosis."}, {"pubmed": 29087303, "text": "PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors."}, {"pubmed": 29089464, "text": "EZH2 rs12670401 and rs6464926 polymorphisms, EZH2 and SMYD3 expression, clinical staging, lymph node metastasis, human epidermal growth factor receptor-2 (HER2) status, and metastasis may be correlated with breast cancer susceptibility and prognosis."}, {"pubmed": 29091973, "text": "our studies demonstrate that EZH2 plays a role in endoderm formation and hepatocyte differentiation, but its expression is tightly post-transcriptionally regulated during this process"}, {"pubmed": 29127861, "text": "Altered EZH2 splicing is associated with myelodysplastic syndrome."}, {"pubmed": 29130642, "text": "The data suggest that simultaneous inhibition of DNA methyl transferases and EZH2 leads to an extensive epigenetic reprogramming which allows myeloma cells to (re)gain sensitivity to IMiDs (pomalidomide)."}, {"pubmed": 29132376, "text": "Our data demonstrates that EZH2 participates in Glioblastoma multiforme-induced immune deficient and EZH2 suppression in Glioblastoma multiforme can remodel microglia immune functions"}, {"pubmed": 29141691, "text": "Results found EZH2 coupled with HOTAIR to repress miR-193a expression through trimethylation of H3K27 at miR-193a promoter in prostate cancer cell lines."}, {"pubmed": 29161520, "text": "The interaction of methyltransferase EZH2 or demethylase JMJD3 on RGMA, RARb2, AR, PGR, and ERa genes in the progression and aggressiveness of prostate cancer."}, {"pubmed": 29169732, "text": "MiR-4465 suppressed cancer cells proliferation and metastasis by directly targeting the oncogene EZH2."}, {"pubmed": 29174711, "text": "High Ki67, EZH2, and SMYD3 immunoexpression, adjusted for standard clinicopathological parameters, independently predicts outcome in patients with prostate cancer, at diagnosis."}, {"pubmed": 29185157, "text": "Cell adhesion-induced phosphorylation and inactivation of EZH2 confer drug resistance to acute myeloid leukemia cells."}, {"pubmed": 29185984, "text": "Preferential binding of G-quadruplex RNA is conserved, surprisingly using different protein elements. Key RNA-binding residues are spread out along the surface of EZH2."}, {"pubmed": 29193797, "text": "the action of PVT1 is moderately attributable to its repression of ANGPTL4 via association with the epigenetic repressor Ezh2."}, {"pubmed": 29202477, "text": "these observations demonstrate that MYCN upregulates EZH2, leading to inactivation of a tumor suppressor program in neuroblastoma, and support testing EZH2 inhibitors in patients with MYCN-amplified neuroblastoma."}, {"pubmed": 29202777, "text": "Coexistence of BRAF V600E mutation and EZH2 gain is rather prevalent in melanoma."}, {"pubmed": 29207119, "text": "EZH2 overexpression may contribute to tamoxifen resistance in breast cancer, and EZH2 inhibition may reverse tamoxifen resistance in breast cancer by regulating the cell cycle via the demethylation of the p16 gene."}, {"pubmed": 29212856, "text": "High EZH2 expression is associated with Tamoxifen Resistance in Breast Cancer."}, {"pubmed": 29221985, "text": "PPI decreased EZH2 expression. Silenced HOTAIR reduced EZH2 and DNMT1 expressions. Exogenously expressed HOTAIR resisted PPI-inhibited EZH2 and DNMT1 expressions, EZH2 promoter activity and cell growth. Excessive EZH2 antagonized PPI-suppressed DNMT1 protein expression or vice versa. The interactions among HOTAIR, DNMT1 and EZH2, and reciprocal regulation of DNMT1 and EZH2 contribute to the overall responses of PPI."}, {"pubmed": 29248547, "text": "a tumor-promoting role of EZH2 in primary cutaneous anaplastic large-cell lymphoma (PCALCL)."}, {"pubmed": 29270748, "text": "Upregulation of circRNA BCRC4 promoted apoptosis and inhibited viability of bladder cancer cells, up-regulated BCRC4-increased miR-101 level, which suppressed EZH2 expression in both RNA and protein levels."}, {"pubmed": 29272522, "text": "Alterations of EZH2, KMT2C, and CHD4 at genetic level or protein level could perturb epigenetic program, leading to malignant transformation in glioma."}, {"pubmed": 29275295, "text": "Enhancer of zeste homolog 2 (EZH2) overexpression is associated with malignant potential in thyroid cancer, and may thus be a useful prognostic marker of aggressive thyroid cancer."}, {"pubmed": 29286132, "text": "EZH2 increases STAT3 phosphorylation and upregulates the expression of 72 kDa type IV collagenase and overexpression of EZH2 was demonstrated to increase the proliferation and invasive potential of renal cell carcinoma cells."}, {"pubmed": 29294297, "text": "impairs dental pulp cell mineralization via the Wnt/beta-catenin pathway"}, {"pubmed": 29316949, "text": "These findings indicated that EZH2 facilitates galectin-9 expression by epigenetically repressing miR-22 and that galectin-9, which is known as an immunosuppressant, also functions as a tumor suppressor in HCC."}, {"pubmed": 29321554, "text": "In univariable analysis, patients carrying mutations in DNMT3A, U2AF1, and EZH2 had worse overall and relapse-free survival."}, {"pubmed": 29335012, "text": "Ezh2 regulates PTEN/AKT signaling by directly binding to the promoter regions of PTEN in Gastric Cancer."}, {"pubmed": 29344674, "text": "Long non-coding RNA H19 was found to play an oncogenic role in oral squamous cell carcinoma cells by regulating EZH2 and by targeting miR138."}, {"pubmed": 29351847, "text": "we report that AMPK phosphorylates the histone methyltransferase EZH2 at T311 to disrupt the interaction between EZH2 and SUZ12, another core component of the polycomb repressive complex 2 (PRC2), leading to attenuated PRC2-dependent methylation of histone H3 at Lys27. As such, PRC2 target genes, many of which are known tumor suppressors, were upregulated upon T311-EZH2 phosphorylation."}, {"pubmed": 29358618, "text": "EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental."}, {"pubmed": 29359794, "text": "Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes."}, {"pubmed": 29371630, "text": "In the former, p53 binds to the CDH1 (encoding E-cadherin) locus to antagonize EZH2-mediated H3K27 trimethylation (H3K27me3) to maintain high levels of acetylation of H3K27 (H3K27ac)."}, {"pubmed": 29393360, "text": "Heat-treated human dermal fibroblast exhibited a reduction in lncRNA LET expression and increase in EZH2 expression."}, {"pubmed": 29394319, "text": "these data indicate that RING1B and EZH2 repress the innate inflammatory cutaneous squamous cell carcinoma function and impair tumor immunosurveillance"}, {"pubmed": 29396474, "text": "the findings provide preliminary evidence suggesting potential of high level of EZH2 expression as a prognostic marker in smoking-associated breast cancer."}, {"pubmed": 29408583, "text": "Confirmation of an oncogenic role for LINC00319 in clinical specimens and cellular experiments, showing the potential LINC00319/miR-450b-5p/EZH2 pathway in lung adenocarcinoma tumorigenesis."}, {"pubmed": 29415665, "text": "Data suggest the polycomb repressive complex 2 subunits EZH2, SUZ12, and EED protein axis as promising therapeutic target for treating sarcoma."}, {"pubmed": 29416002, "text": "Findings revealed that EZH2 affects ACD of VSMCs and the pathologic process of AD via regulating ATG5 and ATG7 expression and MEK-ERK1/2 signaling."}, {"pubmed": 29425303, "text": "We find that co-occupancy of PLZF and EZH2 on chromatin at PLZF target genes is not associated with SUZ12 or trimethylated lysine 27 of histone H3 (H3K27me3) but with the active histone mark H3K4me3 and active transcription. Removal of EZH2 leads to an increase of PLZF binding and increased gene expression."}, {"pubmed": 29438697, "text": "Ezh2 and Runx1 mutations collaborate to initiate lympho-myeloid leukemia in early thymic progenitors"}, {"pubmed": 29445179, "text": "Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription."}, {"pubmed": 29479874, "text": "three single nucleotide polymorphismSNP rs2302427, rs3757441, and rs41277434 of Enhancer of Zeste Homolog 2 (EZH2) investigated show significant association with the elevated risk of hepatocellular carcinoma (HCC)."}, {"pubmed": 29487009, "text": "combined panel had the highest sensitivity and specificity at 96.3% and 100%, which was significantly or marginally higher than those of EZH2, C-KIT, and CD205 alone"}, {"pubmed": 29489508, "text": "High EZH2 levels significantly associated with elevated proliferation rates (P=0.0012) and with elevated percentage of positive cells for p53 (P=0.011) in Intestinal neuroendocrine tumors."}, {"pubmed": 29501388, "text": "Using CACNA1C promoter deletion constructs to analyse the modulation of a reporter gene in SH-SY5Y neuroblastoma cells, study identified a positive regulator within the region of -399 to -149 at the promoter & a repressor in the region of -838 to -399. Bioinformatic analysis using ENCODE ChIP-seq data demonstrated binding of transcription factor EZH2 at CACNA1C transcriptional start site."}, {"pubmed": 29507419, "text": "Study demonstrated that the high expression of EZH2 correlated with poor prognosis of neuroblastoma (NB) patients. Its depletion significantly induced neuronal differentiation. Further results indicated that NTRK1 is one of the EZH2-mediated epigenetic silencing targets in NB cells and regulates the EZH2-dependent undifferentiated status of NB."}, {"pubmed": 29530475, "text": "High EZH2 expression is associated with cholangiocarcinoma."}, {"pubmed": 29530751, "text": "RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia"}, {"pubmed": 29532870, "text": "The results indicated that when STAT3 signaling activity was attenuated by Stattic or enhanced with a STAT3 plasmid, the EZH2/miR-200 axis was markedly altered, thus resulting in modulation of the invasion and migration of OSCC cell lines."}, {"pubmed": 29555646, "text": "These data establish that Ezh2 is intrinsically dispensable for FL HSCs and provides proof of principle that modulation of epigenetic regulators in niche components can exert a marked cell-extrinsic impact."}, {"pubmed": 29557496, "text": "A high expression level of EZH2 was seen in CALR-mutant-positive primary myelofibrosis patients. The expression levels of hsa-miR-19a and hsa-miR-128 in the peripheral blood of patients with CALR mutations were significantly lower than in those with JAK2 mutation and normal controls. These microRNAs could participate in silencing EZH2 in patients with CALR mutations."}, {"pubmed": 29575713, "text": "Results found that EZH2 gene was amplified and upregulated in ovarian neoplasm tumors. EZH2 was also identified as a principal interacting proteins of druggable network."}, {"pubmed": 29581297, "text": "Results demonstrate that EZH2 inhibition enhances HCC eradication by NK cells and that EZH2 functions, in part, as an oncogene by inhibiting immune response."}, {"pubmed": 29630085, "text": "EZH2, ET-1, and CD34 may act as biomarkers of aggressive cervical squamous cell carcinoma"}, {"pubmed": 29630768, "text": "Findings indicate a mechanism fot the role of enhancer of zeste homolog 2 (EZH2) in ovarian cancer cisplatin resistance."}, {"pubmed": 29654889, "text": "Data indicated that EZH2 expression is regulated by HOXB9 in colon cancer cells. Overexpression of non acetylated HOXB9 upregulates EZH2 whereas AcK27-HOXB9 suppressed it."}, {"pubmed": 29674685, "text": "Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation."}, {"pubmed": 29689244, "text": "miR-26b may regulate EZH2 expression in breast cancer and may be useful as a therapeutic target for inflammatory breast cancer and noninflammatory locally advanced breast cancer"}, {"pubmed": 29705809, "text": "High glucose enhances the formation of EZH2/Snail/HDAC1 complex in the nucleus, which in turn causes E-cadherin repression."}, {"pubmed": 29710537, "text": "the hsa_circ_0071589/miR-600/EZH2 axis may play critical regulatory roles in the pathogenesis of colorectal cancer."}, {"pubmed": 29726819, "text": "In ovarian cancer, histone-lysine N-methyltransferase (EZH2) is commonly overexpressed and therefore potentially serves as an effective therapeutic target [Review]."}, {"pubmed": 29743723, "text": "In vivo delivery of miR-138 mimics or pharmacological inhibitor of EZH2."}, {"pubmed": 29748098, "text": "High EZH2 expression is associated with high-grade upper tract urothelial carcinoma."}, {"pubmed": 29759640, "text": "High EZH2 expression was associated with activation of tumor angiogenesis and predicted recurrence and prognosis of intrahepatic cholangiocarcinoma."}, {"pubmed": 29768655, "text": "These findings indicate that the let-7e/EZH2/H3K27me3/NF-kappaB p65 pathway is a novel regulatory axis of TNF-alpha expression."}, {"pubmed": 29789597, "text": "The current study was to determine the role of methyltransferase EZH2 and its catalysed H3K27 trimethylation (H3K27me3) in liver failure."}, {"pubmed": 29789713, "text": "FOXD2-AS1 acted as a tumor inducer in GC partly through EphB3 inhibition by direct interaction with EZH2 and LSD1."}, {"pubmed": 29790898, "text": "Data show that miR-1301 inhibited the expression of enhancer of zeste homolog 2 protein (EZH2) by binding to the 3' untranslated regions (3'-UTR) of EZH2 gene."}, {"pubmed": 29793547, "text": "AFAP1-AS1 epigenetically silences p21 transcription by binding to EZH2 thus promoting non-small cell lung cancer cell growth."}, {"pubmed": 29803673, "text": "We characterized a lncRNA, PCa specific expression and EZH2-associated transcript (PCSEAT, annotated as PRCAT38), which is specifically overexpressed in prostate cancer. PCSEAT promotes cell proliferation, at least in part by affecting miR-143-3p- and miR-24-2-5p-mediated regulation of EZH2."}, {"pubmed": 29848731, "text": "Enhancer of zeste homolog 2 (EZH2) was frequently observed in patients with resected small cell lung cancer (SCLC) , but no significant associations were found between its expression and the clinicopathological characteristics and postoperative survivals."}, {"pubmed": 29852354, "text": "Curcumol inhibits proliferation and induces apoptosis by targeting EZH2."}, {"pubmed": 29858685, "text": "Primary cutaneous follicle center lymphomas with concomitant 1p36 deletion and TNFRSF14 mutations frequently express high levels of EZH2 protein."}, {"pubmed": 29859193, "text": "FOXP4-AS1 is overexpressed in osteosarcoma (OS), and is the independent risk factor in OS prognosis. Upregulated FOXP4-AS1 promotes the proliferation, migration and cell cycle, but inhibits apoptosis of OS cells. Furthermore, FOXP4-AS1 participates in the development and progression of OS by downregulating LATS1 via binding to LSD1 and EZH2."}, {"pubmed": 29870057, "text": "Loss-of-function assays demonstrated that silenced FAM83H-AS1 obviously suppressed cell proliferation via regulating the cell-cycle distribution and cell apoptosis rate, and mechanistic experiments revealed that FAM83H-AS1 could epidemically silence CDKN1A expression through recruiting EZH2 to the promoter of CDKN1A, thereby influencing the cell cycle and proliferation."}, {"pubmed": 29896299, "text": "The study exemplifies flow-dependent epigenetic regulation of endothelial gene expression, and also suggests that targeting the EZH2/H3K27me3/IGFBP5 pathway may offer novel therapeutics for inflammatory disorders such as atherosclerosis."}, {"pubmed": 29940916, "text": "EZH2 as a relevant coregulator for estrogen-related receptors alpha, beta and gamma in breast carcinoma."}, {"pubmed": 29941599, "text": "results show the effect of individual O-GlcNAcylation sites on the function of EZH2 and suggest an alternative approach to tumor suppression through selective inhibition of EZH2 O-GlcNAcylation."}, {"pubmed": 29959321, "text": "Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program driven by FOXC1."}, {"pubmed": 29972783, "text": "macroH2A1.2 physically and functionally interacts with the histone methyltransferase EZH2 and elevates Histone 3 lysine 27 trimethylation levels to keep LOX gene in a repressed state."}, {"pubmed": 29982334, "text": "Somatic mutations in EZH2 were associated with sporadic parathyroid adenomas in a Chinese population."}, {"pubmed": 29992318, "text": "EZH2 acts antagonistically to AKT signaling in maintaining H3K27 methylome through epigenetic silencing of IGFBP4. Igfbp4 down-regulation significantly correlated with EZH2 overexpression and poor survivals of HCC patients."}, {"pubmed": 30004110, "text": "MDS associated with myeloproliferative features had more EZH2, ASXL1 and STAG2 mutations"}, {"pubmed": 30008323, "text": "Gain of EZH2 promotes loss of primary cilia in benign melanocytic lesions, enhancing pro-tumorigenic WNT/beta-catenin signaling, and is itself sufficient to drive metastatic melanoma in benign cells."}, {"pubmed": 30022044, "text": "p38-mediated phosphorylation at threonine 367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis."}, {"pubmed": 30031020, "text": "Findings indicate that EZH2 pathway is significantly upregulated in the PCs of CLL/SLL lymph nodes, providing further evidence for the distinguished biological features of the PCs."}, {"pubmed": 30031062, "text": "High EZH2 expression is associated with gastric cancer."}, {"pubmed": 30038060, "text": "he SLC34A2-ROS-HIF-1-induced overexpression of EZH2 promotes colorectal cancer (CRC) cells proliferation and chemo-resistance to apoptosis. SLC34A2-ROS-HIF-1-EZH2 signaling pathway might serve as a novel therapeutic target against CRC."}, {"pubmed": 30066891, "text": "Mechanistic studies in human breast cancer cell lines revealed that miR-92b directly targeted EZH2 promoting autophagy, and inhibiting the viability and invasion of breast cancer cells."}, {"pubmed": 30071900, "text": "EZH2 interacts with PCNA and dimethylates PCNA at lysine 110.  Dimethylation of PCNA is essential for DNA polymerase delta binding to PCNA and DNA replication."}, {"pubmed": 30072740, "text": "EZH2 is directly targeted by KDM8 and involved in sustaining the survival of the prostate cancer cells under androgen-deprived conditions.  In enzalutamide-resistant cells, the expression of EZH2 is elevated and EZH2 inhibitors resensitize the cells toward enzalutamide."}, {"pubmed": 30093632, "text": "Both O-GlcNAcylation transferase (OGT) and EZH2 are posttranscriptionally inhibited by microRNA-101. O-GlcNAcylation and H3K27me3 modification in the miR-101 promoter region inhibited the transcription of miR-101, resulting in the upregulation of OGT and EZH2 in metastatic CRC, thus forming a vicious cycle. O-GlcNAcylation,negatively regulated by microRNA-101, likely promotes CRC metastasis by enhancing EZH2 stability."}, {"pubmed": 30105513, "text": "Enhancer of Zeste Homolog 2 (EZH2), SET domain, bifurcated 1 protein (SETDB1), lysine-specific histone demethylase 1 (LSD1), histone H3 methylation (H3K9me3 and H3K27me3) expression are altered in colorectal cancer (CRC) and may play a role in colorectal carcinogenesis."}, {"pubmed": 30105866, "text": "our study indicated that HOXB13-AS1 could regulate HOXB13 gene expression by methylation HOXB13 promoter and acts as an epigenetic oncogenic in glioma."}, {"pubmed": 30106089, "text": "The study demonstrated the oncogenic role of CASC9 in drugresistant breast cancer by binding to EZH2 and regulating the MDR1 gene. Modulation of CASC9 expression may be a promising target in the therapy of breast cancer and drugresistant breast cancer."}, {"pubmed": 30112706, "text": "Tazemetostat, first-in-class EZH2 inhibitor, demonstrated enhanced clinical activity in mutant follicular lymphoma and diffuse large B cell lymphoma. With the early activity noted by tazemetostat in B cell lymphomas, the role of EZH2 inhibition in NHL is becoming more evident."}, {"pubmed": 30119259, "text": "HOXD-AS1 could interact with EZH2, and then repress p57 expression, to aggravate osteosarcoma oncogenesis."}, {"pubmed": 30120321, "text": "the high expression of EZH2 is a promising marker in distinguishing well-differentiated LMS from cellular leiomyoma, or well-differentiated ERMS from fetal rhabdomyoma, and the upregulation of EZH2 protein expression may occur at transcriptional level."}, {"pubmed": 30131250, "text": "miR-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant glioma cell proliferation"}, {"pubmed": 30150059, "text": "These findings demonstrate a novel working model in which EZH2 mediates AR-induced Wnt/beta-catenin signaling activation through epigenetic modification."}, {"pubmed": 30151890, "text": "Immunohistochemical analysis revealed that the CDCA7/EZH2 axis was clinical relevant. These findings suggest CDCA7 plays a crucial role in TNBC progression by transcriptionally upregulating EZH2."}, {"pubmed": 30166592, "text": "In ovarian cancer cells, increased expression of EZH2 activates cellular survival pathways, resulting in the resistance to cisplatin. Inhibition of c-Myc-miR-137-EZH2 pathway re-sensitizes resistant cells to cisplatin. Clinical studies further confirm the activated c-Myc-miR-137-EZH2 pathway in platinum drug-resistant or recurrent ovarian cancer patients."}, {"pubmed": 30213970, "text": "network analysis of the central circadian pathway genes linked their expression to the up regulated expression of the histone methyltransferase gene EZH2, a gene that when mutated in both humans and mice controls overall skeletal growth"}, {"pubmed": 30218753, "text": "Our data suggest that EZH2 and H3K27me3 are important prognostic markers and potential therapeutic targets in extranodal NK/T-cell lymphoma, nasal type"}, {"pubmed": 30258009, "text": "Results provide evidence that EZH2 cooperates with lncRNA ANRIL supporting the proliferation of HTLV-1-infected cells, which is thought to be critical for oncogenesis."}, {"pubmed": 30266084, "text": "the results of our studies illuminate how SNHG1 formed a regulatory network to confer an oncogenic function in colorectal cancer and suggest that SNHG1 may serve as a potential target for colorectal cancer diagnosis and treatment."}, {"pubmed": 30280514, "text": "EZH2, a target of miR-144, serves as an oncogene in LUAD. EZH2 was upregulated in lung adenocarcinoma (LUAD) cells. Its knockdown could suppress the propagation and invasion of LUAD cells."}, {"pubmed": 30282996, "text": "MEG3 executed its functions via EZH2 to regulate the downstream target gene LATS2."}, {"pubmed": 30304920, "text": "EZH2 regulates the expression of miR-139-5p via H3K27me3, and the EZH2/miR-139-5p axis participates in the progression of Pancreatic cancer."}, {"pubmed": 30305602, "text": "data demonstrated that in brain glioma cells, the decrease of EZH2 level could suppress cell proliferation and tumorigenesis potency, and meanwhile inhibit the expressions of oncogenes including c-myc and Akt."}, {"pubmed": 30314898, "text": "mechanistic investigation demonstrated that the oncogenic activity of PCAT6 is partially attributable to its repression of LATS2 via association with the epigenetic repressor EZH2 (Enhancer of zeste homolog 2)."}, {"pubmed": 30342849, "text": "report a newly identified regulatory mechanism HANR/miR-214/EZH2/TGF-beta axis, which is implicated in tumorigenesis and progression of hepatocellular carcinoma"}, {"pubmed": 30343006, "text": "EZH2-expressing lung adenocarcinomas were shown to express the PD-L1 protein more frequently than were nonexpressing lesions. This study provides the first evidence of a possible association between the EZH2 and PD-L1 expression in patients with resected lung adenocarcinoma."}, {"pubmed": 30353102, "text": "The miR-142-3p was epigenetically silenced by EZH2-recruited DNMT1 and suppressed nasopharyngeal carcinoma cell metastasis and Epithelial to Mesenchymal Transition."}, {"pubmed": 30367633, "text": "The EZH2 expression is decreased in multiple sclerosis patients"}, {"pubmed": 30374835, "text": "EZH2, KDM6A, and KDM6B genes synergistically affect H3K27me for gastric cancer susceptibility."}, {"pubmed": 30389560, "text": "lncRNA FOXC2-AS1 accelerated the tumor progression of prostate cancer cells by regulating the proliferation and tumor growth through miR-1253/EZH2 axis."}, {"pubmed": 30397178, "text": "As a novel regulator, lnc-LBCS plays an important tumor-suppressor role in BCSCs' self-renewal and chemoresistance, contributing to weak tumorigenesis and enhanced chemosensitivity. The lnc-LBCS-hnRNPK-EZH2-SOX2 regulatory axis may represent a therapeutic target for clinical intervention in chemoresistant bladder cancer."}, {"pubmed": 30408551, "text": "EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression."}, {"pubmed": 30420287, "text": "LSINCT5 interacted with EZH2 to suppress the expression of APC, a negative regulator of the Wnt/beta-catenin pathway."}, {"pubmed": 30425057, "text": "High EZH2 expression and Stabilization is associated with Glioma Tumorigenesis."}, {"pubmed": 30458017, "text": "Adenocarcinoma-specific mRNA expression levels of EZH2 and RRM1 are associated with poor post-surgical survival in the first set of patients, but not replicated in a clinically and pathologically matched independent validation set. This study highlights challenges associated with clinical translation of prognostic biomarkers."}, {"pubmed": 30469511, "text": "EZH2 up-regulation is correlated with tumor aggressiveness and adverse patient outcomes in head and neck squamous cell carcinoma."}, {"pubmed": 30487153, "text": "These results demonstrate that EZH2 is crucial for the intricate epigenetic regulation of not only lytic but also latent gene expression of Epstein-Barr virus in Akata cells."}, {"pubmed": 30487290, "text": "Ezh2 inhibition may restrict cell proliferation and promote defined adaptive responses. Targeting these responses potentially improves outcomes in Kras-driven non-small-cell lung cancers."}, {"pubmed": 30510991, "text": "Destabilized FOXP3-EZH2 protein interaction via diverse mechanisms and consequent Treg abnormality may drive gastrointestinal inflammation."}, {"pubmed": 30517868, "text": "EZH2 is a transcriptional activator, a key target of which is AR, and suggests a drug-combinatory approach to treat advanced prostate cancer."}, {"pubmed": 30527357, "text": "these results indicate that changes in EZH2 expression lead to changes in CEP55 expression in lung adenocarcinoma, and these changes are associated with its prognosis"}, {"pubmed": 30539787, "text": "Inhibition of EZH2 attenuates fibrogenic gene transcription in TGF-beta-treated hepatic stellate cells and reduces liver fibrosis in vivo."}, {"pubmed": 30542123, "text": "EZH2 levels can be used to identify more aggressive phenotypes in UC patients, thereby improving our prognostic knowledge."}, {"pubmed": 30551433, "text": "TUG1 could epigenetically suppress miR-34a expression via recruiting Enhancer of zeste homolog 2 (EZH2)."}, {"pubmed": 30569799, "text": "Our data highlighted that PCAT6 acts as a key activator of ARC expression by forming a complex with EZH2, inhibiting cell apoptosis and contributing to colon cancer progression. These findings elucidated that PCAT6 may be a novel prognostic predictor and therapeutic target of colon cancer"}, {"pubmed": 30578411, "text": "UL1 regulated EZH2 expression to promote the production of cytokines, and finally significantly aggravating the breast cancer cell metastasis and angiogenesis through the PI3K-AKT-mTOR signaling pathway."}, {"pubmed": 30593723, "text": "study demonstrated that TUG1 promotes the migration and invasion of human adenomyotic epithelial cells, and EGR1/TUG1/EZH2/TIMP2 may be a potential therapeutic target for adenomyosis."}, {"pubmed": 30621625, "text": "We found that Ezh2 was induced in our established Doc resistant (DocR) cells, which was attributable to the silenced expression of miR-101-3p and miR-138-5p."}, {"pubmed": 30622230, "text": "USP44 promotes the tumorigenesis of prostate cancer cells partly by stabilizing EZH2."}, {"pubmed": 30628724, "text": "Data support the idea that in addition to functioning as a transcriptional repressor, EZH2 is also an androgen receptor coactivator and activates many downstream targets in prostate cancer."}, {"pubmed": 30632221, "text": "Study finds that higher MYC levels are associated with increased EZH2, and pharmacological blockade of EZH2 is a potential therapeutic strategy for aggressive medulloblastoma with elevated MYC."}, {"pubmed": 30655550, "text": "CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer."}, {"pubmed": 30677405, "text": "overexpression of ZH2 could at least partially reverse the tumor suppressive effects of miR-31 indicating direct involvement of ZH2 in the miR-31 mediated inhibitory effects on advanced gastric cancer cell proliferation"}, {"pubmed": 30692641, "text": "Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer."}, {"pubmed": 30692681, "text": "EZH2(Y646X) alters the topology and function of chromatin domains to promote synergistic oncogenic programs."}, {"pubmed": 30700785, "text": "The EZH2 SANT1 domain is a histone reader providing sensitivity to the modification state of the H4 tail."}, {"pubmed": 30710146, "text": "A targetable vulnerability associated with NFATc2 and EZH2 expression in melanoma cells belonging to different mutational subsets."}, {"pubmed": 30716533, "text": "a putative mechanism for promotion of carcinogenesis in early-stage colon cancers by loss of immunosuppressive molecules by epigenetic silencing through NF-kappaB-mediated EZH2/YY1 axis"}, {"pubmed": 30723117, "text": "EZH2 cooperates with gain-of-function p53 mutants to promote prostate cancer growth and metastasis."}, {"pubmed": 30728347, "text": "Drinking during adolescence also contributed to significant decreases in activity-regulated cytoskeleton-associated protein (ARC) expression which also appeared to be mediated by increased EZH2 deposition of repressive H3K27me3 at the ARC synaptic activity response element."}, {"pubmed": 30747066, "text": "Anti-cancer Effects of Curcumin on Myelodysplastic Syndrome through the Inhibition of Enhancer of Zeste Homolog-2 (EZH2)."}, {"pubmed": 30755708, "text": "EZH2 is involved in the maintenance of preplasmablast transitory immature proliferative state that supports their amplification."}, {"pubmed": 30760814, "text": "Genome-wide expression analysis reveals six contravened targets of EZH2 associated with breast cancer patient survival."}, {"pubmed": 30779601, "text": "the interaction between Smad3 and EZH2 targets the core polycomb assembly to defined regions of the genome to regulate transcriptional repression and forms a molecular switch that controls promoter access through epigenetic mechanisms leading to gene silencing."}, {"pubmed": 30786928, "text": "Lnc-PDZD7 promotes stemness properties and suppresses chemosensitivity though the miR-101/EZH2/ATOH8 pathway."}, {"pubmed": 30809307, "text": "EZH2 and TET1 operate in trans to more tightly control target gene activity in Triple-negative breast cancer"}, {"pubmed": 30811870, "text": "EZH2 silencing and PTEN overexpression significantly abrogated the SOX2-OT overexpression-mediated promotion of laryngeal squamous cell carcinoma (LSCC) cell malignant behavior. Collectively, our findings demonstrate that SOX2-OT inhibits PTEN expression to facilitate LSCC development through EZH2-mediated H3K27me3"}, {"pubmed": 30844722, "text": "review of how EZH2 contributes to stem cell maintenance and cell lineage determination (including gonadogenesis, neurogenesis, myogenesis, osteogenesis, hematopoiesis, lymphopoiesis, adipogenesis, epidermal differentiation and hepatogenesis), and the regulation of EZH2 by phosphorylation and different signaling pathways [review]"}, {"pubmed": 30853334, "text": "It is possible that the development of combinations that target DNMT,EZH2, or HDAC, or that complement their downstream effects in a more targeted way, may be useful in curtailing resistance to immunotherapy."}, {"pubmed": 30858506, "text": "In silico modeling and calculations of the free energy changes resulting from these variants suggested that they not only destabilize the EED protein structure but also adversely affect interactions between EED, EZH2, and/or H3K27me3."}, {"pubmed": 30867289, "text": "functions mostly within canonical PRC2 and exhibits proliferation-dependent redundancy that shapes mutational signatures in cancer"}, {"pubmed": 30868890, "text": "miR-101 inhibited autophagy and proliferation and promoted apoptosis via targeting EZH2 in laryngeal squamous cell carcinoma. EZH2 up-regulation weakened miR-101-mediated anti-autophagy, anti-proliferation and pro-apoptosis effects."}, {"pubmed": 30879952, "text": "EZH2 in Ewing sarcoma cells directly binds to the promoter regions of genes encoding for two key enzymes of GD2 biosynthesis, and EZH2 inhibition enhances expression of these genes. GD2 surface expression in Ewing sarcoma cells is not associated with distinct in vitro proliferation, colony formation, chemosensitivity, or in vivo tumorigenicity"}, {"pubmed": 30883033, "text": "The data indicate that the aberrant expression of NUDT21 contributes to Preeclampsia (PE) by targeting 3'-UTR of EZH2 mRNA. These findings may provide novel targets for future investigations into therapeutic strategies for PE"}, {"pubmed": 30885343, "text": "this study shows that highly expressed EZH2 in combination with BAP1 and MTAP loss is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia"}, {"pubmed": 30903272, "text": "EZH2 may play a role in the pathogenesis of endocervical neoplasia, and the detection of robust expression of EZH2 might be a useful differential diagnostic tool in problematic endocervical lesions."}, {"pubmed": 30912166, "text": "dephosphorylation of EZH2 at S21 site mediated the RECK dysregulation by ERK1/2 signaling"}, {"pubmed": 30952377, "text": "we found that EZH2 influences gastric cancer cells proliferation partly through regulating p21 expression"}, {"pubmed": 30967505, "text": "Studied interactions and binding between enhancer of zeste 2(EZH2) mutants and Histone 3 in activation of the Polycomb Repressor Complex 2 methyltransferase function."}, {"pubmed": 30968962, "text": "Study demonstrates that EZH2 tightly cooperates with genome caretaker BRCA1 in the regulation of the phenotype and properties of prostate cancer stem cells."}, {"pubmed": 30971429, "text": "these results indicate that EZH2 inhibition promotes lipoprotein-dependent lipid accumulation via inducing ApoE expression in adipocytes, suggesting a novel mechanism of lipid regulation by EZH2."}, {"pubmed": 31002139, "text": "LncRNA PVT1 knockdown affects proliferation and apoptosis of uveal melanoma cells by inhibiting EZH2."}, {"pubmed": 31004581, "text": "The results revealed that FOXD2-AS1 could epigenetically silence CDKN1B by recruiting EZH2 to CDKN1B promoter region."}, {"pubmed": 31020497, "text": "Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression."}, {"pubmed": 31023785, "text": "Identification of mutations in the PRC2 components EED and SUZ12 in the majority of MPNSTs may imply noncanonical oncogenic activities of the intact component, EZH2, and provide new opportunities for therapeutic intervention."}, {"pubmed": 31028191, "text": "our study reveals an elevated expression of DAB2IP which could be modulated via the parallel down-regulation of EZH2 and mir-363-3p."}, {"pubmed": 31036541, "text": "EZH2 is expressed at significantly higher levels in BRCA1-deficient breast cancers.  EZH2 overexpression can identify patients with breast cancer who benefit significantly from intensified DSB-inducing platinum-based chemotherapy independent of BRCA1-like status."}, {"pubmed": 31037158, "text": "A cisplatin-HOXB13-ABCG1/EZH2/Slug network may account for a novel mechanism underlying cisplatin resistance."}, {"pubmed": 31042721, "text": "Results found that EZH2 overexpression was significantly correlated with poor disease-free and overall survival of patients with lung adenocarcinoma. Also, EZH2 was shown to be an independent predictor of EMT marker expression, Vimentin, and vice versa."}, {"pubmed": 31053162, "text": "Substitution of Ezh2-dCas9 with KRAB-dCas9 enabled long-term repression at some target genes (e.g., SNURF) but not at HER2, at which H3K9me3 and DNA methylation were transiently acquired and subsequently lost."}, {"pubmed": 31071316, "text": "XIST plays an important role in progression of Laryngeal squamous cell carcinoma by modulating the miR-124-EZH2 axis."}, {"pubmed": 31081092, "text": "LncRNA MSTO2P promotes proliferation and autophagy of lung cancer cells by up-regulating EZH2 expression."}, {"pubmed": 31087496, "text": "Targeting EZH2 as a novel therapeutic strategy for sorafenib-resistant thyroid carcinoma."}, {"pubmed": 31092221, "text": "Results confirmed that WHSC1 expression was suppressed by EZH2 knockdown or inhibition, indicating that EZH2 is upstream of WHSC1 in ovarian clear cell carcinoma cells."}, {"pubmed": 31096221, "text": "We suggest that the expression of enhancer of zeste homolog 2 is not associated with the polycomb repressive complex 2 pathway and increases in patients with H3K27M-mutant diffuse midline glioma and a poor prognosis."}, {"pubmed": 31097223, "text": "The DDX11-AS1 suppressed LATS2 expression by interacting with EZH2 and DNMT1 in hepatocellular carcinoma cells."}, {"pubmed": 31104332, "text": "high pretreatment EZH2 expression in prostate cancer in diagnostic biopsies is associated with an increased risk of postradiotherapy metastatic disease recurrence, but EZH2 function may only at most play a modest role in promoting prostate cancer cell radioresistance."}, {"pubmed": 31106974, "text": "EZH2 expression levels were increased in whole blood, neutrophils, monocytes, B cells, and CD4+ T cells in lupus patients."}, {"pubmed": 31126817, "text": "Our findings suggest that overexpression of the PRC2 key components especially EZH2 in both nucleus and cytoplasm can be potentially used as a prognostic marker for cholangiocarcinoma."}, {"pubmed": 31138033, "text": "miR-32 acts an important role in inhibiting glioma cell proliferation and metastasis and suppresses the expression of ABCC4 by directly targeting its 3'-untranslated region. The miR-32/enhancer of zeste homolog 2 axis may provide new insights to the treatment for glioma."}, {"pubmed": 31140859, "text": "EZH2 was recruited to the promoter of p21 accompanied with H3K27me3 enrichment and transcription silencing.  EZH2 attenuates chemoresistance of breast cancer cells to taxol by dampening p21 epigenetically."}, {"pubmed": 31180543, "text": "Knockdown of linc00467 altered the expression of downstream genes, including HtrA serine peptidase 3 (HTRA3), and RNA immunoprecipitation and chromatin immunoprecipitation assays indicated that linc00467 recruited EZH2 to the HTRA3 promoter to inhibit its expression."}, {"pubmed": 31197517, "text": "miR-124-3p functioned as a negative regulator to inhibit the proliferation, migration and invasion of ESCC cells by directly targeting EZH2."}, {"pubmed": 31204938, "text": "miR-101 can inhibit the cell proliferation and induce cell apoptosis of mantle cell lymphoma by targeting EZH2"}, {"pubmed": 31216925, "text": "EZH2 directly binds to the IGF1R promoter along with MYC and upregulates IGF1R expression in chronic lymphocytic leukaemia, leading to downstream PI3K activation."}, {"pubmed": 31219209, "text": "Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2."}, {"pubmed": 31256157, "text": "This study shows that EZH2, which is required in the activation of dendritic cells, mediates the epigenetic modification in Allergen immunotherapy and stresses the importance of patient adherence during Allergen immunotherapy."}, {"pubmed": 31273190, "text": "SNHG14 serves as a facilitator in colorectal carcer through targeting EZH2-repressed EPHA7."}, {"pubmed": 31273598, "text": "data suggest that EZH2 plays an important role in the development of intestinal inflammation and necroptosis. EZH2 expression was decreased in patients with inflammatory bowel disease. EZH2 downregulation increased the expression of inflammatory factors, including TNF-alpha, IL-8, IL-17, CCL5, and CCL20 in a Caco-2 cell model."}, {"pubmed": 31273925, "text": "Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop."}, {"pubmed": 31282094, "text": "NF-kappaB/NKILA signaling modulates the anti-cancerous effects of EZH2 inhibition."}, {"pubmed": 31285428, "text": "EZH2 methyltransferase and JMJD3/UTX demethylases were deregulated during hepatic differentiation of human HepaRG cells."}, {"pubmed": 31305292, "text": "Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptor."}, {"pubmed": 31317325, "text": "Loss of EZH2 at tumor invasion front, but not in tumor center was correlated with unfavorable prognosis and more advanced tumor stages."}, {"pubmed": 31331645, "text": "The present results indicate that EZH2 regulates the immunosuppressive molecule PD-L1 expression via HIF-1alpha in non-small cell lung cancer cells."}, {"pubmed": 31331874, "text": "Study of 211 Tunisian patients with de novo acute myeloid leukemia (AML) and 14 healthy donors showed presence of EZH2 mutations was significantly associated with failure of consolidation therapy. When EZH2 mutations were associated with mutations in FLT3 or IDH2, a short duration of progression free survival was observed, and CD7 aberrant markers conferred a poor prognosis in EZH2 mutated patients"}, {"pubmed": 31332986, "text": "role of NSD2 and EZH2 in the pathogenesis of endometrial carcinoma"}, {"pubmed": 31352449, "text": "EZH2 is a promising diagnostic biomarker for malignancy in effusion cytology"}, {"pubmed": 31363169, "text": "EZH2 mostly works as a transcriptional inducer in adrenocortical carcinoma, through cooperation with the transcription factor E2F1 and it has three positive targets involved in cell cycle regulation and mitosis i.e., RRM2, PTTG1 and ASE1/PRC1."}, {"pubmed": 31366503, "text": "This is the first study to show that Wedelolactone (WL) induces inhibition of H3K27 methylation via EZH2 modulation and decreases cell proliferation in mantle cell lymphoma (MCL) , in vitro. WL is proposed as a promising agent and a novel epigenetic approach in MCL investigation and treatment."}, {"pubmed": 31368152, "text": "EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells."}, {"pubmed": 31376657, "text": "DLEU2 accelerates the proliferative, migratory and invasive abilities of hepatocellular carcinoma cells via binding to EZH2."}, {"pubmed": 31383940, "text": "Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression."}, {"pubmed": 31389610, "text": "LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2."}, {"pubmed": 31408621, "text": "in vivo experiments demonstrated that the EZH2 inhibitor GSK126 significantly inhibited Ang-II-induced atrial enlargement and fibrosis and reduced AF vulnerability."}, {"pubmed": 31413097, "text": "EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia."}, {"pubmed": 31424661, "text": "Authors conclude that the normal expression of EZH2 in cancer tissue controls cancer stem cell expansion, because it is highly elevated in EZH2-silencing cancer tissue."}, {"pubmed": 31431463, "text": "EZH2 is involved in the generation of IDH-wild-type diffuse astrocytic gliomas"}, {"pubmed": 31434700, "text": "These findings uncover an important role of MELK and USP36 in mediating EZH2 stability in extranodal natural killer/T-cell lymphoma (NKTL). Moreover, MELK overexpression led to decreased sensitivity to bortezomib treatment in NKTL based on deprivation of EZH2 ubiquitination."}, {"pubmed": 31468686, "text": "by redistributing EZH2 across the genome, cancer cells subvert developmental transcriptional programmes that specify normal cell identity and remove physiological breaks that restrain cell proliferation."}, {"pubmed": 31476446, "text": "Recuperative effect of metformin loaded polydopamine nanoformulation promoting EZH2 mediated proteasomal degradation of phospho-alpha-synuclein in Parkinson's disease model."}, {"pubmed": 31479715, "text": "High EZH2 expression is associated with non-small cell lung cancer."}, {"pubmed": 31497936, "text": "LINC01303 functions as a competing endogenous RNA to regulate EZH2 expression by sponging miR-101-3p in gastric cancer."}, {"pubmed": 31518916, "text": "EZH2 and H3K27me3 was significantly upregulated in the circulation of septic patients, whereas patients who survived presented downregulated the expression of EZH2 on CD14+ monocytes. EZH2 could be a potential biomarker predicting clinical outcome and a new target for therapeutic interference in sepsis."}, {"pubmed": 31545422, "text": "High EZH2 expression is associated with epithelialmesenchymal transition in head and neck squamous cell carcinoma."}, {"pubmed": 31557401, "text": "LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2."}, {"pubmed": 31562203, "text": "Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer."}, {"pubmed": 31582742, "text": "LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression."}, {"pubmed": 31582835, "text": "EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway."}, {"pubmed": 31617275, "text": "Upregulation of nuclear-enriched abundant transcript 1 confers oxaliplatin resistance to gastric cancer."}, {"pubmed": 31636385, "text": "HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer."}, {"pubmed": 31640461, "text": "Clinical and biological significance of EZH2 expression in endometrial cancer."}, {"pubmed": 31642440, "text": "Low expression of EZH2 in the colon tissue of children with Hirschsprung's disease may be one of the causes of inadequate expression of GFRalpha1 and onset of Hirschsprung's disease"}, {"pubmed": 31646568, "text": "LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1."}, {"pubmed": 31666665, "text": "Cigarette smoke affects the onco-suppressor DAB2IP expression in bronchial epithelial cells of COPD patients."}, {"pubmed": 31669648, "text": "The oncogenic function of circ-EZH2 was partly dependent on its modulation of DDAH1 and CBX3."}, {"pubmed": 31693890, "text": "Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis."}, {"pubmed": 31704732, "text": "EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATM."}, {"pubmed": 31704857, "text": "The somatic mutations in JAK2 influence the clinical behavior of the disease. We found that ASXL1 or EZH2 mutation acquisition after JAK2 leads to polycythemia vera, while ASXL1 mutation acquisition before JAK2 leads to essential thrombocythemia or primary myelofibrosis. Mutations in TP53, ASXL1, and splicing genes are associated with the prognosis of myeloproliferative neoplasms."}, {"pubmed": 31718595, "text": "These results suggest a potential role of EZH2 for the PTC growth and metastasis. As a novel therapy, a pharmacological therapy targeting EZH2 has full potential in treatment of PTC."}, {"pubmed": 31724824, "text": "review the PRC2 complex and clinical syndromes of overgrowth and intellectual disability associated with core components EZH2, EED, and SUZ12"}, {"pubmed": 31727135, "text": "The epigenetic modificator EZH2 can suppress the expression of immune checkpoint inhibitor PD-L1 by directly upregulating the promoter H3K27me3 levels of CD274 and IRF1 in hepatoma cells, and might serve as a potential therapeutic target for combination of immunotherapy for immune-activated HCC."}, {"pubmed": 31732666, "text": "Long noncoding RNA HERES appears to be a transacting factor that regulates CACNA2D3, SFRP2, and CXXC4 simultaneously to activate Wnt signaling pathways in esophageal squamous cell carcinoma through an interaction with EZH2 via its G-quadruple structure-like motif."}, {"pubmed": 31747378, "text": "LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis."}, {"pubmed": 31747604, "text": "Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas."}, {"pubmed": 31751560, "text": "EGFRvIII-mediated epigenetic suppression of ARHI promoted glioma cell proliferation and migration via upregulating EZH2."}, {"pubmed": 31773700, "text": "MicroRNA-130-5p promotes invasion as well as migration of lung adenocarcinoma cells by targeting the EZH2 signaling pathway."}, {"pubmed": 31784651, "text": "A lncRNA coordinates with Ezh2 to inhibit HIF-1alpha transcription and suppress cancer cell adaption to hypoxia."}, {"pubmed": 31794134, "text": "EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia."}, {"pubmed": 31811272, "text": "A TGF-beta-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis."}, {"pubmed": 31823218, "text": "Prognostic Value of TWIST1 and EZH2 Expression in Colon Cancer."}, {"pubmed": 31841965, "text": "LncGAS5 mediates Th1/Th2 differentiation partly through downregulating T-bet and EZH2."}, {"pubmed": 31842978, "text": "Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/beta-catenin signaling pathway by targeting EZH2."}, {"pubmed": 31843273, "text": "Results confirm the differential expression of EZH2 in uterine cancers compared to normal tissues. However, there were no statistically significant differences in survival associated with EZH2 expression in patients with endometrial cancer."}, {"pubmed": 31846764, "text": "Global characterization of proteome and lysine methylome features in EZH2 wild-type and mutant lymphoma cell lines."}, {"pubmed": 31855281, "text": "EZH2 enhances expression of CCL5 to promote recruitment of macrophages and invasion in lung cancer."}, {"pubmed": 31858557, "text": "Circular RNA TTBK2 promotes the development of human glioma cells via miR-520b/EZH2 axis."}, {"pubmed": 31860165, "text": "The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription."}, {"pubmed": 31861475, "text": "We analyzed the expression of MELK and two putative targets, Forkhead Box M1 (FOXM1) and Enhancer of Zeste Homolog 2 (EZH2), in a collection of human iCCA by real-time RT-PCR and immunohistochemistry (IHC). The effects on iCCA growth of both the multi-kinase inhibitor OTSSP167 and specific small-interfering RNA (siRNA) against MELK were investigated in iCCA cell lines."}, {"pubmed": 31871160, "text": "Study investigated how EZH2 triggers B2 short interspersed nuclear element (SINE) cleavage and found that B2 is a self-cleaving RNA that depends on EZH2 to accelerate its intrinsic activity. Contact with EZH2 accelerates cleavage rate by >100-fold, suggesting that EZH2 promotes a cleavage-competent RNA conformation. B2 SINE is an epigenetic ribozyme that functions as a transcriptional switch during the stress response."}, {"pubmed": 31886200, "text": "results suggest a scale of measure for EZH2 expression in pediatric MDS, where aberrant EZH2 expression may be a potential biomarker of disease evolution."}, {"pubmed": 31891591, "text": "This is the first study to identify a role for EZH2 in controlling disease progression and uncovers an innate protective mechanism in epilepsy."}, {"pubmed": 31894346, "text": "lncRNA PVT1 promotes hepatitis B viruspositive liver cancer progression by disturbing histone methylation on the cMyc promoter."}, {"pubmed": 31910305, "text": "Ezh2 Ameliorates Osteoarthritis by Activating TNFSF13B."}, {"pubmed": 31914379, "text": "The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections."}, {"pubmed": 31917284, "text": "Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma."}, {"pubmed": 31927050, "text": "demonstrated that the methyltransferase EZH2 related up-regulation of lncRNA PCAT1 along with down-regulation of E-cadherin could be essential in oncogenesis of endometrial carcinoma in both EC cells and patient subjects"}, {"pubmed": 31943751, "text": "E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2."}, {"pubmed": 31952907, "text": "EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis."}, {"pubmed": 31968251, "text": "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer."}, {"pubmed": 31991488, "text": "EZH2 seems to be upregulated by MYC, to rely on TP53 alterations."}, {"pubmed": 32054404, "text": "The protective effects of microRNA-26a in steroid-induced osteonecrosis of the femoral head by repressing EZH2."}, {"pubmed": 32062383, "text": "LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4."}, {"pubmed": 32066746, "text": "Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia."}, {"pubmed": 32103168, "text": "SMURF2 prevents detrimental changes to chromatin, protecting human dermal fibroblasts from chromosomal instability and tumorigenesis."}, {"pubmed": 32127003, "text": "Verification of EZH2 as a druggable target in metastatic uveal melanoma."}, {"pubmed": 32129914, "text": "Enhancer of zeste homolog 2 (EZH2) interacts with 3'-end of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and knockdown of MALAT1 disrupts occupancy of EZH2 on miR-22 promoter. Cooperating with EZH2, MALAT1 positively regulated snail family transcriptional repressor 1 (SNAI1) by repressing miR-22 and inhibiting E-cadherin expression, playing a vital role in epithelial to mesenchymal transition."}, {"pubmed": 32141531, "text": "Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition."}, {"pubmed": 32157157, "text": "Long noncoding RNA NEAT1 suppresses hepatocyte proliferation in fulminant hepatic failure through increased recruitment of EZH2 to the LATS2 promoter region and promotion of H3K27me3 methylation."}, {"pubmed": 32194081, "text": "Inhibition of EZH2 reduces LPS-induced injury in Caco-2 cells by mediating ANGPTL4 and CREB1"}, {"pubmed": 32194873, "text": "ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma."}, {"pubmed": 32234906, "text": "The frequencies of high enhancer of zeste homolog 2 (EZH2) and multiple myeloma SET domain (MMSET) expression were significantly higher in both MBC and TNDC than in normal tissue.EZH2 and MMSET may be useful therapeutic targets in Metaplastic breast carcinoma."}, {"pubmed": 32242003, "text": "Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression."}, {"pubmed": 32243864, "text": "DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes"}, {"pubmed": 32271434, "text": "MiR-92b inhibits proliferation and invasion of lung cancer by targeting EZH2."}, {"pubmed": 32271438, "text": "EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p."}, {"pubmed": 32291076, "text": "Study analyzed RNA-seq and ChIP-seq data in EZH2-deficient human embryonic stem cells and the result demonstrated that EZH2-mediated H3K27me3 inhibits human ACE2 expression."}, {"pubmed": 32292524, "text": "Circular RNA SAMD4A controls adipogenesis in obesity through the miR-138-5p/EZH2 axis."}, {"pubmed": 32312833, "text": "The EZH2-PHACTR2-AS1-Ribosome Axis induces Genomic Instability and Promotes Growth and Metastasis in Breast Cancer."}, {"pubmed": 32312841, "text": "Polycomb-like Protein 3 Induces Proliferation and Drug Resistance in Multiple Myeloma and Is Regulated by miRNA-15a."}, {"pubmed": 32322039, "text": "Mutational mechanisms of EZH2 inactivation in myeloid neoplasms."}, {"pubmed": 32329150, "text": "SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1."}, {"pubmed": 32348690, "text": "LINP1 promotes the progression of cervical cancer by scaffolding EZH2, LSD1, and DNMT1 to inhibit the expression of KLF2 and PRSS8."}, {"pubmed": 32360600, "text": "EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma."}, {"pubmed": 32366675, "text": "Dual Regulation of Histone Methylation by mTOR Complexes Controls Glioblastoma Tumor Cell Growth via EZH2 and SAM."}, {"pubmed": 32370988, "text": "Decreased miR-124 contributes to the epithelial-mesenchymal transition phenotype formation of lung adenocarcinoma cells via targeting enhancer of zeste homolog 2."}, {"pubmed": 32373959, "text": "Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer."}, {"pubmed": 32380038, "text": "FBXW7 promotes pathological cardiac hypertrophy by targeting EZH2-SIX1 signaling."}, {"pubmed": 32396861, "text": "Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response."}, {"pubmed": 32409309, "text": "YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators."}, {"pubmed": 32420685, "text": "Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer."}, {"pubmed": 32449315, "text": "Long intergenic noncoding RNA 00021 promotes glioblastoma temozolomide resistance by epigenetically silencing p21 through Notch pathway."}, {"pubmed": 32457468, "text": "EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair."}, {"pubmed": 32474518, "text": "Targeting EZH2 depletes LMP1-induced activated regulatory T cells enhancing antitumor immunity in nasopharyngeal carcinoma."}, {"pubmed": 32483123, "text": "CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation."}, {"pubmed": 32522890, "text": "LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK."}, {"pubmed": 32533097, "text": "The BLIMP1-EZH2 nexus in a non-Hodgkin lymphoma."}, {"pubmed": 32552947, "text": "[Expression and Clinical Significance of EZH2 in Patients with Diffuse Large B Cell Lymphoma Accompanied by HBV Infection]."}, {"pubmed": 32595202, "text": "Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer."}, {"pubmed": 32619406, "text": "SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways."}, {"pubmed": 32626980, "text": "Effects of miR1955p on cell proliferation and apoptosis in gestational diabetes mellitus via targeting EZH2."}, {"pubmed": 32633340, "text": "Knockdown of ZEB2-AS1 inhibits cell proliferation, invasion and induces apoptosis in osteosarcoma by combining with EZH2."}, {"pubmed": 32635858, "text": "Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells."}, {"pubmed": 32663416, "text": "Long non-coding RNA AWPPH enhances malignant phenotypes in nasopharyngeal carcinoma via silencing PTEN through interacting with LSD1 and EZH2."}, {"pubmed": 32668764, "text": "Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma."}, {"pubmed": 32676814, "text": "Contribution of DNA methylation and EZH2 in SRBC down-regulation in gastric cancer."}, {"pubmed": 32701505, "text": "The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis."}, {"pubmed": 32710193, "text": "CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6."}, {"pubmed": 32723346, "text": "EZH2: a novel target for cancer treatment."}, {"pubmed": 32725802, "text": "Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression."}, {"pubmed": 32725924, "text": "Utility of highly expressed EZH2 in pleural effusion cytology for the diagnosis of mesothelioma."}, {"pubmed": 32729661, "text": "Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma."}, {"pubmed": 32735528, "text": "FOXM1-Dependent Transcriptional Regulation of EZH2 Induces Proliferation and Progression in Prostate Cancer."}, {"pubmed": 32748461, "text": "Enhancer of zeste 2 polycomb repressive complex 2 subunit polymorphisms in melanoma skin cancer risk."}, {"pubmed": 32814835, "text": "E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression."}, {"pubmed": 32816857, "text": "SUMOylation of E2F1 Regulates Expression of EZH2."}, {"pubmed": 32816909, "text": "EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells."}, {"pubmed": 32825929, "text": "The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions."}, {"pubmed": 32846854, "text": "Effect of enhancer of zeste homolog 2 mutations on the prognosis of patients with myelodysplastic syndrome: A meta-analysis."}, {"pubmed": 32855270, "text": "Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2."}, {"pubmed": 32885590, "text": "The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2."}, {"pubmed": 32895488, "text": "Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis."}, {"pubmed": 32899608, "text": "Elucidating the Role of Ezh2 in Tolerogenic Function of NOD Bone Marrow-Derived Dendritic Cells Expressing Constitutively Active Stat5b."}, {"pubmed": 32907838, "text": "EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6."}, {"pubmed": 32917647, "text": "Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer."}, {"pubmed": 32920200, "text": "Loss of histone lysine methyltransferase EZH2 confers resistance to tyrosine kinase inhibitors in non-small cell lung cancer."}, {"pubmed": 32929617, "text": "LINC01133 and LINC01243 are positively correlated with endometrial carcinoma pathogenesis."}, {"pubmed": 32934212, "text": "EZH2 reduction is an essential mechanoresponse for the maintenance of super-enhancer polarization against compressive stress in human periodontal ligament stem cells."}, {"pubmed": 32938196, "text": "EZH2 inhibition: a promising strategy to prevent cancer immune editing."}, {"pubmed": 32941921, "text": "Inhibition of EZH2 via the STAT3/HOTAIR signalling axis contributes to cell cycle arrest and apoptosis induced by polyphyllin I in human non-small cell lung cancer cells."}, {"pubmed": 32964984, "text": "LncRNA FOXC2-AS1 stimulates proliferation of melanoma via silencing p15 by recruiting EZH2."}, {"pubmed": 32990923, "text": "EZH2 knockdown in tamoxifen-resistant MCF-7 cells unravels novel targets for regaining sensitivity towards tamoxifen."}, {"pubmed": 33009487, "text": "EZH2 overexpression dampens tumor-suppressive signals via an EGR1 silencer to drive breast tumorigenesis."}, {"pubmed": 33011750, "text": "EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation."}, {"pubmed": 33026112, "text": "Inhibition of EZH2 attenuates coronary heart disease by interacting with microRNA-22 to regulate the TXNIP/nuclear factor-kappaB pathway."}, {"pubmed": 33035457, "text": "Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial."}, {"pubmed": 33057161, "text": "EZH2 regulates expression of FOXC1 by mediating H3K27me3 in breast cancers."}, {"pubmed": 33063698, "text": "Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review."}, {"pubmed": 33068867, "text": "Lymphocyte expression of EZH2 is associated with mortality and secondary infectious complications in sepsis."}, {"pubmed": 33069730, "text": "EZH2 Regulates the Correlation between Skin Regeneration and the Duration of Mechanical Stretch."}, {"pubmed": 33091189, "text": "Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer."}, {"pubmed": 33092789, "text": "Macrophages-stimulated PRMT1-mediated EZH2 methylation promotes breast cancer metastasis."}, {"pubmed": 33177650, "text": "EZH2 inhibition reduces cartilage loss and functional impairment related to osteoarthritis."}, {"pubmed": 33180829, "text": "EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma."}, {"pubmed": 33187138, "text": "Downregulation of the Polycomb-Associated Methyltransferase Ezh2 during Maturation of Hippocampal Neurons Is Mediated by MicroRNAs Let-7 and miR-124."}, {"pubmed": 33197837, "text": "High EZH2 expression in ductal carcinoma in situ diagnosed on breast core needle biopsy is an independent predictive factor for upgrade on surgical excision."}, {"pubmed": 33205541, "text": "PARP1 and PRC2 double deficiency promotes BRCA-proficient breast cancer growth by modification of the tumor microenvironment."}, {"pubmed": 33207561, "text": "EZH2 as a Potential Target for NAFLD Therapy."}, {"pubmed": 33207890, "text": "miR-101 suppresses colon cancer cell migration through the regulation of EZH2."}, {"pubmed": 33208750, "text": "EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy."}, {"pubmed": 33215433, "text": "Upregulation of long noncoding RNA FERRE promoted growth and invasion of breast cancer through modulating miR-19a-5p/EZH2 axis."}, {"pubmed": 33226554, "text": "Expression and DNA methylation profiles of EZH2-target genes in plasma exosomes and matched primary tumor tissues of the patients with diffuse large B-cell lymphoma."}, {"pubmed": 33230143, "text": "Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer."}, {"pubmed": 33233721, "text": "Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma."}, {"pubmed": 33246425, "text": "Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer."}, {"pubmed": 33268767, "text": "Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML)."}, {"pubmed": 33277782, "text": "EZH2 is a potential prognostic predictor of glioma."}, {"pubmed": 33283749, "text": "[Research Progress of Expression and Clinical Significant of EZH2 in Hematological Malignancies--Review]."}, {"pubmed": 33288562, "text": "EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First Treatment."}, {"pubmed": 33290872, "text": "MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2)."}, {"pubmed": 33293663, "text": "LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression."}, {"pubmed": 33296708, "text": "YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer."}, {"pubmed": 33299646, "text": "Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma."}, {"pubmed": 33299862, "text": "Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis."}, {"pubmed": 33313943, "text": "Effect of EZH2 on pulmonary artery smooth muscle cell migration in pulmonary hypertension."}, {"pubmed": 33331071, "text": "Enhancer of zeste homolog 2 participates in the process of atherosclerosis by modulating microRNA-139-5p methylation and signal transducer and activator of transcription 1 expression."}, {"pubmed": 33336896, "text": "Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2."}, {"pubmed": 33389794, "text": "USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B-cell lymphoma."}, {"pubmed": 33391480, "text": "Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis."}, {"pubmed": 33408782, "text": "EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells."}, {"pubmed": 33416105, "text": "Downregulation of hsa_circ_0026123 suppresses ovarian cancer cell metastasis and proliferation through the miR1243p/EZH2 signaling pathway."}, {"pubmed": 33531586, "text": "Molecular profiling of epigenetic landscape of cancer cells during extracellular matrix detachment."}, {"pubmed": 33546582, "text": "Long non-coding RNA CIR inhibits chondrogenic differentiation of mesenchymal stem cells by epigenetically suppressing ATOH8 via methyltransferase EZH2."}, {"pubmed": 33550923, "text": "MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2."}, {"pubmed": 33556366, "text": "Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer."}, {"pubmed": 33559868, "text": "ERO1alpha mediates endoplasmic reticulum stress-induced apoptosis via microRNA-101/EZH2 axis in colon cancer RKO and HT-29 cells."}, {"pubmed": 33589600, "text": "SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop."}, {"pubmed": 33589750, "text": "EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity."}, {"pubmed": 33664859, "text": "PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression."}, {"pubmed": 33692439, "text": "EZH2 is associated with cartilage degeneration in osteoarthritis by promoting SDC1 expression via histone methylation of the microRNA-138 promoter."}, {"pubmed": 33709190, "text": "LINC00152 mediates CD8(+) T-cell infiltration in gastric cancer through binding to EZH2 and regulating the CXCL9, 10/CXCR3 axis."}, {"pubmed": 33712646, "text": "Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML."}, {"pubmed": 33721449, "text": "MicroRNA-137 targets EZH2 to exert suppressive functions in uveal melanoma via regulation of Wnt/beta-catenin signaling and epithelial-to-mesenchymal transition."}, {"pubmed": 33748276, "text": "Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2."}, {"pubmed": 33761351, "text": "An interdependent network of functional enhancers regulates transcription and EZH2 loading at the INK4a/ARF locus."}, {"pubmed": 33788986, "text": "A novel EZH2 gene variant in a case of Weaver syndrome with postaxial polydactyly."}, {"pubmed": 33795875, "text": "A PRC2-independent function for EZH2 in regulating rRNA 2'-O methylation and IRES-dependent translation."}, {"pubmed": 33800594, "text": "Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis."}, {"pubmed": 33803922, "text": "Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach."}, {"pubmed": 33821477, "text": "A rare variant in EZH2 is associated with prostate cancer risk."}, {"pubmed": 33845873, "text": "Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients."}, {"pubmed": 33849069, "text": "Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis."}, {"pubmed": 33879635, "text": "SPRY4 suppresses proliferation and induces apoptosis of colorectal cancer cells by repressing oncogene EZH2."}, {"pubmed": 33901010, "text": "Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis."}, {"pubmed": 33978549, "text": "Targeting EZH2-mediated methylation of histone 3 inhibits proliferation of pediatric acute monocytic leukemia cells in vitro."}, {"pubmed": 34015321, "text": "EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability."}, {"pubmed": 34031939, "text": "EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARgamma."}, {"pubmed": 34044429, "text": "A Cohort Study of the Prognostic Impact of Exon-16 EZH2 Mutations in a Mexican-Mestizo Population of Patients with Diffuse Large B-Cell Lymphoma."}, {"pubmed": 34067359, "text": "DNMT3A Mutation-Induced CDK1 Overexpression Promotes Leukemogenesis by Modulating the Interaction between EZH2 and DNMT3A."}, {"pubmed": 34076983, "text": "EZH2-mediated long-chain non-coding RNA LINC00963 promotes proliferation and invasion of glioma cells through inhibiting p21 expression."}, {"pubmed": 34087994, "text": "Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming."}, {"pubmed": 34102285, "text": "Myristoylation-mediated phase separation of EZH2 compartmentalizes STAT3 to promote lung cancer growth."}, {"pubmed": 34115196, "text": "An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy."}, {"pubmed": 34115825, "text": "Dual role of EZH2 in megakaryocyte differentiation."}, {"pubmed": 34140011, "text": "Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma."}, {"pubmed": 34160745, "text": "MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2."}, {"pubmed": 34195851, "text": "lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR1385p in cutaneous squamous cell carcinoma."}, {"pubmed": 34210752, "text": "AP-2alpha-Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis."}, {"pubmed": 34217898, "text": "Horizontal transfer of the stemness-related markers EZH2 and GLI1 by neuroblastoma-derived extracellular vesicles in stromal cells."}, {"pubmed": 34257556, "text": "Diagnostic Utility of BAP1, EZH2 and Survivin in Differentiating Pleural Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia: Immunohistochemical Study."}, {"pubmed": 34273373, "text": "PBDEs affect inflammatory and oncosuppressive mechanisms via the EZH2 methyltransferase in airway epithelial cells."}, {"pubmed": 34288823, "text": "MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2."}, {"pubmed": 34307682, "text": "miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2."}, {"pubmed": 34325277, "text": "The effects of miR-26b-5p on fibroblast-like synovial cells in rheumatoid arthritis (RA-FLS) via targeting EZH2."}, {"pubmed": 34376807, "text": "EZH2 expression is associated with inferior overall survival in mantle cell lymphoma."}, {"pubmed": 34405442, "text": "An NF-kappaB-responsive long noncoding RNA, PINT, regulates TNF-alpha gene transcription by scaffolding p65 and EZH2."}, {"pubmed": 34405537, "text": "NBPF4 mitigates progression in colorectal cancer through the regulation of EZH2-associated ETFA."}, {"pubmed": 34425630, "text": "Histone methyltransferase Ezh2 negatively regulates NK cell terminal maturation and function."}, {"pubmed": 34478526, "text": "Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype."}, {"pubmed": 34493171, "text": "Prognostic significance of EZH2 and ARID1A expression in urothelial carcinoma: an immunohistochemical study."}, {"pubmed": 34493753, "text": "Reciprocal regulation of endothelial-mesenchymal transition by MAPK7 and EZH2 in intimal hyperplasia and coronary artery disease."}, {"pubmed": 34509612, "text": "Histone methyltransferase EZH2 epigenetically affects CCNA1 expression in acute myeloid leukemia."}, {"pubmed": 34510715, "text": "P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization."}, {"pubmed": 34512145, "text": "Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network."}, {"pubmed": 34519570, "text": "LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene."}, {"pubmed": 34537772, "text": "Mesenchymal Stem Cell-Derived Exosome-Containing Linc00632 Regulates GATA Binding Protein-3 Expression in Allergic Rhinitis by Interacting with Enhancer of Zeste Homolog 2 to Inhibit T Helper Cell 2 Differentiation."}, {"pubmed": 34545456, "text": "Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2."}, {"pubmed": 34551671, "text": "Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression."}, {"pubmed": 34564701, "text": "Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer."}, {"pubmed": 34614148, "text": "EZH2 knockout in oral cavity basal epithelia causes more invasive squamous cell carcinomas."}, {"pubmed": 34614259, "text": "EZH2-mediated SLC7A11 upregulation via miR-125b-5p represses ferroptosis of TSCC."}, {"pubmed": 34617573, "text": "Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP."}, {"pubmed": 34653429, "text": "The molecular mechanisms and therapeutic potential of EZH2 in breast cancer."}, {"pubmed": 34655667, "text": "EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition."}, {"pubmed": 34663788, "text": "ELK4-mediated lncRNA SNHG22 promotes gastric cancer progression through interacting with EZH2 and regulating miR-200c-3p/Notch1 axis."}, {"pubmed": 34666800, "text": "CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition."}, {"pubmed": 34668273, "text": "EZH2 upregulates the expression of MAPK1 to promote intervertebral disc degeneration via suppression of miR-129-5p."}, {"pubmed": 34706521, "text": "Prognostic and predictive value of EZH2 expression and the tumor immune microenvironment in Merkel cell carcinoma."}, {"pubmed": 34739394, "text": "Curcumol inhibits malignant biological behaviors and TMZ-resistance in glioma cells by inhibiting long noncoding RNA FOXD2-As1-promoted EZH2 activation."}, {"pubmed": 34766670, "text": "Long noncoding RNA SNHG6 promotes oesophageal squamous cell carcinoma by downregulating the miR-101-3p/EZH2 pathway."}, {"pubmed": 34789568, "text": "CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping."}, {"pubmed": 34802040, "text": "Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies."}, {"pubmed": 34811354, "text": "LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p."}, {"pubmed": 34815475, "text": "EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine."}, {"pubmed": 34820775, "text": "Downregulation of EZH2 in Trophoblasts Induces Decidual M1 Macrophage Polarization: a Potential Cause of Recurrent Spontaneous Abortion."}, {"pubmed": 34825659, "text": "Functional relationship of SNP (Ala490Thr) of an epigenetic gene EZH2 results in the progression and poor survival of ER+/tamoxifen treated breast cancer patients."}, {"pubmed": 34825669, "text": "The association between lncRNA H19 and EZH2 expression in patients with EBV-positive laryngeal carcinoma."}, {"pubmed": 34851506, "text": "Ezh2 promotes TRbeta lysine methylation-mediated degradation in hepatocellular carcinoma."}, {"pubmed": 34857732, "text": "Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression."}, {"pubmed": 34906772, "text": "EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects."}, {"pubmed": 34915417, "text": "Non-coding RNAs-EZH2 regulatory mechanisms in cervical cancer: The current state of knowledge."}, {"pubmed": 34967593, "text": "Mutational Analysis of EZH2 Gene in Patients with Colorectal Adenoma Reveals a Genetic Variant Associated with Risk of Malignant Transformation."}, {"pubmed": 35031563, "text": "Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress."}, {"pubmed": 35032074, "text": "Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy."}, {"pubmed": 35048632, "text": "Evaluation of EZH2 and ERRalpha in colorectal carcinoma: an immunohistochemical study."}, {"pubmed": 35083555, "text": "Histone methyltransferase EZH2 in proliferation, invasion, and migration of fibroblast-like synoviocytes in rheumatoid arthritis."}, {"pubmed": 35085106, "text": "EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis."}, {"pubmed": 35085770, "text": "NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1."}, {"pubmed": 35094010, "text": "Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer."}, {"pubmed": 35163710, "text": "EZH2-CCF-cGAS Axis Promotes Breast Cancer Metastasis."}, {"pubmed": 35181615, "text": "Morphoproteomics Identifies SIRT1, EZH2 and CXCR4 Pathways in Diffuse Large B-Cell Lymphoma: Therapeutic Implications."}, {"pubmed": 35182680, "text": "EZH2 suppresses insulinoma development by epigenetically reducing KIF4A expression via H3K27me3 modification."}, {"pubmed": 35184652, "text": "Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1."}, {"pubmed": 35188401, "text": "Tumor suppressive lncRNA MEG3 binds to EZH2 and enhances CXCL3 methylation in gallbladder cancer."}, {"pubmed": 35193055, "text": "EZH2-mediated H3K27me3 promotes autoimmune hepatitis progression by regulating macrophage polarization."}, {"pubmed": 35197928, "text": "EZH2 Mediates Proliferation, Migration, and Invasion Promoted by Estradiol in Human Glioblastoma Cells."}, {"pubmed": 35210568, "text": "EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis."}, {"pubmed": 35245884, "text": "The combined use of long non-coding RNA HOTAIR and polycomb group protein EZH2 as a prognostic marker of lung adenocarcinoma."}, {"pubmed": 35303175, "text": "Lnc-IL7R alleviates PM2.5-mediated cellular senescence and apoptosis through EZH2 recruitment in chronic obstructive pulmonary disease."}, {"pubmed": 35346226, "text": "LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2."}, {"pubmed": 35414117, "text": "LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1."}, {"pubmed": 35504958, "text": "Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes."}, {"pubmed": 35509134, "text": "Inverse co-expression of EZH2 and acetylated H3K27 in prostatic tissue."}, {"pubmed": 35523402, "text": "USP7 inhibits TIMP2 by up-regulating the expression of EZH2 to activate the NF-kappaB/PD-L1 axis to promote the development of cervical cancer."}, {"pubmed": 35537449, "text": "NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition."}, {"pubmed": 35538070, "text": "EZH2 engages TGFbeta signaling to promote breast cancer bone metastasis via integrin beta1-FAK activation."}, {"pubmed": 35596973, "text": "Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus."}, {"pubmed": 35604910, "text": "Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3Kalpha inhibitors in oesophageal squamous cell carcinoma."}, {"pubmed": 35609316, "text": "EZH2 enhances proliferation and migration of trophoblast cell lines by blocking GADD45A-mediated p38/MAPK signaling pathway."}, {"pubmed": 35627262, "text": "High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma."}, {"pubmed": 35659256, "text": "The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma."}, {"pubmed": 35661922, "text": "H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas."}, {"pubmed": 35680984, "text": "EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization."}, {"pubmed": 35795677, "text": "EZH2 Promotes T Follicular Helper Cell Differentiation Through Enhancing STAT3 Phosphorylation in Patients With Primary Sjogren's Syndrome."}, {"pubmed": 35804015, "text": "DNMT1-mediated epigenetic silencing of TRAF6 promotes prostate cancer tumorigenesis and metastasis by enhancing EZH2 stability."}, {"pubmed": 35813302, "text": "Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology."}, {"pubmed": 35818168, "text": "EZH2 promotes the progression of osteosarcoma through the activation of the AKT/GSK3beta pathway."}, {"pubmed": 35864175, "text": "EZH2 regulates a SETDB1/DeltaNp63alpha axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma."}, {"pubmed": 35933601, "text": "Emerging role of EZH2 in rheumatic diseases: A comprehensive review."}, {"pubmed": 35939884, "text": "EZH2 affects malignant progression and DNA damage repair of lung adenocarcinoma cells by regulating RAI2 expression."}, {"pubmed": 35960849, "text": "Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma."}, {"pubmed": 35970825, "text": "Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands."}, {"pubmed": 36029259, "text": "Impact of a cell cycle and an extracellular matrix remodeling transcriptional signature on tumor progression and correlation with EZH2 expression in meningioma."}, {"pubmed": 36038549, "text": "Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer."}, {"pubmed": 36048167, "text": "EZH2 Protein Expression in Estrogen Receptor Positive Invasive Breast Cancer Treated With Neoadjuvant Endocrine Therapy: An Exploratory Study of Association With Tumor Response."}, {"pubmed": 36050791, "text": "The role of LINC01419 in regulating the cell stemness in lung adenocarcinoma through recruiting EZH2 and regulating FBP1 expression."}, {"pubmed": 36053032, "text": "Long non-coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2-mediated epigenetic modification."}, {"pubmed": 36057370, "text": "Single-cell RNA sequencing reveals intra-tumoral heterogeneity of glioblastoma and a pro-tumor subset of tumor-associated macrophages characterized by EZH2 overexpression."}, {"pubmed": 36071871, "text": "Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1alpha)."}, {"pubmed": 36086687, "text": "Role of EZH2 in adipogenesis and obesity: Current state of the art and implications - A review."}, {"pubmed": 36087568, "text": "Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription."}, {"pubmed": 36094360, "text": "MLL1:EZH2 Ratio in Uterine Secretions and Endometrial Receptivity in Patients with Endometriosis."}, {"pubmed": 36104682, "text": "EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment."}, {"pubmed": 36127410, "text": "SMYD3 regulates gastric cancer progression and macrophage polarization through EZH2 methylation."}, {"pubmed": 36129843, "text": "U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes."}, {"pubmed": 36179694, "text": "PI3Kbeta-regulated beta-catenin mediates EZH2 removal from promoters controlling primed human ESC stemness and primitive streak gene expression."}, {"pubmed": 36191822, "text": "The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization."}, {"pubmed": 36195655, "text": "Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration."}, {"pubmed": 36220978, "text": "Ezh2[Y641F] mutations co-operate with Stat3 to regulate MHC class I antigen processing and alter the tumor immune response in melanoma."}, {"pubmed": 36239569, "text": "Effects of EZH2 on Invasion and Migration of Endometrial Stromal Cells in Endometriosis Patients by Regulating PCDH10 Gene H3K27 Methylation."}, {"pubmed": 36271224, "text": "The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy."}, {"pubmed": 36274363, "text": "Non-canonical transcriptional regulation of INHAT subunit SET/TAF-Ibeta by EZH2."}, {"pubmed": 36300627, "text": "A cryptic transactivation domain of EZH2 binds AR and AR's splice variant, promoting oncogene activation and tumorous transformation."}, {"pubmed": 36309370, "text": "Association of EZH2 Genotypes With Oral Cancer Risk."}, {"pubmed": 36309571, "text": "A GRIP-1-EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a."}, {"pubmed": 36316365, "text": "EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas."}, {"pubmed": 36358967, "text": "EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis."}, {"pubmed": 36403545, "text": "EZH2 deregulates BMP, Hedgehog, and Hippo cell signaling pathways in esophageal squamous cell carcinoma."}, {"pubmed": 36446780, "text": "EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis."}, {"pubmed": 36449143, "text": "Tumor- and metastasis-promoting roles of miR-488 inhibition via HULC enhancement and EZH2-mediated p53 repression in gastric cancer."}, {"pubmed": 36456043, "text": "EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes."}, {"pubmed": 36464274, "text": "The E2F6 Transcription Factor is Associated with the Mammalian SUZ12-Containing Polycomb Complex."}, {"pubmed": 36476271, "text": "The role of EZH1 and EZH2 in development and cancer."}, {"pubmed": 36517590, "text": "EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma."}, {"pubmed": 36524678, "text": "Decreased Expression of EZH2 in Granulosa Cells Contributes to Endometriosis-Associated Infertility by Targeting IL-1R2."}, {"pubmed": 36545914, "text": "Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer."}, {"pubmed": 36552722, "text": "Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway."}, {"pubmed": 36564076, "text": "HMGA2 Synergizes with EZH2 to Mediate Epithelial Cell Inflammation and Apoptosis in Septic Lung Dysfunction."}, {"pubmed": 36619221, "text": "EZH2 promotes angiogenesis in peritoneal dialysis by epigenetically activating SP4 expression in the IL-6/sIL-6R signalling pathway."}, {"pubmed": 36622753, "text": "EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression."}, {"pubmed": 36629984, "text": "SPOCK2 and SPRED1 function downstream of EZH2 to impede the malignant progression of lung adenocarcinoma in vitro and in vivo."}, {"pubmed": 36708555, "text": "Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia."}, {"pubmed": 36718085, "text": "Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate Cancer."}, {"pubmed": 36724065, "text": "Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho."}, {"pubmed": 36738498, "text": "The pharmacological and biological importance of EZH2 signaling in lung cancer."}, {"pubmed": 36768289, "text": "Resistance to BRAF Inhibitors: EZH2 and Its Downstream Targets as Potential Therapeutic Options in Melanoma."}, {"pubmed": 36813772, "text": "LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2."}, {"pubmed": 36820722, "text": "Effects of enhancer of zeste homolog 2 and mucin 1 expressions on treatment response in breast cancer."}, {"pubmed": 36858198, "text": "EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance."}, {"pubmed": 36877334, "text": "Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/beta-Catenin Pathway in Gastric Cancer."}, {"pubmed": 36897808, "text": "Ezh2 Knockout in B Cells Impairs Plasmablast Differentiation and Ameliorates Lupus-like Disease in MRL/lpr Mice."}, {"pubmed": 36946271, "text": "Expressions of EZH2 and NOTCH3 pathway in osteosarcoma and their roles in osteosarcoma stem cells."}, {"pubmed": 36973442, "text": "Drug addiction unveils a repressive methylation ceiling in EZH2-mutant lymphoma."}, {"pubmed": 36974822, "text": "EZH2 Expression Correlates With T-Cell Infiltration in Oral Leukoplakia and Predicts Cancer Transformation."}, {"pubmed": 37001595, "text": "Epigenetic reactivation of PEG3 by EZH2 inhibitors suppresses renal clear cell carcinoma progress."}, {"pubmed": 37021526, "text": "Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation."}, {"pubmed": 37029114, "text": "Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization."}, {"pubmed": 37037414, "text": "Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma."}, {"pubmed": 37037595, "text": "EZH2 controls epicardial cell migration during heart development."}, {"pubmed": 37069142, "text": "Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer."}, {"pubmed": 37140546, "text": "Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components."}, {"pubmed": 37147437, "text": "EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes."}, {"pubmed": 37148376, "text": "The roles of EZH2 in cancer and its inhibitors."}, {"pubmed": 37157015, "text": "Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma."}, {"pubmed": 37175580, "text": "Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer."}, {"pubmed": 37198149, "text": "The EZH2-PRC2-H3K27me3 axis governs the endometrial cell cycle and differentiation for blastocyst invasion."}, {"pubmed": 37198697, "text": "EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4."}, {"pubmed": 37207700, "text": "EZH2 can be used as a therapeutic agent for inhibiting endothelial dysfunction."}, {"pubmed": 37210576, "text": "EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer."}, {"pubmed": 37212947, "text": "Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC)."}, {"pubmed": 37225847, "text": "Dysregulation of iron homeostasis by TfR-1 renders EZH2 wild type diffuse large B-cell lymphoma resistance to EZH2 inhibition."}, {"pubmed": 37311441, "text": "EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target."}, {"pubmed": 37353042, "text": "JARID2 and EZH2, the eminent epigenetic drivers in human cancer."}, {"pubmed": 37458071, "text": "The role of EZH2 in ocular diseases: a narrative review."}, {"pubmed": 37467626, "text": "Review: Targeting EZH2 in neuroblastoma."}, {"pubmed": 37475584, "text": "Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer."}, {"pubmed": 37491334, "text": "Ezh2 emerges as an epigenetic checkpoint regulator during monocyte differentiation limiting cardiac dysfunction post-MI."}, {"pubmed": 37498408, "text": "EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A."}, {"pubmed": 37598282, "text": "Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma."}, {"pubmed": 37619672, "text": "Brucea javanica oil inhibits tongue squamous cell invasion and metastasis by regulating miR-138-EZH2 pathway."}, {"pubmed": 37644332, "text": "Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway."}, {"pubmed": 37726387, "text": "Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma."}, {"pubmed": 37762082, "text": "USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation."}, {"pubmed": 37787267, "text": "Meta-analysis of Genetic polymorphism of Enhancer of Zeste Homolog2 gene in cancer susceptibility."}, {"pubmed": 37800319, "text": "EZH2 Promotes Corneal Endothelial Cell Apoptosis by Mediating H3K27me3 and Inhibiting HO-1 Transcription."}, {"pubmed": 37803297, "text": "Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner."}, {"pubmed": 37851112, "text": "lncRNA SNHG9 enhances liver cancer stem cell self-renewal and tumorigenicity by negatively regulating PTEN expression via recruiting EZH2."}, {"pubmed": 37862922, "text": "Epigenetic regulation of enhancer of zeste homolog 2 (EZH2) -Yin Yang 1 (YY1) axis in cancer."}, {"pubmed": 37889101, "text": "Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis."}, {"pubmed": 37951195, "text": "LncRNA AOC4P recruits TRAF6 to regulate EZH2 ubiquitination and participates in trophoblast glycolysis and M2 macrophage polarization which is associated with recurrent spontaneous abortion."}, {"pubmed": 37990130, "text": "EZH2 is a key component of hepatoblastoma tumor cell growth."}, {"pubmed": 38008711, "text": "EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A."}, {"pubmed": 38030172, "text": "Long Non-coding RNA LINC00152 Requires EZH2 to Promote Mesothelioma Cell Proliferation, Migration, and Invasion."}, {"pubmed": 38031139, "text": "EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma."}, {"pubmed": 38048186, "text": "Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/beta-catenin signaling pathway."}, {"pubmed": 38072134, "text": "Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations."}, {"pubmed": 38114929, "text": "Long non-coding RNA SNHG4 aggravates cigarette smoke-induced COPD by regulating miR-144-3p/EZH2 axis."}, {"pubmed": 38146588, "text": "Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas."}, {"pubmed": 38155599, "text": "miR-26a-5p restoration via EZH2 silencing blocks the IL-6/STAT3 axis to repress the growth of prostate cancer."}, {"pubmed": 38199479, "text": "MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo."}, {"pubmed": 38220465, "text": "[Research progress of methyltransferase EZH2 in cardiovascular diseases]."}, {"pubmed": 38244292, "text": "Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic."}, {"pubmed": 38245345, "text": "Simulated microgravity altered the gene expression profiles and inhibited the proliferation of Kupffer cells in the early phase by downregulating LMO2 and EZH2."}, {"pubmed": 38265267, "text": "EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas."}, {"pubmed": 38266459, "text": "HOMER3 promotes liver hepatocellular carcinoma cancer progression by -upregulating EZH2 and mediating miR-361/GPNMB axis."}, {"pubmed": 38305289, "text": "DLEU2/EZH2/GFI1 Axis Regulates the Proliferation and Apoptosis of Human Bone Marrow Mesenchymal Stem Cells."}, {"pubmed": 38309675, "text": "The competitive mechanism of EZH1 and EZH2 in promoting oral squamous cell carcinoma."}, {"pubmed": 38331087, "text": "EZH2-mediated development of therapeutic resistance in cancer."}, {"pubmed": 38393645, "text": "EZH2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action."}, {"pubmed": 38460798, "text": "TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present."}, {"pubmed": 38461243, "text": "MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2."}, {"pubmed": 38477804, "text": "EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features."}, {"pubmed": 38574630, "text": "Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through EZH2."}, {"pubmed": 38652219, "text": "MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2."}, {"pubmed": 38665021, "text": "EZH2 Promotes Multiple Myeloma Progression via STAT3 Pathway Activation."}, {"pubmed": 38672463, "text": "Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells."}, {"pubmed": 38677505, "text": "LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1."}, {"pubmed": 38678670, "text": "Identification and functional analysis of the hub Ferroptosis-Related gene EZH2 in diabetic kidney disease."}, {"pubmed": 38842201, "text": "RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer."}, {"pubmed": 38862595, "text": "Enzyme-independent role of EZH2 in regulating cell cycle progression via the SKP2-KIP/CIP pathway."}, {"pubmed": 38871245, "text": "YTHDF1 promotes the osteolytic bone metastasis of breast cancer via inducing EZH2 and CDH11 translation."}, {"pubmed": 38923455, "text": "UBR7 in concert with EZH2 inhibits the TGF-beta signaling leading to extracellular matrix remodeling."}, {"pubmed": 39013911, "text": "NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression."}], "genomic_pos": {"chr": "7", "end": 148884321, "ensemblgene": "ENSG00000106462", "start": 148807257, "strand": -1}, "genomic_pos_hg19": {"chr": "7", "end": 148581413, "start": 148504475, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0000082", "qualifier": "involved_in", "term": "G1/S transition of mitotic cell cycle"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0000122", "pubmed": 20154697, "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006325", "qualifier": "involved_in", "term": "chromatin organization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006355", "qualifier": "involved_in", "term": "regulation of DNA-templated transcription"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008284", "pubmed": 18713946, "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010718", "pubmed": 20154697, "qualifier": "involved_in", "term": "positive regulation of epithelial to mesenchymal transition"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014013", "qualifier": "involved_in", "term": "regulation of gliogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014834", "qualifier": "involved_in", "term": "skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014898", "qualifier": "involved_in", "term": "cardiac muscle hypertrophy in response to stress"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021695", "qualifier": "involved_in", "term": "cerebellar cortex development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021766", "qualifier": "involved_in", "term": "hippocampus development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030183", "qualifier": "involved_in", "term": "B cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030216", "qualifier": "involved_in", "term": "keratinocyte differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030335", "pubmed": 35609316, "qualifier": "involved_in", "term": "positive regulation of cell migration"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0031048", "pubmed": 23435381, "qualifier": "involved_in", "term": "regulatory ncRNA-mediated heterochromatin formation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0031507", "qualifier": "involved_in", "term": "heterochromatin formation"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0031509", "pubmed": 9214638, "qualifier": "involved_in", "term": "subtelomeric heterochromatin formation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032259", "qualifier": "involved_in", "term": "methylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032355", "qualifier": "involved_in", "term": "response to estradiol"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0034244", "qualifier": "involved_in", "term": "negative regulation of transcription elongation by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035984", "qualifier": "involved_in", "term": "cellular response to trichostatin A"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0036211", "qualifier": "involved_in", "term": "protein modification process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0036333", "qualifier": "involved_in", "term": "hepatocyte homeostasis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0042752", "pubmed": 16717091, "qualifier": "involved_in", "term": "regulation of circadian rhythm"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043406", "pubmed": 20154697, "qualifier": "involved_in", "term": "positive regulation of MAP kinase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043547", "pubmed": 20154697, "qualifier": "involved_in", "term": "positive regulation of GTPase activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045617", "qualifier": "involved_in", "term": "negative regulation of keratinocyte differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045814", "pubmed": 20154697, "qualifier": "involved_in", "term": "negative regulation of gene expression, epigenetic"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045814", "pubmed": 24623306, "qualifier": "involved_in", "term": "negative regulation of gene expression, epigenetic"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0045814", "qualifier": "involved_in", "term": "negative regulation of gene expression, epigenetic"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045892", "pubmed": 16179254, "qualifier": "involved_in", "term": "negative regulation of DNA-templated transcription"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0048387", "pubmed": 16179254, "qualifier": "involved_in", "term": "negative regulation of retinoic acid receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048511", "qualifier": "involved_in", "term": "rhythmic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048863", "qualifier": "involved_in", "term": "stem cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051154", "qualifier": "involved_in", "term": "negative regulation of striated muscle cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051932", "qualifier": "involved_in", "term": "synaptic transmission, GABAergic"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070301", "qualifier": "involved_in", "term": "cellular response to hydrogen peroxide"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070314", "qualifier": "involved_in", "term": "G1 to G0 transition"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071168", "qualifier": "involved_in", "term": "protein localization to chromatin"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071902", "pubmed": 20154697, "qualifier": "involved_in", "term": "positive regulation of protein serine/threonine kinase activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0090183", "qualifier": "involved_in", "term": "regulation of kidney development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0097421", "qualifier": "involved_in", "term": "liver regeneration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0140718", "qualifier": "involved_in", "term": "facultative heterochromatin formation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1900006", "qualifier": "involved_in", "term": "positive regulation of dendrite development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1900016", "qualifier": "involved_in", "term": "negative regulation of cytokine production involved in inflammatory response"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1902808", "pubmed": 18713946, "qualifier": "involved_in", "term": "positive regulation of cell cycle G1/S phase transition"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904772", "qualifier": "involved_in", "term": "response to tetrachloromethane"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:2000134", "qualifier": "involved_in", "term": "negative regulation of G1/S transition of mitotic cell cycle"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:2000737", "qualifier": "involved_in", "term": "negative regulation of stem cell differentiation"}], "CC": [{"evidence": "IGI", "gocategory": "CC", "id": "GO:0000781", "pubmed": 9214638, "qualifier": "located_in", "term": "chromosome, telomeric region"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0000785", "pubmed": 19734898, "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 19144645, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005677", "qualifier": "part_of", "term": "chromatin silencing complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005694", "pubmed": 19734898, "qualifier": "is_active_in", "term": "chromosome"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005721", "qualifier": "part_of", "term": "pericentric heterochromatin"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0035098", "qualifier": "part_of", "term": "ESC/E(Z) complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0035098", "pubmed": [15385962, 20075857, 23104054, 23273982, 24474760], "qualifier": "part_of", "term": "ESC/E(Z) complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0045120", "qualifier": "located_in", "term": "pronucleus"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0045202", "qualifier": "located_in", "term": "synapse"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0000979", "qualifier": "enables", "term": "RNA polymerase II core promoter sequence-specific DNA binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0001222", "pubmed": 29628311, "qualifier": "enables", "term": "transcription corepressor binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0003682", "qualifier": "enables", "term": "chromatin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003682", "pubmed": 20154697, "qualifier": "enables", "term": "chromatin binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0003714", "qualifier": "enables", "term": "transcription corepressor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [11571280, 16179254, 16357870, 17560333, 19734898, 20075857, 20543829, 22009739, 22094255, 22439931, 22897849, 23142980, 23238014, 23455924, 23684459, 24074865, 24183680, 24474760, 24981860, 25416956, 25417162, 26496610, 27705803, 27728805, 27728808, 28229514, 29628311, 29909548, 30026490, 30510991, 30923826, 31515488, 32051553, 34591612, 35016035, 37553330], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016279", "pubmed": 19144645, "qualifier": "enables", "term": "protein-lysine N-methyltransferase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0016279", "qualifier": "enables", "term": "protein-lysine N-methyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0031490", "pubmed": 19734898, "qualifier": "enables", "term": "chromatin DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042054", "pubmed": 15385962, "qualifier": "enables", "term": "histone methyltransferase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0042054", "pubmed": 26694085, "qualifier": "enables", "term": "histone methyltransferase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0043021", "qualifier": "enables", "term": "ribonucleoprotein complex binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0046976", "qualifier": "enables", "term": "histone H3K27 methyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0046976", "pubmed": [22323599, 30923826], "qualifier": "enables", "term": "histone H3K27 methyltransferase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0046976", "pubmed": [28229514, 30026490], "qualifier": "enables", "term": "histone H3K27 methyltransferase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0046976", "pubmed": 24474760, "qualifier": "enables", "term": "histone H3K27 methyltransferase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0070878", "qualifier": "enables", "term": "primary miRNA binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0106222", "qualifier": "enables", "term": "lncRNA binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0140938", "qualifier": "enables", "term": "histone H3 methyltransferase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0140951", "qualifier": "enables", "term": "histone H3K27 trimethyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990841", "pubmed": 24623306, "qualifier": "enables", "term": "promoter-specific chromatin binding"}]}, "homologene": {"genes": [[7165, 1268848], [7227, 39203], [7955, 768133], [8364, 550047], [9031, 420784], [9544, 709075], [9598, 745437], [9606, 2146], [9615, 475511], [9913, 509106], [10090, 14056], [10116, 312299]], "id": 37926}, "interpro": [{"desc": "SANT/Myb domain", "id": "IPR001005", "short_desc": "SANT/Myb"}, {"desc": "SET domain", "id": "IPR001214", "short_desc": "SET_dom"}, {"desc": "Histone-lysine N-methyltransferase EZH1/EZH2", "id": "IPR021654", "short_desc": "EZH1/EZH2"}, {"desc": "CXC domain", "id": "IPR026489", "short_desc": "CXC_dom"}, {"desc": "Tesmin/TSO1-like CXC domain", "id": "IPR033467", "short_desc": "Tesmin/TSO1-like_CXC"}, {"desc": "Polycomb repressive complex 2 subunit EZH1/EZH2, tri-helical domain", "id": "IPR041343", "short_desc": "PRC2_HTH_1"}, {"desc": "Pre-SET CXC domain", "id": "IPR041355", "short_desc": "Pre-SET_CXC"}, {"desc": "EZH2, SET domain", "id": "IPR044439", "short_desc": "EZH2_SET"}, {"desc": "Histone-lysine N-methyltransferase EZH1/2-like", "id": "IPR045318", "short_desc": "EZH1/2-like"}, {"desc": "SET domain superfamily", "id": "IPR046341", "short_desc": "SET_dom_sf"}, {"desc": "EZH1/2, MCSS domain", "id": "IPR048358", "short_desc": "EZH1/2_MCSS"}], "ipi": ["IPI00171252", "IPI00376787", "IPI00935586", "IPI00945286", "IPI00946998", "IPI00947348", "IPI00947357"], "map_location": "7q36.1", "name": "enhancer of zeste 2 polycomb repressive complex 2 subunit", "other_names": ["enhancer of zeste homolog 2", "histone-lysine N-methyltransferase EZH2", "lysine N-methyltransferase 6"], "pantherdb": {"HGNC": "3527", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "107940", "ortholog_type": "LDO", "panther_family": "PTHR45747", "taxid": 10090, "uniprot_kb": "Q61188"}, {"RGD": "1595860", "ortholog_type": "LDO", "panther_family": "PTHR45747", "taxid": 10116, "uniprot_kb": "B5DFE2"}, {"Ensembl": "ENSGALG00000043399", "ortholog_type": "LDO", "panther_family": "PTHR45747", "taxid": 9031, "uniprot_kb": "A0A1D5PN50"}, {"ZFIN": "ZDB-GENE-050114-1", "ortholog_type": "O", "panther_family": "PTHR45747", "taxid": 7955, "uniprot_kb": "E7FFB7"}, {"ZFIN": "ZDB-GENE-041111-259", "ortholog_type": "LDO", "panther_family": "PTHR45747", "taxid": 7955, "uniprot_kb": "Q08BS4"}, {"WormBase": "WBGene00003220", "ortholog_type": "LDO", "panther_family": "PTHR45747", "taxid": 6239, "uniprot_kb": "O17514"}, {"FlyBase": "FBgn0000629", "ortholog_type": "LDO", "panther_family": "PTHR45747", "taxid": 7227, "uniprot_kb": "P42124"}, {"TAIR": "2196110", "ortholog_type": "O", "panther_family": "PTHR45747", "taxid": 3702, "uniprot_kb": "O65312"}, {"TAIR": "2132178", "ortholog_type": "O", "panther_family": "PTHR45747", "taxid": 3702, "uniprot_kb": "Q9ZSM8"}, {"TAIR": "2005501", "ortholog_type": "LDO", "panther_family": "PTHR45747", "taxid": 3702, "uniprot_kb": "P93831"}], "uniprot_kb": "Q15910"}, "pathway": {"biocarta": {"id": "prc2pathway", "name": "the prc2 complex sets long-term gene silencing through modification of histone tails"}, "kegg": [{"id": "hsa00310", "name": "Lysine degradation - Homo sapiens (human)"}, {"id": "hsa05206", "name": "MicroRNAs in cancer - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1257604", "name": "PIP3 activates AKT signaling"}, {"id": "R-HSA-1257604", "name": "PIP3 activates AKT signaling"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-212165", "name": "Epigenetic regulation of gene expression"}, {"id": "R-HSA-212300", "name": "PRC2 methylates histones and DNA"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-2262752", "name": "Cellular responses to stress"}, {"id": "R-HSA-2559580", "name": "Oxidative Stress Induced Senescence"}, {"id": "R-HSA-2559583", "name": "Cellular Senescence"}, {"id": "R-HSA-3214841", "name": "PKMTs methylate histone lysines"}, {"id": "R-HSA-3247509", "name": "Chromatin modifying enzymes"}, {"id": "R-HSA-4839726", "name": "Chromatin organization"}, {"id": "R-HSA-5617472", "name": "Activation of anterior HOX genes in hindbrain development during early embryogenesis"}, {"id": "R-HSA-5619507", "name": "Activation of HOX genes during differentiation"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-6807070", "name": "PTEN Regulation"}, {"id": "R-HSA-6807070", "name": "PTEN Regulation"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8943724", "name": "Regulation of PTEN gene transcription"}, {"id": "R-HSA-8943724", "name": "Regulation of PTEN gene transcription"}, {"id": "R-HSA-8953750", "name": "Transcriptional Regulation by E2F6"}, {"id": "R-HSA-8953897", "name": "Cellular responses to stimuli"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9609646", "name": "HCMV Infection"}, {"id": "R-HSA-9609690", "name": "HCMV Early Events"}, {"id": "R-HSA-9645723", "name": "Diseases of programmed cell death"}, {"id": "R-HSA-9710421", "name": "Defective pyroptosis"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}], "wikipathways": [{"id": "WP2023", "name": "Cell Differentiation - Index expanded"}, {"id": "WP2369", "name": "Histone Modifications"}, {"id": "WP2853", "name": "Endoderm differentiation"}, {"id": "WP2916", "name": "Interactome of polycomb repressive complex 2 (PRC2)"}, {"id": "WP3584", "name": "MECP2 and Associated Rett Syndrome"}, {"id": "WP4204", "name": "Tumor suppressor activity of SMARCB1"}, {"id": "WP4239", "name": "Epithelial to mesenchymal transition in colorectal cancer"}, {"id": "WP4258", "name": "LncRNA involvement in canonical Wnt signaling and colorectal cancer"}, {"id": "WP4336", "name": "ncRNAs involved in Wnt signaling in hepatocellular carcinoma"}, {"id": "WP4553", "name": "FBXL10 enhancement of MAP-ERK signaling in diffuse large B-cell lymphoma"}]}, "pdb": ["4MI0", "4MI5", "5GSA", "5H14", "5H15", "5H17", "5H19", "5H24", "5H25", "5HYN", "5IJ7", "5IJ8", "5LS6", "5U5T", "5U62", "5WG6", "5WUK", "6C23", "6C24", "6LO2", "6P5L", "6U4Y", "6WKR", "7AT8", "7QJG", "7QJU", "7QK4", "8FYH"], "pfam": ["PF00856", "PF11616", "PF18118", "PF18264", "PF21358"], "pharmgkb": "PA27939", "pharos": {"target_id": 17250, "tdl": "Tclin"}, "pir": "G02838", "prosite": ["PS50280", "PS51633"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF221115", "relationship": "is"}, {"id": "GNF249147", "relationship": "is"}, {"id": "GNF249148", "relationship": "is"}, {"id": "GNF249149", "relationship": "is"}, {"id": "GNF249150", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF163418", "relationship": "is"}, "GNF_hs-Origene": [{"id": "GNF035796", "relationship": "is"}, {"id": "GNF037026", "relationship": "is"}, {"id": "GNF043809", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082137", "relationship": "is"}, {"id": "GNF082138", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053081", "relationship": "is"}, {"id": "GNF057848", "relationship": "is"}, {"id": "GNF072994", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF062261", "relationship": "is"}, {"id": "GNF062262", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF004314", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF234225", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF101518", "relationship": "is"}, {"id": "GNF141173", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000007.14", "NC_060931.1", "NG_032043.1"], "protein": ["NP_001190176.1", "NP_001190177.1", "NP_001190178.1", "NP_004447.2", "NP_694543.1", "XP_005250019.1", "XP_005250020.1", "XP_005250021.1", "XP_011514185.1", "XP_011514187.1", "XP_011514189.1", "XP_011514191.1", "XP_011514192.1", "XP_011514194.1", "XP_011514195.1", "XP_011514196.1", "XP_011514197.1", "XP_011514198.1", "XP_011514201.1", "XP_011514203.1", "XP_016867306.1", "XP_016867308.1", "XP_016867309.1", "XP_047275945.1", "XP_047275946.1", "XP_047275947.1", "XP_047275948.1", "XP_047275949.1", "XP_047275950.1", "XP_047275951.1", "XP_047275952.1", "XP_047275953.1", "XP_047275954.1", "XP_047275955.1", "XP_047275956.1", "XP_047275957.1", "XP_047275958.1", "XP_047275960.1", "XP_047275961.1", "XP_047275962.1", "XP_047275963.1", "XP_047275964.1", "XP_047275965.1", "XP_054213455.1", "XP_054213456.1", "XP_054213457.1", "XP_054213458.1", "XP_054213459.1", "XP_054213460.1", "XP_054213461.1", "XP_054213462.1", "XP_054213463.1", "XP_054213464.1", "XP_054213465.1", "XP_054213466.1", "XP_054213467.1", "XP_054213468.1", "XP_054213469.1", "XP_054213470.1", "XP_054213471.1", "XP_054213472.1", "XP_054213473.1", "XP_054213474.1", "XP_054213475.1", "XP_054213476.1", "XP_054213477.1", "XP_054213478.1", "XP_054213479.1", "XP_054213480.1", "XP_054213481.1", "XP_054213482.1", "XP_054213483.1", "XP_054213484.1", "XP_054213485.1", "XP_054213486.1", "XP_054213487.1", "XP_054213488.1", "XP_054213489.1", "XP_054213490.1", "XP_054213491.1"], "rna": ["NM_001203247.2", "NM_001203248.2", "NM_001203249.2", "NM_004456.5", "NM_152998.3", "XM_005249962.5", "XM_005249963.5", "XM_005249964.5", "XM_011515883.3", "XM_011515885.3", "XM_011515887.4", "XM_011515889.3", "XM_011515890.3", "XM_011515892.3", "XM_011515893.3", "XM_011515894.3", "XM_011515895.3", "XM_011515896.3", "XM_011515899.4", "XM_011515901.4", "XM_017011817.3", "XM_017011819.2", "XM_017011820.3", "XM_047419989.1", "XM_047419990.1", "XM_047419991.1", "XM_047419992.1", "XM_047419993.1", "XM_047419994.1", "XM_047419995.1", "XM_047419996.1", "XM_047419997.1", "XM_047419998.1", "XM_047419999.1", "XM_047420000.1", "XM_047420001.1", "XM_047420002.1", "XM_047420004.1", "XM_047420005.1", "XM_047420006.1", "XM_047420007.1", "XM_047420008.1", "XM_047420009.1", "XM_054357480.1", "XM_054357481.1", "XM_054357482.1", "XM_054357483.1", "XM_054357484.1", "XM_054357485.1", "XM_054357486.1", "XM_054357487.1", "XM_054357488.1", "XM_054357489.1", "XM_054357490.1", "XM_054357491.1", "XM_054357492.1", "XM_054357493.1", "XM_054357494.1", "XM_054357495.1", "XM_054357496.1", "XM_054357497.1", "XM_054357498.1", "XM_054357499.1", "XM_054357500.1", "XM_054357501.1", "XM_054357502.1", "XM_054357503.1", "XM_054357504.1", "XM_054357505.1", "XM_054357506.1", "XM_054357507.1", "XM_054357508.1", "XM_054357509.1", "XM_054357510.1", "XM_054357511.1", "XM_054357512.1", "XM_054357513.1", "XM_054357514.1", "XM_054357515.1", "XM_054357516.1"], "translation": [{"protein": "XP_047275954.1", "rna": "XM_047419998.1"}, {"protein": "XP_016867306.1", "rna": "XM_017011817.3"}, {"protein": "XP_054213462.1", "rna": "XM_054357487.1"}, {"protein": "XP_054213478.1", "rna": "XM_054357503.1"}, {"protein": "XP_047275950.1", "rna": "XM_047419994.1"}, {"protein": "XP_011514203.1", "rna": "XM_011515901.4"}, {"protein": "XP_011514198.1", "rna": "XM_011515896.3"}, {"protein": "XP_047275948.1", "rna": "XM_047419992.1"}, {"protein": "XP_047275956.1", "rna": "XM_047420000.1"}, {"protein": "XP_011514191.1", "rna": "XM_011515889.3"}, {"protein": "XP_054213465.1", "rna": "XM_054357490.1"}, {"protein": "XP_054213466.1", "rna": "XM_054357491.1"}, {"protein": "XP_054213456.1", "rna": "XM_054357481.1"}, {"protein": "XP_016867309.1", "rna": "XM_017011820.3"}, {"protein": "XP_054213476.1", "rna": "XM_054357501.1"}, {"protein": "XP_054213482.1", "rna": "XM_054357507.1"}, {"protein": "NP_694543.1", "rna": "NM_152998.3"}, {"protein": "XP_047275953.1", "rna": "XM_047419997.1"}, {"protein": "XP_047275962.1", "rna": "XM_047420006.1"}, {"protein": "XP_054213468.1", "rna": "XM_054357493.1"}, {"protein": "XP_047275946.1", "rna": "XM_047419990.1"}, {"protein": "XP_054213457.1", "rna": "XM_054357482.1"}, {"protein": "XP_011514197.1", "rna": "XM_011515895.3"}, {"protein": "XP_054213473.1", "rna": "XM_054357498.1"}, {"protein": "XP_047275945.1", "rna": "XM_047419989.1"}, {"protein": "XP_011514185.1", "rna": "XM_011515883.3"}, {"protein": "XP_054213491.1", "rna": "XM_054357516.1"}, {"protein": "XP_047275957.1", "rna": "XM_047420001.1"}, {"protein": "XP_054213485.1", "rna": "XM_054357510.1"}, {"protein": "XP_047275960.1", "rna": "XM_047420004.1"}, {"protein": "XP_011514192.1", "rna": "XM_011515890.3"}, {"protein": "XP_011514194.1", "rna": "XM_011515892.3"}, {"protein": "XP_054213490.1", "rna": "XM_054357515.1"}, {"protein": "XP_011514201.1", "rna": "XM_011515899.4"}, {"protein": "XP_047275958.1", "rna": "XM_047420002.1"}, {"protein": "XP_047275961.1", "rna": "XM_047420005.1"}, {"protein": "XP_054213475.1", "rna": "XM_054357500.1"}, {"protein": "XP_047275949.1", "rna": "XM_047419993.1"}, {"protein": "XP_054213460.1", "rna": "XM_054357485.1"}, {"protein": "XP_054213484.1", "rna": "XM_054357509.1"}, {"protein": "XP_005250021.1", "rna": "XM_005249964.5"}, {"protein": "XP_011514189.1", "rna": "XM_011515887.4"}, {"protein": "XP_054213487.1", "rna": "XM_054357512.1"}, {"protein": "XP_054213483.1", "rna": "XM_054357508.1"}, {"protein": "XP_054213469.1", "rna": "XM_054357494.1"}, {"protein": "XP_011514195.1", "rna": "XM_011515893.3"}, {"protein": "XP_054213472.1", "rna": "XM_054357497.1"}, {"protein": "XP_054213480.1", "rna": "XM_054357505.1"}, {"protein": "XP_054213479.1", "rna": "XM_054357504.1"}, {"protein": "NP_001190177.1", "rna": "NM_001203248.2"}, {"protein": "XP_047275965.1", "rna": "XM_047420009.1"}, {"protein": "XP_011514187.1", "rna": "XM_011515885.3"}, {"protein": "XP_047275955.1", "rna": "XM_047419999.1"}, {"protein": "XP_005250020.1", "rna": "XM_005249963.5"}, {"protein": "XP_054213464.1", "rna": "XM_054357489.1"}, {"protein": "XP_054213461.1", "rna": "XM_054357486.1"}, {"protein": "NP_001190176.1", "rna": "NM_001203247.2"}, {"protein": "NP_001190178.1", "rna": "NM_001203249.2"}, {"protein": "XP_054213455.1", "rna": "XM_054357480.1"}, {"protein": "XP_054213458.1", "rna": "XM_054357483.1"}, {"protein": "XP_047275963.1", "rna": "XM_047420007.1"}, {"protein": "XP_054213471.1", "rna": "XM_054357496.1"}, {"protein": "XP_005250019.1", "rna": "XM_005249962.5"}, {"protein": "XP_054213489.1", "rna": "XM_054357514.1"}, {"protein": "XP_054213486.1", "rna": "XM_054357511.1"}, {"protein": "XP_047275952.1", "rna": "XM_047419996.1"}, {"protein": "NP_004447.2", "rna": "NM_004456.5"}, {"protein": "XP_011514196.1", "rna": "XM_011515894.3"}, {"protein": "XP_054213474.1", "rna": "XM_054357499.1"}, {"protein": "XP_054213477.1", "rna": "XM_054357502.1"}, {"protein": "XP_054213488.1", "rna": "XM_054357513.1"}, {"protein": "XP_047275947.1", "rna": "XM_047419991.1"}, {"protein": "XP_054213467.1", "rna": "XM_054357492.1"}, {"protein": "XP_054213459.1", "rna": "XM_054357484.1"}, {"protein": "XP_054213463.1", "rna": "XM_054357488.1"}, {"protein": "XP_054213470.1", "rna": "XM_054357495.1"}, {"protein": "XP_016867308.1", "rna": "XM_017011819.2"}, {"protein": "XP_047275951.1", "rna": "XM_047419995.1"}, {"protein": "XP_047275964.1", "rna": "XM_047420008.1"}, {"protein": "XP_054213481.1", "rna": "XM_054357506.1"}]}, "reporter": {"HG-U133_Plus_2": "203358_s_at", "HG-U95Av2": "37305_at", "HTA-2_0": "TC07001993.hg.1", "HuEx-1_0": ["3078348", "3919610"], "HuGene-1_1": "8143663", "HuGene-2_1": "17064105"}, "retired": [136049, 392834], "summary": "This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Multiple alternatively splcied transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Feb 2011].", "symbol": "EZH2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1333368"}, "unigene": ["Hs.732308", "Hs.444082"], "uniprot": {"Swiss-Prot": "Q15910", "TrEMBL": ["A0A090N8E9", "S4S3R8", "G3XAL2", "A0A804HLB8", "A0A804HJH1", "E9PDH6"]}, "wikipedia": {"url_stub": "EZH2"}}